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Purpose. Oral delivery of peptide and protein drugs to fish has potential advantages to 
the aquaculture industry. However, the bioavailability of proteins and peptides from the 
intestinal tract is very low. This can be attributed inpart to the extensive lumenal and 
mucosa! proteolytic activities of the intestine. In this study the metabolic activities of the 
Quinnat salmon (Oncorhynchus tshawytscha) intestinal tract towards bovine serum 
albumin (BSA), human (hLHRH) and salmon (sLHRH) luteinizing-hormone releasing 
hormones were investigated. To overcome this metabolic barrier a number of proteolytic 
inhibitors were investigated to stabilise the protein and peptides drugs in the intestine, 
improving their opportunity for absorption across the salmon intestine. 
Methods. The extent of BSA degradation was determined by the formation of acid 
soluble peptides from BSA, measured by the method of Lowry. The metabolic stability 
hLHRH and sLHRH were determined using a capillary electrophoresis (CE) assay. 
Binding of proteins and proteolytic substrates to the polyacrylic acid, specifically 
Carbopol ® 934P (CP934P), was studied by centrifugal filtration. Gel filtration and 
reverse phase HPLC was used to determine the stability of trypsin in the presence of 
CP934P. 
Results. The lower intestinal tract of the salmon is divided into three anatomically 
distinct sections: anterior, middle and posterior. The lumenal proteolytic activities of the 
posterior intestinal section towards BSA were approximately half that of the anterior and 
middle sections. The half-lives of the LHRH analogues in the posterior intestinal sections 
were 2-fold longer than for the anterior and middle sections. Intestinal lumenal 
proteolytic activities towards BSA and the LHRH analogues correlated with higher 
activities towards the synthetic substrates of chymotrypsin, trypsin and elastase. LHRH 
analogues were shown to be rapidly hydrolysed by bovine a-chymotrypsin, whereas 
bovine trypsin and porcine elastase hydrolysed the LHRH analogues slowly by 
companson. 
111 
Proteolytic activity of the posterior mucosal homogenates towards BSA was 4-fold higher 
than for the middle mucosal homogenates. LHRH analogues were hydrolysed by the 
posterior mucosal homogenate, whereas in the middle mucosal homogenate they were 
stable. The higher metabolic instability of LHRH analogues in .the poste1ior mucosal 
homogenate correlated with higher chymotryptic-lik:e activity. 
Soybean trypsin inhibitor (SBTI) was the most effective inhibitor, stabilising the LHRH 
analogues against the lumenal proteolytic activity of the intestine and increasing their 
half-lives in the anterior, middle and posterior section between 7.5..: and 15-fold. CP934P 
(0.35% w/v, pH 8.0 at 15°C) increased the half-lives of the LHRH analogues in the 
anterior, middle and posterior sections between 1. 7- and 2. 7-fold. The rates of 
degradation in the presence of CP934P followed pseudo-zero order kinetics, indicating 
that the mechanism of inhibition was not autolysis. 
CP934P (0.35% w/v, pH 7 at 37°C) inhibited the rate of hydrolysis of N-a-benzyol-L-
arginine ethyl ester (BAEE) and hLHRH by trypsin to 34% and 28% of the control 
activity, respectively. CP934P completely stabilised hLHRH in the presence of bovine a-
chymotrypsin. Binding studies showed 68% of the trypsin and 22% of chymotrypsin; 
10% ofBAEE was bound to CP934P, but no LHRH was bound. Lower specific activities 
of the unbound CP934P treated proteases indicate that inactivation of the proteases is also 
occurring. No low molecular weight autolysis products of trypsin could be identified by 
gel filtration. Reverse phase HPLC analysis of the unbound CP934P treated trypsin 
suggests a number of conformational forms of trypsin. The equilibrium binding capacity 
was 30 mg of trypsin to lg of CP934P. 
IV 
Conclusions. Chymotryptic-like activity of the salmon intestinal tract is a major 
metabolic barrier to the oral absorption of the LHRH analogues. The chymotryptic-like 
activities of the intestinal lumen and the intestinal mucosa are most likely due to the 
pancreatic secreted chymotrypsin and the intestinal brush-border membrane protease 
endopeptidase 24.18, respectively. The co-administration of SBTI with LHRH analogues 
in oral formulations could improve the oral absorption ofLHRH analogues in salmon. 
The inhibition of lumenal proteolytic activity by CP934P is the result of enzyme-polymer 
interaction, thereby reducing the free concentration of protease and in part denaturing the 
protease. The posterior intestine of salmon is the most metabolically favourable site for 
the oral delivery of peptides and proteins; however the LHRH analogues will have to 
overcome the higher endopeptidase 24.18 activity present in the posterior mucosa. 
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represents the mean± s.d. of three experiments. 
Figure 4.12 Effect of pH on binding of trypsin (300 µg/ml) to CP934P 
(0.35% w/v) at pH 6.0, 7.0 and 8.0 (Section 4.4.1.6). Each point represents 
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The Food and Agriculture Organisation of the United Nations (1997) believes that the 
increases in world wide demand for fish will be met by the aquaculture industry. It has 
been predicated that by the year 2020 the aquaculture industry will be bigger than the 
worlds entire fisheries (Holmes, 1996). However the farming of fish in high 
concentrations is associated with a number of problems, including poor reproduction and 
disease. With an increased demand for aquaculture there is an associated increase in the 
demand for better methods of peptide and protein of drug delivery to control these 
problems. Much of the research has focused on the delivery of the reproductive hormone 
luteinizing hormone-releasing hormone (LHRH) and its analogues (Van Der Kraak et al., 
1983, Peter et al., 1988, Zohar et al., 1989), growth hormone and various vaccines 
(Austin, 1984). 
Typically these compounds are delivered to fish by injection, implant or dip. However 
these treatments require removal and frequent handling (intensive manipulation) of fish 
which can create sites for bacterial infection and cause stress to fish resulting in loss of 
appetite and poor reproductivity. One strategy to overcome these problems is to 
incorporate the drug into the fish diet. However to achieve sufficient absorption of 
peptide or protein drugs across the intestinal tract a number of barriers have to be 
overcome. This Introduction reviews the barriers to the oral delivery of peptides and 
proteins, in particular those of the teleost fish (fish with bony skeletons) and strategies 
used to improve their oral absorption across the intestinal tract. 
'I 
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1.2 Intestinal barriers 
1.2.1 Biochemical barriers 
Firstly, the metabolic barrier of the intestinal lumen plays an important role in the 
inactivation of the peptide drugs before reaching the systemic circulation. The lumen 
contains proteases secreted from the pancreas and peptidases sloughed off the mucosal 
membrane. The pancreatic proteases include the serine endopeptidases trypsin, 
chymotrypsin and elastase and also the exopeptidases, carboxypeptidases A and B. 
Specificities of these proteases are shown in Table 1.1 (Woodley, 1994). The lumenal 
concentrations of the pancreatic enzymes decrease towards the colon (Layer et al., 1990). 
It is believed that low amounts of pancreatic enzymes in the colon are due to their 
adsorption to the wall of the small intestine and their inactivation during transit, possibly 
by autolysis (Bahe et al., 1986). The proteolytic activity of the colonic contents towards a 
number of proteins is considerably lower than the ileum (Gibson et al., 1989). The major 
proteases present within the colon are believed to be of bacterial origin (Macfarlane et al., 
1988, Gibson et al., 1989). Proteases can be secreted by bacteria or released from the 
cytosol after lysis of the bacterium. Microbial proteases have not been well characterised 
although serine, cysteine and metalloproteases have been identified in the colonic 
.contents of humans (Macfarlane et al., 1988, Gibson et al., 1989). 
Table 1.1 Proteases secreted into the lumen. Specificity is indicated by filled circle. 
Trypsin H2NO-O--o-e±-o-ocooH Arg, Lys 
Chymotrypsin H2NO-~o-e±-o-ocooH Phe, Tyr 
Elastase . H2NO-O--o-e±-o-ocooH Ala, Gly, Ile, Leu, Val 
Carboxypeptidase A H2N0-0-0-0-0-,i,ecooH Tyr, Phe, Ile, Thr, Glu, His, Ala 












Brush-border membranes of the enterocytes contain a number of peptidases (Figure 1.1). 
These peptidases form the second biochemical barrier to peptide absorption. At least 
twelve exo- and endopeptidases have been identified so far in the brush-border 
membranes of mammals (Table 1.2) (Woodley, 1994). The activities of these brush-
border enzymes have been shown to differ along the intestinal tracts of rat, rabbit and 
human (Bai et al., 1995a). · 
Table 1.2 Membrane bound peptidases. Specificity indicated by filled circle 
Aminopeptidase N H2N.±-o-0-o-0-ocooH Many 
Aminopeptidase A H2NJ:-o-o-o-0-0cooH Asp, Glu 
,I, 
Aminopeptidase P H2Ne-O-O-O-O-OcooH Pro 
Aminopeptidase W H2N.±-o-0-0-0-0cooH Trp, Tyr, Phe 
Dipeptidyl peptidase IV H 2NO-e!--0-o-0-0cooH Pro, Ala 
y-glutamyl transpeptidase H2N.Lo-o-o-0-0cooH y-glutamic acid 
Peptidylpeptidase A H2NO-O-O-oi ...... cooH His-Leu 
Carboxypeptidase M H2N0-0-0-o-olecooH Lys, Arg 
Carboxypeptidase P H2N0-0-0-0-olecooH Pro, Gly, Ala 
y-glutamyl carboxypeptidase H2N0-0-0-0-ol.cooH y-glutamic acid 
Endopeptidase-24.11 H2No-o--+e-o-0-0cooH Hydrophobic amino acids 
Endopeptidase-24.18 HzNO-oJ.-!:-0-0-0cooH Aromatic amino acids 
If a peptide is absorbed into the enterocyte cell it can come in contact with cytosolic 
peptidases. The cytosol of the mammalian enterocytes contains 
di- and tri- peptidases (Bai and Amidon, 1992) as well as proteases capable of 
hydrolysing larger peptides (Bai, 1994a and 1995). Peptides that enter the enterocyte by 





contain a large number of peptidases (Barrett and Heath, 1977, Walker, 1981, Marcon-
Genty et al., 1989). The lysosomal peptidases are known as cathepsins; so far eight 
exopeptidases and nine endopeptidases have been identified (Bohley and Seglen, 1992). 
1.2.2 Transport barrier 
Peptides can be absorbed across the epithelial cell surface by a number of routes or 
mechanisms. In general peptides have poor intrinsic permeability across biological 
membranes due to their size, charge, conformation, hydrogen bonding capacity and 
hydrophilic nature (Burton et al., 1991). There are four possible routes or mechanisms for 
the passage of peptides across intestinal mucosa; these are shown schematically in Figure 
1.1. The first three routes are considered transcellular transport since the molecule travels 














Figure 1.1 The putative mechanisms of uptake of proteins and peptides by intestinal 
epithelium. (i) carrier mediated, (ii) receptor mediated or transcytosis, (iii) passive 





i) Membrane carrier systems have been identified which facilitate the absorption of di-
(Cheesman and Parsons, 1974), tri- (Sleisenger et al., 1979) and tetra-peptides (Smithson 
and Gray, 1977) in the mammalian small intestine. A number of studies have shown that 
+ 
peptide transport is Na -dependent and occurs against the concentration gradient, while a 
variety of other studies have shown the transport to be Na+ -independent (Cheeseman and 
Parsons, 1974, Ganapathy et al., 1981). Dipeptides and tripeptides were shown to be 
transported by a proton gradient-energised transport system in brush-border membrane 
vesicles (BBMV) isolated from the rabbit small intestine (Ganapathy and Leibach, 1983). 
ii) Endocytotic uptake can be divided into two processes, pinocytosis, which involves the 
ingestion of fluid and solutes including proteins and peptides via small vesicles(< 150 
nm in diameter) and phagocytosis, which involves the ingestion oflarge particles(> 250 
nm in diameter). 
Specific transepithelial mechanisms which facilitate the uptake of a number of proteins 
including growth factors and immunoglobulins have been identified in the immature 
intestine of humans (Chu and Walker, 1991, Koldovsky et al., 1991). 
In the mature intestine, uitrastructure studies of horseradish peroxidase (HRP) provided 
direct evidence of non-specific transport of proteins through the vesicular compartments 
of the enterocyte (Cornell et al., 1971). It is believed that the macromolecules can enter 
the cell in a non-specific manner by two mechanisms: by binding to the apical membrane 
followed by endocytosis or by being in solution close to the invaginating membrane 
which engulfs the protein in the developing vesicle. Gonnella and Neutra (1984) observed 
that proteins that enter the enterocyte when bound to the apical surface bypass the 
lysosomal system whereas proteins that enter from solution are exposed to the lysosomal 
enzymes within the enterocyte. 
Specialised epithelial cells known as "M" cells have been shown to transport proteins 
such as ferratin (Boclanan and Cooper, 1973) and HRP (Owen, 1977) across the 
:, 
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intestinal epithelium. The proteins are incorporated into membrane compartments, 
transferred across the cell, and extruded from the serosal surface into the interstitium 
containing lymphoid cells (Owen, 1977). 
iii) Passive diffusion of a peptide will depend on its ability to be incorporated into and 
diffuse through the lipid bilayer matrix of the membrane. Hydrophobicity of the molecule 
has been shown to be a good predictor of passive diffusion across cell membranes (Smith 
et al., 1975, Leo et al., 1977, Artursson, 1990, Artursson and Karlsson, 1991). Banks and 
Kastin (1985) showed that the flux of peptides across the blood-brain barrier can be 
related to its partitioning behavior between n-octanol and water, which is a measure of 
hydrophobicity. However, in vitro studies using human intestinal Caco-2 cell monolayers 
showed that the desolvation energy (hydrogen bond potential) required to break the 
hydrogen bonds in the lumenal fluid limits the entry of the peptide into the membrane 
(Conradi et al., 1991). This relationship was extended to in vivo studies which also 
showed that the absorption was inversely correlated to the number of calculated hydrogen 
bonding sites for model peptides (Karls et al., 1991). 
iv) The paracellular route involves diffusion through the extracellular space between 
adjacent enterocytes. Tight junctions are the rate-limiting barriers that restrict flow 
through the paracellular pathway (Powell, 1981 ). The calculated pore radius of the 
intestinal tight junction is 5 nm (Pappenheimer, 1987, Pappenheimer and Reiss, 1987). 
Results with hamster intestine suggest that polypeptides of 11 amino acids long 
(MW 1900) can cross via the tight junctions but for larger macromolecules such as HRP 
(MW 40 000) this transport route is not possible under the same physiological conditions 
(Atisook and Madara, 1991). This route has two main advantages over the transcellular 
route; the peptide avoids biochemical barriers of the enterocytes and the absorption of the 
peptide is not limited by its desolvation energy (Conradi et al., 1991). 
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1.2.3 P-glycoprotein efflux pump 
Drugs absorbed from the intestine may be secreted back into the intestinal lumen by a 
P-glycoprotein efflux carrier system present in the brush border membranes of 
enterocytes and colonocytes (Thietbaut et al., 1987, Burton et al., 1993, Fricker et al., 
1996). The P-glycoprotein efflux carrier system was shown to be saturable and ATP 
dependent. Burton et al. (1993) showed for the first time the participation of 
P-glycoprotein efflux system in the active resistance to peptide transport in Caco-2 cells. 
The transport of the model peptide AcPhe(NMPhe)2NH2 in the basolateral to apical 
direction was greater than the apical to basolateral direction in Caco-2 cell monolayers. 
The basolateral transport was reduced in the presence of the P-glycoprotein inhibitor 
verapamil. Burton et al. (1993) speculated that P-glycoprotein may present an additional 
barrier to the non-specific intestinal absorption of peptides. Other studies have shown 
peptides to be substrates for the P-glycoprotein (Toppmeyer et al., 1994, Lang et al., 
1997); however the importance of the P-glycoprotein transport system in the intestinal 








1.3 Strategies to improve peptide and protein delivery 
1.3.1 Protease inhibitors 
Protease inhibitors should 1mprove the oral absorption of therapeutic peptides and 
proteins by reducing their proteolytic breakdown in the intestinal tract. A number of 
investigators have attempted to enhance the oral delivery of peptides and proteins by 
using protease inhibitors, notably the pancreatic protease inhibitors. 
1.3.1.1 Serine protease inhibitors 
~ 
Aprotinin (MW 6 500) has inhibitory activity towards both trypsin and chymotrypsin 
(Kassell et al., 1965). A number of investigators have shown that the co-administration of 
this inhibitor with peptide has improved the absorption of the peptide across the intestine. 
Co-administration of aprotinin with insulin and sodium salicylate (an enhancer) 
potentiated the amount of insulin absorbed across the colon of the rat (Nishiata et al., 
1983). Aprotinin and sodium cholate (an enhancer) improved the absorption of intact 
insulin across the ileal intestine of rat 200-fold (Ziv et al., 1986). No damage to the 
intestine was observed by the presence of sodium cholate and aprotinin in the intestinal 
lmnen. The inclusion of aprotinin in insulin-containing capsules also increased the 
absorption of insulin across the colon of pigs (Elias et al., 1992). 
Two serine protease inhibitors have been isolated from soybean, Kuntiz inhibitor, 
MW 22 000 (Kruntiz, 1947) and the Bowman-Birk type inhibitor (MW 7 975) (Seidl and 
Liener, 1972). Kuntiz type inhibitor is known as a strong inhibitor of bovine trypsin and 
weak inhibitor of bovine chymotrypsin, while the Bowman-Birk type inhibitor is a strong 
inhibitor of both serine proteases. Kidron et al. (1982) observed that the direct injection 
of insulin into the rat ileal lumen only .resulted in significant lowering of blood glucose 
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1.3.1.2 Low molecular weight peptidase inhibitors 
There are peptidases present in the intestine which have a large number of specificities 
(Tables 1.1 & 1.2). A number of compounds have been shown to have specific inhibitory 
activity towards these peptidases in vitro (Table 1.3). A major limitation is that a number 
of these low molecular weight inhibitors including elastinal and bestatin can cause 
systemic side effects when given orally (Yagi et al., 1980, Ito et al., 1983) . 
In vitro studies showed that thiorphan inhibited 85% of the hydrolytic activity of rat 
intestinal brush-borders membranes towards an anti AIDS octapeptide drug (Su and 
Amidon, 1995), however the effect of this inhibitor on improving oral bioavailability of 
the octapeptide was not tested. 
Puromycin and bestatin (0.5 mM) both protected metkephamid from proteolytic 
degradation in the perfused small intestine ofrat (Taki et al., 1995). However only 
puromycin significantly improved the absorption of metkephamid across the small 
intestine. It was suggested that puromycin is able to diffuse into the intestinal cell with 
metkephamid protecting it from proteolytic attack during permeation across the cell. 
Table 1.3 Specificity oflow molecular weight peptidase inhibitors. 
Inhibitor Specific inhibitory activity Reference 
Bestatin leucine aminopeptidase, Suda et al. (1976) 
aminopeptidase B, and 
aminopeptidase N 
Amastatin aminopeptidase A and leucine Aoyagi et al. (1978) 
aminopeptidase 
Puromycin aminopeptidase B aiid N Taki et al. (1995) 
Elastinal elastase Umezawa et al. (1973) 




1.3.1.3 Bile salts 
In vitro experiments have shown bile salts inhibit proteolytic enzymes of the intestinal 
lumen (Bai et al., 1995b) and mucosa in mammals (Yamamoto et al., 1990, Bai, 1994a). 
Bile salts are amphipathic compounds and therefore at a certain concentration they self 
associate to form micelles. This concentration is known as the critical micelle 
concentration (CMC). The CMC of a molecule can change depending on the solution pH, 
temperature, counter ion and electrolyte concentration (Florence and Attwood, 1998). 
Roda et al. (1990) reported the CMCs of deoxycholic, glycocholic, glycodeoxycholic and 
taurocholic acids in deionised water to be 10, 12, 6, and 10 mM respectively, while in 
150 mM sodium chloride the respective CMCs were 3, 10, 2 and 6 mM. 
Deoxycholate at 25 mM was shown to be more effective than the enzyme inhibitors 
aprotinin (0.015 mM) or p-.chloromercuriphenylsulfonic acid (0.05 mM) in protecting 
insulin and proinsulin from the proteolytic activity of the ileal and rectal mucosa! 
homogenates of rabbits (Yamamoto et al., 1990). Glycocholate at 20 mM also inhibited 
the degradation of the peptide ebiratide in the intestinal lumen and mucosal homogenates 
ofrat (Okagawa et al., 1994). The mechanism of enzyme inhibition by bile salts above 
the CMC may be due to the entrapment the protein or peptide protecting it from the 
proteolytic enzymes (Lee et al., 1991). However, studies at high concentrations ofbiie 
salt(> 5 mM) have resulted in permanent damage to the intestinal cells (Mekhjian and 
Phillips, 1970). Damage of cells is believed to be due to the detergent characteristics ~f 
bile salt molecules (Shiau, 1981, Lester et al., 1983). 
The mechanism of enzyme inhibition by bile salts at concentrations below CMC is not 
well understood. Bile salts at 2 mM are able to inhibit the insulin degrading activity by 
lumenal contents of the colon of rats. Glycodeoxycholate, deoxycholate and 
taurodeoxycholate were described as weak to moderate inhibitors, inhibiting insulin 
degrading activity by 36, 24 and 20% of the control activity, respectively (Bai et al., 
1995b). Interestingly, taurocholate and glycocholate at 2 mM were not effective 








Bile salts at 2 mM have also been shown to inhibit the proteolytic activities of the rat 
intestinal brush-border peptidases (Bai, 1994a). Bile salts sodium deoxycholate and 
sodium glycodeoxycholate, inhibited endopeptidase-24.11 by 17 and 29% of the control 
activity. Endopeptidase-2 was inhibited by sodium glycocholate (20%), sodium 
taurocholate (47%) and sodium taurodeoxycholate (41 %). Dipeptidyl peptidase IV was 
inhibited by sodium taurocholate (32%) and sodium taurodeoxycholate (19%), and 
carboxypepitdase P was inhibited by sodium deoxycholate (50%) and sodium 
taurodeoxycholate (57%). No bile salts inhibited the activity of aminopeptidases W 
andP. 
Since endopeptidase 24.11 and endopeptidase-2 have similar substrate specificities and 
are inhibited by different bile salts, enzyme inhibition cannot be due to competition 
between substrate and bile salt for the substrate binding site (Bai, 1994a). The author 
speculated that bile salts at concentrations below their CMC bind to the enzymes 
resulting in conformational changes to the three-dimensional protein structure rendering it 
inactive. Previously, Milov et al. (1992) showed bile salts bind at 3 to 6 sites on human 
carbonic anhydrase I and II, resulting in conformational changes and inhibition of 
enzymatic activity. 
1.3.1.4 Chelating agents 
Complexing agents inhibit enzymes by sequestering divalent cations from the enzyme 
structure. Divalent cations are co-factors important for the maintenance of the protein 
structure required for their activity. Zinc requiring enzymes such as carboxypeptidase A, 
Band aminopeptidase N are effectively inhibited by complexing agents such as EDTA 
(Ikesue et al., 1993, Bernkop-Schnilrch and Krajicek, 1998). 
EDTA improved the stability of the neuroleptic peptide, Des-enkephalin-y-endorphin in 
the rectal lumen and ligated colon of rat (van Hoogdalem et al., 1989). However EDTA 
was only effective in improving oral bioavailability of the peptide in the presence of a 









Bacitracin, a cyclic dodecapeptide (MW 1423) obtained from Bacillus licheniformis 
inhibits the activity of aminopeptidase N by chelation of Zn2+ from the enzyme . 
(Sangadala et al., 1994). In situ experiments showed bacitracin to be more effective than 
soybean trypsin inhibitor and aprotinin in promoting the absorption of biologically active 
insulin across the large intestine of rat (Yamamoto et al., 1994). However, bacitracin was 
ineffective in promoting absorption of biologically active insulin in the small intestine of 
rat. 
Since the effect of chelating agents depends on the relative affinity of chelator and 
enzyme for the divalent ion, not all enzymes requiring divalent cations for their stability 
are inhibited by chelating agents. Binding of calcium to trypsin has been shown to 
increase the stability of trypsin against autolysis (Bode and Schwager, 1975). However 
incubation ofEDTA with trypsin had no effect on the enzymatic activity of trypsin 
(Russin et al., 1974, Lue.Ben et al., 1996, Bernkop-Schnurch and Krajicek, 1998). Russin 
et al. (1974) showed that EDTA reduced the autolytic stability of bacterial trypsin only in 
the presence of 8 M urea. This suggests that the calcium is tightly bound and only 
accessible to chelation by EDTA after some relaxation of the protein conformation . 
1.3.1.5 Mucoadhesive polymer$ 
Polymers of acrylic acid have been shown to inhibit a broad range of proteolytic enzymes 
of the gastrointestinal tract in vitro (Bai et al., 1995b, Lue.Ben et al., 1996c). These 
polymers are used in oral formulations for their mucoadhesive properties (Gu et al., 1988, 
Harris et al., 1990). The inhibitory activity of these polymers was first observed when 
dispersions of polycarbophil (1 % w/v) completely inhibited the proteolytic degradation of 
9-desglycinamide, 8-arginine vasopressin by the mucosal homogenate of rat (Lehr et al., 
1992a). Junginger and co-workers further demonstrated that the acrylic acid polymers, 
polycarbophil and Carbopol 934P were able to inhibit a large range oflumenal 
proteolytic enzymes including: trypsin, a-chymotrypsin, carboxypeptidase A and 






rat (LueBen et al., 1996a). It was postulated that the inhibitory effect of these polymers is 
based on their ability to complex essential divalent ions from the enzyme structure 
(Lue13en et al., 1995). 
It has also been suggested that inhibition of proteases by polyacrylic acid was dependent 
on the polymers ability to reduce the local pH below the optimum pH for the proteolytic 
activity (Bai et al., 1995b). Polyacrylic acids, including Carbopol 974P, 971P and 934P 
were shown to inhibit the hydrolysis of insulin, calcitonin and insulin-like growth factor 
by trypsin, chymotrypsin and microbial proteases of the rat colon (Bai et al., 1995b). The 
degree of inhibition correlated with the ability of the polyacrylic acid to lower the pH in 
vitro (Bai et al., 1995b). 
These polymers offer a number of advantages over other protease inhibitors. Polyacrylic 
acids are not absorbed across the intestinal wall and therefore are not likely to have 
systemic toxicity. They have inhibitory activity towards a broad range of enzymes 
including those of the lumen and the brush borders.Also having mucoadhesive 
properties, the inhibitory activity of the polymer may be localised. 
More recently, Bernkop-Schnilrch and co-workers have developed several mucoadhesive 
polymer-inhibitor conjugates that protect co-administered peptides from specific 
proteolytic attack, for review Bernkop-Schniirch (1998. The immobilization of protease 
inhibitors on mucoadhesive polymers offers several potential advantages. Conjugated 
inhibitors will not reach the systemic circulation and the mucoadhesive properties of the 
polymers will provide intimate and prolonged contact of the inhibitor to the adsorbing 
intestinal membrane. 
Chymotryptic inhibitors, chymostatin- and soybean trypsin inhibitor (Bowman-Birk) 
were conjugated to polyacrylic acid (Carbopol 940). The soybean trypsin inhibitor -
polymer conjugate was 17% more effective in the inhibition of chymotrypsin than the 












trypsin inhibitor - polymer conjugate was 35% lower than the unmodified polymer and 
the chymostatin - polymer conjugate (Bernkop-Schniirch and Apprich, 1997). 
The aminopeptidase inhibitor, bacitracin was conjugated to Carbopol 940 and had greater 
inhibitory effect on aminopeptidase activity compared to the unconjugated bacitracin 
(Bernkop-Schriurch and Marschtitz, 1997). However, in this study it was also observed 
that the neutralised Carbopol 940P inhibited the activity of aminopeptidase N, but weakly 
by comparison. 
EDTA was covalently attached to chitosan, Carbopol 934P and polycarbophil (Bernkop-
Schntirch and Krajicek, 1998). Chitosan-EDTA conjugates had the strongest inhibitory 
effect on carboxypeptidase A and aminopeptidase N. The chitosan-EDTA conjugate 
exhibited the highest affinity and lowest capacity for both calcium and zinc, suggesting 
binding affinity for divalent ions to be a more important parameter in enzyme inhibition. 
1.3.2 Permeation enhancers 
Penetration enhancers improve oral absorption by their action on the transcellular and/or 
paracellular transport routes (Figure 1.1 ). The two main classes of permeation enhancers 
are chelating agents and detergents. Most permeation enhancers are detergents including 
bile salts, sodium dodecyl sulfate and Triton X-100. It is believed that their detergent 
properties alter the membrane lipid organisation, increasing transport via the transcellular 
route. Chelating agents effect the paracellular pathway by disrupting the integrity of 
occluding junctional complexes by chelating calcium or magnesium from the tight 
junctions (Tindall, 1964, Gumbiner, 1987). There is an enormous literature on 
enhancement of drug permeability across the intestinal tract. It is beyond the scope of this 
introduction to review it all but recent reviews include Aungst (1993) and Sayani and 
Chein (1996). 
Numerous studies have shown that bile salts improve the absorption of peptides and 
proteins across the intestinal tract (Ziv et al., 1981, Kidron et al., 1982). Model 
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membrane studies have shown bile salts at low concentration (below the CMC) increase 
bilayer permeability, however at higher concentrations (usually above the CMC) bile salts 
cause disruption to the bilayer (Walde et al., 1987). Common bile salts can be divided 
into two groups: the dihydroxy- and the trihydroxy-bile salts such as deoxycholate (DOC) 
and cholate, respectively. The dihydroxy-bile salts have been found to be more effective 
absorption enhancers than the tri - hydroxy bile salts ( Chadwick et al., 1979, Ziv et al., 
1983); however the dihydroxy-bile salts are more damaging morphologically (Teem and 
Philips, 1972, Chadwick et al., 1979). Direct injection of insulin with 2 mg of either 
cholate or DOC into the colon promoted absorption of insulin across the intestinal 
epithelium in :q_ormal and diabetic rats (Kidron et al., 1982). DOC was shown to be more 
effective than the trihydroxy cholate in promoting insulin absorption (Kidron et al., 
1982). 
Chelating agent, citric acid has been reported to enhance the membrane absorption of 
heparin (Sue et al., 1976) and LHRH (Okada et al., 1982). Citric acid was shown to act as 
a permeation enhancer at concentrations as low as 0.1 mM in Caco-2 cell monolayers 
(Cho et al., 1989). EDTA increased the permeation of thyrotropin-releasing hormone and 
Met-enkephalin analogues across Caco-2 cell monolayers (Lang et al., 1997). 
Acrylic acid polymers have been shown to increase the permeation of peptides via the 
paracellular route (Lue13en et al., 1994). Junginger and co-workers reported that 
polyacrylic acids reduced the trans epithelium electrical resistance (TEER) of Caco-2 cell 
monolayers; which suggested opening of the tight junctions. Junginger and co-workers 
postulated that the polyacrylic acids disrupted the integrity of the tight junctions by 
chelating calcium from the tight junctions (Lue13en et al., 1994, Borchard et al., 1996). 
However the opening of the tight junctions to the paracellular transport of FITC-dextran 
(MW 4 400) only occurred at pH 4.0, but not at pH 7.4. It is not known whether the 
paracellular transport is due to the action of the polyacrylic acid or due to the damage of 
cells at the low pH. Only when polyacrylic acid was applied to the basolateral side did the 









previously demonstrated that EDTA i~ more effective in opening tight junctions when 
applied to the basolateral side of Caco-2 monolayers (Noach et al., 1993). 
Chitosan is a linear polycationic polysaccharide composed of poly(2-deoxy-2-amino 
glucan). It was reported to enhance the absorption of insulin and calcitonin across the 
nasal epithelium (Illum et al., 1994). The enhanced absorption of the peptide drugs was 
believed to be due the mucoadhesive properties of the chitosans and the enhancement of 
the paracellular transport route. Application of chitosan to the apical side of Caco-2 cell · 
also increased the permeability of the paracellular transport marker mannitol (Artursson 
et al., 1994 ). The influence of chitosan on transport of the marker molecules was 
strongest when the pH was well below 6.5. At pH 6.0, 4.9, and 4.0 the apparent 
permeability coefficients ofmannitol were 1.7, 2.9, and 4.9 emfs x 107, respectively. As 
chitosan has an average pKa of 6.5, it was postulated that charge density is important for 
enhancement of the intestinal mucosa."Work by Schipper et al. (1996) showed that 
enhancement is dependent on the interaction of positively charged chitosan polymer with 
the negatively charged surface of the epithelial cell membrane. 
Intraduodenal administration of the peptide analogue buserelin in the presence of chitosan 
resulted in a 5-fold increase in its systemic absorption (Lue.Ben et al., 1996b). Chitosan 
was more effective than polyacrylic acids in improving the absorption ofbuserelin. Since 
chitosan did not inhibit trypsin and carboxypeptidase B activity it was concluded that the 
permeation barrier is greater than the metabolic barrier for the oral absorption of 
buserelin. 
In vitro studies by Lue.Ben et al. (1997) demonstrated that chitosan (1 % w/v) was more 
effective than the polyacrylic acid, polycarbophil (1 % w/v) in enhancing the absorption 
of 9-desglycinamide, 8 -arginine vasopressin (DGV AP) across Caco-2 cell monolayers. 
However in the rat vertically perfused intestinal loop, both polymers enhanced the 












DGV AP via the paracellular route whereas polycarbophil enhanced transport by 
protecting the peptide from the metabolic activity of the intestine. 
Chitosan is poorly soluble at neutral and alkaline pH. More recently a water soluble 
derivative of chitosan, N-trimethyl chitosan chloride (TMC) was synthesised (Kotze et 
al., 1997). The N-trimethyl chitosan at pH 7.4 reduced the TEER, presumably by opening 
the tight junctions and enhanced the transport of mannitol, FITC-Dextran 4400 and 
buserelin across the Caco-2 cell monolayers. Kotze et al. (1997) compared the enhancing 
effects of two chitosan salts, hydrochloride and glutamate and TMC at 1.5% (w/v) at pH 
values between 4.4 and 6.2. All chitosans improved the adsorption of peptide drugs 
across Caco-2 cell monolayers. The rank order of effectiveness at 1.5% (w/v) was 
chitosan hydrochloride> chitosan glutamate> TMC. However due to TMCs higher 
solubility, permeation enhancement could be improved by increasing the concentration of 
TMC to 2.5% (w/v) . 
1.3.3 Chemical modification 
Chemical modification of peptides offers a number of advantages, including increased 
potency, resistance to proteolysis and increased in membrane permeability. The modified 
peptide may be active in its own right or active only after regeneration in vivo after 
adsorption. 
The LHRH analogue leuprolide [D-Leu6, Pro6NEt] LHRH, was chemically modified at 
positions 1, 2, or 3 and N-methylated at positions 1, 2, or 4 (Raviv et al., 1992). The 
analogues were tested for receptor binding, LH release from rat pituitary cells, clearance, 
stability towards chymotrypsin and rat intestinal degradation. The analogues illAe-Ser4, 
NMe-Phe2, NAc-Sarl and 1-NaI3 -LHRH showed up to 60-fold increase in stability 
towards chymotrypsin and a 20-fold increase in stability towards intestinal lumenal 
degradation. Several of the analogues showed potency in the range of leuprolide. There 













suggesting a relationship between clearance and hydrophobicity, Even though these 
analogues were stabilised against enzymatic degradation there was no significant increase 
in intestinal absorption, indicating that intestinal absorption of these analogues is not 
limited by enzymatic stability. 
Recently, Fujita et al. (1996) improved the intestinal absorption of human calcitonin 
(hCT) by chemical modification with short-chain length fatty acids such as acetic acid 
and caproic acid. The fatty acids were attached to s-amino group ofLys18 • The biological 
activities of the acetyl (Ac-hCT) and caproyl (Cap-hCT) derivatives were approximately 
70% and 40% of the native peptide, respectively. The chemical modification of calcitonin 
with fatty acids improved its lipophilicity and metabolic stability in the intestinal mucosa 
ofrats (Fujita et al., 1996). Chemical modification improved small and large intestine 
absorption of calcitonin from 0.5% to 3.5% and 4.5% for Ac-hCT and Cap-hCT, 
respectively. 
Physiological transport pathways including vitamin B 12 (Russell-Jones, 1998) and bile 
salt (Kramer et al., 1994) have been used to improve transport of peptides across 
biological membranes. Hexa- and heptapeptides ofD-amino acids couple to modified bile 
acids showed a 14-fold increase in adsorption across perfused rat ileum (Kramer et al., 












Formulations of peptide and protein drugs are designed to protect the drug from the 
proteolytic enzymes of the intestinal lumen and/or release the drug at the site of the GI 
tract most favorable for absorption. A number of different formulations have been_ 
investigated to improve the absorption of peptide drugs (Table 1.4). 
Table 1.4 Formulations designed to improve the oral delivery of peptides. 
Delivery system 
liposomes 
polyacrylate-coated soft gelatin 
capsules for targeted delivery to 
the colon 
azopolymer-coated hard gelatin 




polyacrylate gel containg long-











Patel et al. (1982) 
Fukunaga et al. ( 1991) 
Touitou and Rubinstein (1986) 
Saffran et al. (1986) 
Michel et al. (1991) 
Constantinides et al. (1994) 
Morimoto et al. (1983) 
Many investigators have speculated that the colon is a superior region for peptide 
absorption. This is based on the assumption that the overall proteolytic activity of the 
colon is low compared to the small intestine (Saffran et al., 1986, Yamamoto et al., 1994) 
and the greater effectivity of permeation enhancers (Ishizawa et al., 1987, Tomita et al., 
1988). To take advantage of the characteristics of the colon a number of different 
potential formulations have been developed to target the colon (Rubinstein et al., 1997). 
Time-controlled and pH-dependant release dosages have been examined for the specific 
delivery of drugs to different regions of the intestine (Murray and Tucker, 1990, Ashford 










time interval believed to be the time required for the dosage form to reach the colon. The 
pH-dependant dosage forms are dependant on the enteric-coating polymer being stable or 
insoluble in the low pH of the stomach or neutral pH of the small intestine but dissolve at 
the higher pH of the colon. Soft gelatin capsules coated with the pH sensitive acrylic 
polymer (Eudragit RS, Land Sat various ratios) containing insulin were shown to release 
the peptide only above pH 7.0. Oral administration of insulin in these capsules to rats 
resulted in significant drop in blood glucose compared to control (Touitou and 
Rubinstein, 1986). However pH-dependant and time-controlled systems lack reliability 
due to large variations in transit times and pH due to diet, food intake, intestinal mobility 
and disease state (Pozzi et al., 1994, Wilding et al., 1994) . 
Many colonic-specific drug delivery systems rely on enzymes unique to the gut 
microflora to release active agents in the colon (Rubinstein et al., 1997). 
Polysaccharidases and azoreductases are the two main classes of enzymes that are 
produced by colon microflora considered reproducible enough to exploit in drug targeting 
(Ashford and Fell, 1994). The most original work in this area was by Saffran and co-
workers (Saffran et al., 1986, Saffran et al., 1990). Solid dosage forms of the peptide 
drug were coated with polymers cross-linked with azo-bonds, which are degraded by the 
indigenous microflora of the colon. A sustained pharmacological response for insulin was 
observed when the coated delivery systems were orally administered to rats. It was 
proposed that once the polypeptide reached the colon the indigenous micro flora reduced 
the azo bonds, thus breaking the cross-links and releasing the polypeptide for absorption. 
Tozaki et al. (1997) demonstrated that chitosan capsules were stable in the stomach and 
the small intestine and were degraded specifically by microorganisms in the rat colon. 
The mechanism by which the chitosan capsules are degraded in rat cecal contents is not 
known. Oral administration of chitosan capsules containing insulin, aprotinin (protease 
inhibitor) and sodium glycocholate ( enhancer) resulted in a significant pharmacological 







Peptides and proteins that are released by formulations at specific sites of the GI tract are 
moved from the site of administration by the cleaning action of the housekeeper wave and 
are hindered from adsorption by the mucus gel on the surface of the intestinal epithelium. 
Polymers which are able to interact with the mucus of the GI tract (mucoadhesives) can 
potentially overcome these problems (Smart et al., 1984, Gu et al., 1988). These 
mucoadhesive polymers have three desirable features for oral drug delivery: prolonging 
residence time at the site of drug absorption, improving contact with the absorbing 
mucosa and localisation in specific regions to improve and enhance the bioavailability of 
the drug. Close contact with the absorbing mucosa might not only promote absorption of 
the drug but could also localise the action of the excipients such as protease inhibitors and 
permeation enhancers present in the formulation. 
The cross-linked polyacrylic acid derivatives polycarbophil (Noveon® AAl, weakly 
crosslinked with divinylglycol) and carbomer (Carbopol®, crosslinked with allyl sucrose) 
have strong mucoadhesive properties (Gu et al., 1988, Harris et al., 1990). Microspheres 
of poly (hydroxyethylmethacrylate) coated with the polycarbophil (Noveon® AAl) or 
Carbopol934 (Carbopol®) were shown to have greater adhesion to pig intestinal mucosa 
than uncoated microspheres in vitro. However, in situ intestinal transit experiments in the 
rat ileum showed that microspheres coated with polycarbophil showed only significant 
mucoadhesive behavior during the first hour of delivery (Junginger et al., 1990). A 
number of other studies have shown that the cross-linked polyacrylic acid derivatives 
improve the absorption of peptides in vivo (Lehr et al., 1992a, Ilan et al., 1996, Baluom et 
al., 1997). However because of their apparent protease inhibitory and mucosal 
permeation enhancement activity (Sections 1.3 .1.5 and 1.3 .2) it is difficult to quantify the 















Chitosan has mucoadhesive properties which are believed to be mediated through ionic 
interaction between positively charged amino groups in chitosan and negatively charged 
sialic acid residues in mucus or on cell surface (Lehr et al., 1992b). Chitosan-coated 
liposomes (CS-liposomes) were shown to have greater adhesiveness to the intestinal 
surface of rat compared to uncoated liposomes (Takeuchi et al., 1996). The oral delivery 
of CS-liposomes containing insulin resulted in a significant drop in blood glucose level in 
rats. When 5 IU of insulin was delivered orally in chitosan-coated liposomes the drop in 
blood glucose was equivalent to only 10% of the biological response observed when the 
formulation was delivered by injection. Oral administration of non-coated liposomes 
resulted in a biological response less than one fifth of the response for CS-liposomes. 
1.4 Oral delivery of peptides and proteins to teleosts 
1.4.1 Digestive tract of gastric teleosts 
In order to achieve oral delivery of peptides an understanding of the anatomy and 
physiology of the intestinal tract is required. A schematic of the gastrointestinal tract of 
the salmon is shown in Figure 1.2. The digestive tract starts with the short oesophagus, 
which joins the J-shape stomach. The stomach has muscular closures at each end, the 
cardiac sphincter anteriorly and the pyloric sphincter (pylorus) posteriorly. Posterior to 
the pylorus is the start of the anterior section of the intestine and adjacent are the hepatic 
and pancreatic ducts which enter into the anterior intestine. At the beginning of the 
anterior section there are clusters of finger like diverticula, called pyloric ceaca. The 
numerous diverticula of the intestine increases the surface area of the intestine. The 
surface area of trout pyloric ceaca was shown to be three times that of the anterior gut and 
twice that of the total intestine (Ezeasor and Stoke, 1980). Bergot et al (1975) referred to 
the pyloric ceaca in rainbow trout as being histologically identical to the anterior 
intestine. The intestinal section posterior to the so-called intestino-rectal valve is 
morphologically distinct from the anterior section. For the purpose of this study the 




intestine which has no pyloric ceaca is further divided into two sections, the middle and 
posterior which are separated by a so-called intestino-rectal valve (Figure 1.2). 
Oesphagus 
~ ~ Intestine ----
Posterior 
.c ~ 
Figure 1.2 Schematic representation of the salmonid gastrointestinal tract. 
Scanning electron microscopy studies in trout showed the different topographical 
characteristics of the ceaca, the intestine (anterior, middle) and the rectal (posterior) 
mucosa (Ezeasor and Stoke, 1980). The surface of the diverticula has numerous parallel 
longitudinal ridges, which are believed to facilitate the passage of food in and out of the 
diverticula. The intestine is covered with numerous short blunt projections, conforming to 
the villi. The villi of the fish intestine appeared thicker and shorter than those described in 
the mammalian intestine. The rectum is deeply folded, the top of the folds are lined by 
non-vacuolated cells, while the sides of the folds have vacuolated cells suggestive of 
protein or other macromolecule uptake by pinocytosis (Ezeasor and Stokoe, 1981). 
The intestinal mucosa ofteleosts is lined with a single layer of columnar epithelium and 
scattered among the epithelial cells are mucus-secreting goblet cells (Fange and Grove, 
1979) (Figure 1.3). Closely following the basal contours of epithelial cells is the basal 
lamina, a narrow band of complex collagen and mucopolysaccharides. Adjacent to the 
basal lamina is the lamina propria, which has a rich supply of blood capillaries (Hinge 
and Grove, 1979, Yasutake and Wales, 1983). Adjacent to the lamina propria is a thin 




two distinct regions known as the stratum compactum and stratum granulosum. The 
stratum granulosum layer is infiltrated by eosinophilic granular cells (EGC). The 
muscularis layer is formed by inner circular and outer longitudinal muscles and is 
surrounded by a serous membrane, composed of simple flat endothelium and a layer of 
loose connective tissue (tella subserosa) (Takashima and Hibiya, 1995). 
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Figure 1.3 Transverse section (200 X) of the wall of the posterior intestine of a salmon (Oncorhynchus tshawytscha). Mounted sections were 
stained with haematoxylin and eosin: (A) epithelium, (B) goblet cell, (C) lamina propr1a, (D) stratum compactum, (E) stratum granulosum, 













1.4.2 Biochemical barriers of the intestinal tract of teleosts 
1.4.2.1 Lumenal proteases 
Proteolytic digestion in the intestine can occur in the gut lumen, either at the cell 
membrane associated with microvillous-brush border or intra-cellularly in the enterocytes 
as mentioned previously (Section 1.2.1). Enzymes found in the intestinal lumen can 
potentially come from either the pancreas or from epithelial cells released from the gut 
wall; however for fish the lumenal proteases are generally considered to be 
predominantly of pancreatic origin (Yoshinaka et al., 1981). The exocrine pancreas is 
found in the fat tissue diffused around the pyloric ceaca (Anderson and Mitchum, 1974). 
The digestive enzymes secreted form the pancreatic tissue are carried into the anterior 
intestine through a series of ducts. The pancreatic proteases that have been detected in 
pyloric ceaca and the intestine of teleosts include the trypsins, chymotrypsins, elastases, 
carboxypeptidases A and Band aminopeptidases (Fange and Grove, 1979, Cohen et al., 
1981a, Clarke et al., 1985). 
Several isoforms of trypsin have been described for teleosts including Atlantic cod 
(Asgeirsson et al., 1989), sardine (Murakami and Noda, 1981), anchovy (Martinez et al., 
1988), Atlantic salmon and rainbow trout (Torrissen, 1984). Interestingly, trypsin 
enzymes isolated from cold-adapted species such as anchovy (Martinez et al., 1988). 
Atlantic cod (Asgeirsson et al., 1989), and salmon (Taran and Smovdyr, 1992) display 
substantially higher catalytic efficiencies (kcat / ~ 1) than mammalian trypsins. Work by 
Fletcher et al. (1987) on rat anionic and cationic isoforms of trypsin showed that the 
substrate binding sites of the two isoforms had different charge distributions and therefore 
may have different binding preferences for protein substrates. Murakami and Noda 
(1981) isolated two trypsin-like proteases from the pyloric ceaca of sardine, but the 
soybean trypsin inhibitor and trypsin specific inhibitor N-p-tosyl-L-lysine chloromethyl 











Mammalian cationic trypsins have been shown to be stabilized against autolysis in the 
presence of calcium ions (Vithayathil et al., 1961, Walsh, 1970). Trypsin enzymes from 
catfish (Yoshinaka et al., 1984), anchovy (Martinez et al., 1988) and carp (Cohen et al., 
1981a) were also shown to _be dependent upon calcium for their stability and activity. 
However trypsin enzymes from sardine (Murakami and Noda, 1981), capelin 
(Hjelmeland and Raa, 1982) and chum salmon (Uchida et al., 1984a, Uchida et al., 
1984b) were not stabilised by calcium. 
Chymotrypsin or chymotrypsin-like enzymes have been isolated from dogfish (Racicot 
and Hultin, 1987, Asgeirsson and Bjarnason, 1991), carp (Cohen et al., 1981a), Atlantic 
cod (Raae and Walther, 1989) and rainbow trout (Kristjansson and Nielsen, 1992). Many 
properties of these enzymes are similar to those of bovine and porcine chymotrypsins, 
however some important differences have been observed. The chymotrypsins from fish 
were shown to have higher catalytic activities than the bovine enzyme (Cohen et al., 
1981b, Ramakrishna et al., 1987, Racicot and Hultin, 1987, Raae, 1990, Kristjansson and 
Nielsen, 1992). 
Two anionic chymotrypsin-like proteases were isolated from the pyloric ceaca ofrainbow 
trout (Kristjansson and Nielsen, 1992). The catalytic efficiencies (k /K ) of the trout 
cat m 
chymotrypsins I and II against a chymotryptic synthetic substrate were approximately 
4 and 7-fold higher than the bovine enzyme, respectively. The trout chymotrypsins 
hydrolytic activities against casein were 3-fold higher than for the bovine enzyme. Trout 
chymotrypsins also showed different heat-stability to bovine trypsin in the presence and 
absence of calcium, indicating different binding affinities for calcium. The different 
calcium-binding properties of the two trout chymotrypsins indicate some structural 
differences may exist in and around the calcium binding loops of these enzymes. 
Interestingly, fish trypsins and chymotrypsins were shown to be more sensitive to 
soybean trypsin inhibitor (Kuntiz type) compared to mammalian enzymes (Croston, 
1960, Krogdahl and Holm, 1983). 
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The serine protease inhibitor aprotinin is a potent inhibitor of mammalian chymotrypsins 
(Kassell et al., 1965). Two isoforms of chymotrypsin isolated from trout had variable 
behaviour towards the aprotinin inhibitor (Blow, 1971). One isoform was inhibited to 
86% of its control activity while the activity of the second isoform was enhanced in the 
presence of inhibitor, suggesting structural differences in the active sites between the 
isoforms. Aprotinin also had a lower inhibitory activity against cod chymotrypsins 
compared to the bovine enzyme (Asgeirsson and Bjamason, 1991). 
Chymotrypsin-like enzymes of trout (Kristjansson and Nielsen, 1992).and carp (Cohen et 
al., 1981) have been shown to be more active at alkaline pH compared to the bovine 
enzyme. The authors suggest that there are different groups involved in stabilising the 
active site conformation of the fish and the bovine enzyme. Chymotrysin enzymes from 
trout (Kristjansson and Nielsen, 1992), carp (Cohen et al., 1981a), and Atlantic cod (Raae 
and Walther, 1989, Asgeirsson and Bjamason, 1991) were shown to consist of a single 
polypeptide chain. This is in contrasts to bovine a-chymotrypsin, which contains three 
polypeptide chains linked together by disulphide bonds (Blow, 1971). 
Pancreatic elastase has been isoiated from gummy shark, red stingray, rainbow trout, 
carp, eel, bluefin tuna, yellowtail, sea bass and angler, confirming that elastase is an 
important enzyme of digestion in fish (Y oshinaka et al., 1985). In anchovy, Martinez and 
Serra (1989) assayed crude intestinal extracts for different proteolytic activities using 
synthetic substrates. Even though proteolytic enzymes have different catalytic activities 
towards substrates, they speculated that elastase was the dominant digestive enzyme in 
the pyloric ceaca and intestine. 
A pancreatic elastase was purified and characterized from a pancreatic extract of the 
catfish (Yoshinaka et al., 1984). The catfish elastase was found to be a serine proteinase 
and showed a high degree of similarity to porcine pancreatic elastase with respect to pH 




from carp pancreas showed high similarities to the respective bovine and porcine 
enzymes (Cohen et al., 1981). The kinetic properties of carp elastase were also found to 
be similar to the respective rat and porcine enzymes (Cohen et al., 1981b). Inhibition of 
carp elastase by turkey ovomucoid was also similar to porcine elastase (Cohen et al., 
1981b). 
An intestinal elastase purified from Atlantic cod had a catalytic efficiency (kcaJK
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2-fold greater than observed for porcine elastase (Raae and Walther, 1989). The elastase 
had the greatest activity towards the carbonyl side of the alanine residues, but also 
hydrolysed valine and leucine residues. The elastase had low heat stability and towards 
acidic pH compared to porcine elastas~. 
Metalloproteinases are a group of proteases that require Zn2+ for activity. This can be 
demonstrated by the loss of activity on the addition of the bivalent chelators EDTA and 
EGTA. Metalloproteinases have been found in bluefi.n tuna, yellowtail (Yoshinaka et al., 
1985), and catfish (Yoshinaka et al., 1984). Interestingly, the metalloproteinase enzyme 
from catfish hydrolyses the elastase substrates elastin and N-succinyl-Ala-Ala-Ala p-
nitrophenyl ester (Yoshinaka et al., 1984). 
There has been relatively little work characterising fish metalloexopeptidases such as 
carboxypeptidase A and Band aminopeptidases. Using synthetic substrates Martinez and 
Serra (1989) demonstrated relatively low activities of carboxypeptidases A and Bin 
crude extracts from the pyloric ceaca and intestine of anchovy. Cohen et al. (198 la) also 








1.4.2.2 Intestinal membrane bound proteases 
Intestinal brush-border enzymes constitute a further biochemical barrier to the intestinal 
absorption of peptides and proteins (Section 1.2.1). Although this barrier has been well 
researched in mammals there has been minimal work on the isolation or characteristion of 
these enzymes in teleost species. It has been suggested that enzymes associated with 
teleosts intestinal cells are similar to those isolated from higher vertebrates, but this 
remains to be confirmed (Ash, 1985, Sire and Vernier, 1992) . 
The activity of the brush-border membrane leucine aminopeptidase was found to be 
evenly distributed along the entire length of the intestine of cottids (W estem, 1971 ), 
catfish and carp (Fraisse et al., 1981). In perch a slight decrease in leucine 
aminopeptidase activity was observed near the rectum (Hirji and Courtney, 1982). 
In rainbow trout Di Constanzo et al. (1983) observed that the leucine aminopeptidase 
activities of the anterior brush-border membranes were 3.5-fold higher than in the 
posterior brush-border membranes. 
An alanine aminopeptidase was purified and characterised from the pyloric caeca of tuna 
(Hajjou and Le Gal, 1994). In contrast to alanine aminopeptideases of mammalian species 
the tuna aminopeptidase was not inhibited by puromycin and only partially inhibited by 
bestatin (Hajjou and Le Gal, 1994) . 
1.4.2.3 Intracellular digestion of proteins and peptides 
Cytosolic peptidases are involved in the metabolism of internalised peptides and proteins 
in mammals (Section 1.2.1). However little work has been done on identifying cytosolic 
proteases of the intestinal enterocytes of fish. Hydrolytic activity towards three specific 
dipeptides, glycyl-leucine, glycyl-phenylalanine and phenylalanyl-glycine was 
determined in the cytosol of trout enterocytes (Ash, 1980). They found that the N-












Rombout et al. (1985) and Georgopoulu et al. (1988) demonstrated the uptake of proteins 
by the posterior intestine of carp and trout, respectively. However in rainbow trout only 
6% of the in vivo administration of horseradish peroxidase (HRP) escaped the lysosomal 
degradation of in the posterior enterocytes and reached systemic circulation 
(Georgopoulu et al., 1988). In trout the tracer proteins HRP and ferratin were localised in 
supranuclear vacuoles where acid phosphatase and cathepsin activities were observed 
(Georgopoulou et al., 1985, Georgopoulou et al., 1986). Antigenic sites of both cathepsin 
B and D indicated the presence of these capthepsins in the supranuclear vaculoar system, 
whereas cathepsin D was also found in the secondary lysosomes of the posterior intestinal 
enterocytes of trout (Georgopoulou et al., 1985, Georgopoulou et al., 1986). Cathepsin D 
and cathepsin B have been shown to play an important role in the lysis of absorbed 
proteins in mammals (Aronson and Barrett, 1978, Barth and Afting, 1984). The posterior 
intestine of the rainbow trout has characteristically high catheptic activity, which 
increases considerably after ingestion of food (Georgopoulou et al., 1985). 
In carp absorbed HRP and ferratin are hydrolysed by the posterior enterocytes in different 
ways (Rombout et al., 1985). HRP is mainly released in the intercellular space where it 
comes into contact with intra-epithelial lymphoid cells; some of the HRP is localised in 
secondary lysosomes of enterocytes. In contrast most of the ferratin appears to end up in 
large supranuclear vacuoles where it is digested slowly. 
1.4.2.4 Biochemical barriers of the immunological system 
During the transepithelial passage proteins and peptides can come in contact with the 
lymphoid tissue associated with both the enterocyte and underlying connective tissue. 
The gut associated lymphoid tissue (G.A...LT) includes lymphocytes, macrophages and 
eosinophilic granulocytes (EGCs) and has been described for goldfish, (Temkin and 
Millan, 1986) channel catfish, (Krementz and Chapman, 1975) salmonids (Ezeasor and 












The posterior intestine ofteleosts has been shown to play a significant role in immunity. 
The absorbing enterocyte of the posterior intestine has been likened to the M cell of the 
mammalian intestinal epithelium with the existence of secretory immunoglobulin 
forming cells. Proteins absorbed by the posterior enterocytes of trout have been identified 
in the macrophages (Rombout et al., 1985, Georgopoulou and Vernier, 1986). 
Rombout et al. (1985) identified ferratin containing macrophages between the epithelial 
cells, in the lamina propria of the posterior intestinal epithelium, after oral intubation of 
ferratin to carp. It is generally accepted that macrophages are antigen-presenting cells in 
the immune system and degrade most of the phagocytosed antigen (V aresio et al., 1980, 
Rombout and van der Berg, 1989) . 
EGCs are also able to internalise macromolecules absorbed by the posterior enterocytes. 
Le Bail et al. (1989) showed that the small amount of intact bovine growth hormone that 
absorbed across the enterocyte into the lamina propria was trapped in EGCs and the 
immune cells in trout yearling. Isolated EGCs from the lamina propria of posterior of 
rainbow trout were shown to endocytose FITC-coupled proteins in vitro (Dorin et al., 
. 1993). Further in vitro work showed that EGCs only endocytose foreign (heterologous) 
proteins while homologous proteins remained associated with the plasma membrane and 
did not enter the cell (Dorin et al., 1993). Innnunoblots showed that the internalised 
heterologous proteins undergo hydrolysis. The activity of cathepsin D increased 
significantly after endocytosis of the heterologous protein. 
Since colonisation of the lamina propria with EGCs occurs during the first year of 
development in rainbow trout (Bergeron and Woodward, 1982), it was suggested that this 
innnunologica~ barrier could be avoided by the oral administration of peptides to 








1.4.3 Absorption of proteins and peptide 
1.4.3.1 Peptide carrier mediated transport 
There are few examples of intestinal peptide transport systems that have been identified 
in teleosts. A proton gradient-energised dipeptide system was demonstrated in the 
intestinal brush border membrane vesicle (BBMV) of the eel (Verri et al., 1992). Two 
proton dependent peptide transport systems were identified in BBMV s of the intestine 
and pyloric ceaca of both tilapia and rockfish (Thamotharan et al., 1996). One of the 
transport systems was high affinity and saturable while the other was low affinity 
non-saturable. 
1.4.3.2 Paracellular route 
There is no direct evidence of absorption of peptides and proteins across the intestinal 
epithelia by the paracellular route. However, Schep et al. (1998) recently showed that the 
salmonid posterior intestine in vivo was permeable to the low molecular weight 
hydrophilic markers fluorescein and mannitol. Since peptides (Nellans, 1991) are thought 
to follow the paracellular route as for fluorescein and mannitol (Ma et al., 1993, Sakai et 
al., 1997), Schep et al. (1998) speculated that peptides could also be absorbed across the 
salmonid posterior intestinal epithelia by the paracellular route. 
1.4.3.3 Transcytosis 
A number of investigators have shown that orally administered proteins cross the 
intestinal epithelium into the systemic circulation intact or partially hydrolyzed 
(Watanabe, 1982, Georgopoulou et al., 1985, McLean and Ash, 1986, Suzuki et al., 
1988). Studies have shown there to be regional differences in the protein absorption in the 
intestine of teleosts. The posterior section of most, if not all, teleosts appears to be 
specialised in the uptake of macromolecules (Noaillac-Depeyre and Gas, 1979, Stroband 
and van der Veen, 1981, Iida and Yamamoto, 1985, Rombout et al., 1985, Georgopoulou 










absorbed by the anterior and posterior intestine of carp, although uptake by the anterior 
intestine was relatively low. 
In vivo oral administration of proteins to trout confirmed that protein absorption takes 
place in the posterior intestine (Georgopoulou et al., 1985). The rate of protein uptake 
was dependent on the size of the protein (Georgopoulou et al., 1985, Georgopoulou et al., 
1986). HRP (MW 40 000) was visualised in mucosal epithelium2 h after oral 
administration whereas human IgG (MW 150 000) and ferritin (MW 460 000) were 
visualised 10 and 18 h after administr~tion. In rainbow trout, cells of the posterior section 
where shown to be structurally differentiated for the absorption of proteins and carrying 
out intracellular digestion (Georgopoulou and Vernier, 1986) like those of the ileum cells 
of suckling rat (Gonnella and Neutra, 1984). 
In carp, HRP and ferritin were shown to be absorbed and processed by the enterocytes in 
different ways (Rombout et al., 1985). A high portion of absorbed HRP was transported 
in vesicles to branch endings of lamellar infoldings of the basal cell membrane . 
Consequently, most of the HRP was released into the intercellular space where it came in 
contact with the intra-epithelial lymphoid cells. Small amounts of absorbed HRP were 
also was found in the secondary lysosomes of the enterocytes. Rombout et al. (1985) 
suggested that HRP is transported across the trout intestinal epithelium by the mechanism 
described for the new-born-rat intestine (Abrahamson and Rodewald, 1981). HRP bound 
to receptors on the apical cell membrane and is transferred into the cell in clathrin coated 
vesicles. The clathrin coat protects these vesicles from fusion with lysosomes. 
Preliminary studies by (Rombout et al., 1985) show that the portion ofHRP found in the 
supranuclear vacuoles decreases with age. Ferritin in contrast was taken up in a 
nonselective manner. Ferritin was taken up by fluid phase endocytosis and is accumulated 








1.4.3.4 P-glycoprotein efflux p~mp in teleosts 
Work in mammalian and intestinal epithelial models suggest that physiological role of the 
P-glycoprotein efflux system is to restrict transcellular flux of some molecules, including 
peptides (Section 1.2.3). Southern blot analysis of a winter flounder genomic library 
indicates that the teleost possess two P-glycoprotein genes. Sequence analysis of two key 
areas of the teleost genes indicate more than 70% sequence identity with mammalian 
genes at the amino acid level (Chan et al., 1992). 
The presence of P-glycoprotein in the intestine ofteleosts was supported by the 
immunoreaction between mammalian polyclonal and monoclonal antibodies against 
P-glycoprotein and the lumenal surface of intestinal epithelium of guppy (Hemmer et al., 
1995). This suggests that the P-glycoprotein efflux system could play a role in the poor 
absorption of peptides across the intestinal epithelia of teleosts. 
1.4.4 Oral peptide and protein delivery 
Early attempts to orally deliver proteins and peptides to salmon generally involved the 
intubation of crude pituitary homogenates that contain various hormones whose 
absorption could only be monitored indirectly by their biological response (Pickford and 
Atz; 1957). Suzuki et al. (1988a) reported that the oral intubation of crude pituitary 
extracts to goldfish induced spermiation and ovulation in goldfish, indicating the 
absorption of physiologically active salmon gonadotropin. The absorption of intact 
gonadotropin was further supported by immunological techniques. 
More recent technological advances in peptide and protein biotech.riology have enabled 
the large scale production of synthetic-or recombinant hormones and their superactive 
analogues for drug delivery. 
Adrenocorticotropic hormone (ACTH), a single chain linear peptide containing 39 amino 









intubation (McLean et al., 1990). The peak plasma concentration of ACTH was observed 
120 min after administration, but the amount of absorbed intact peptide was very low. 
A number of investigators have orally administered superactive analogues of LHRH to 
induce ovulation and spawning in fish. Thomas and Boyd (1989) showed that oral 
administration of the superactive analogue ( des-Gly10-[D-Ala6]-hLHRH (1-9) ethylamide 
(hLHRHa) in dead shrimp induced ovulation in spotted seatrout. They estimated that an 
oral administration of 1.0-2.5 mg/kg of hLHRHa would be sufficient to induce ovulation 
in spotted seatrout, in comparison to an intramuscular injection of only 100 µg/kg body 
for the same species (Thomas and Boyd, 1988). 
Orally induced ovulation of stablefish by hLHRHa required two administrations totaling 
1.5 mg/kg (Solar et al., 1990). However hLHRHa was intubated with sodium bicarbonate 
and L-lysophopsphatidylcholine to elevate the gastric pH and enhance the permeability of 
the intestine, respectively. 
McLean et al. (1991) compared directly the oral absorption ofhLHRH and hLHRHa in 
17B-oestradiol-primed juvenile salmon over a 360 min period. The plasma profiles after 
oral intubation indicate that the superactive hLHRH analogue is absorbed more rapidly 
and in greater quantities (100-fold) than the natural hLHRH hormone. The absorption of 
intact LHRH and hLHRHa was further supported by a significant increase in the plasma 
concentration of gonadotropin. 
Oral administration of the superactive analogue (des-Gly1°-[D-Ala6]-salmon LHRH (1-9) 
ethylamide (sLHRHa) of only 50 µg/kg was required to induce spawning in Thai carp 
(Sukumasavin et al., 1992). This dose is considerably lower than for 17B-oestradiol-
primedjuvenile salmon (2-20 mg/kg) (McLean et al., 1991), spotted seatrout (1 mg/kg) 
(Thomasand Boyd, 1989) and stable fish which required a priming and a secondary dose 
totaling 1.5 mg/kg (Solar et al., 1990). Unlike these species, since Thai carp do not have 




barrier of the gut, therefore increased the opportunity for peptide absorption across the 
gut. 
To increase the oral absorption of intact proteins and peptides a number of investigators 
have used various formulation strategies. The earliest attempt to formulate was by 
delivering salmon pituitary extracts in polyacrylic acid (PAA) gel bases to goldfish by 
oral intubation (Suzuki et al., 1988b). However there was no improvement in the oral 
bioavailability of gonadotropin in goldfish unlike that described for mammals (Section 
1.3.1.5). 
Immunological and biological cell assays demonstrated the absorption of intact 
recombinant hi.nnan growth hormone (hGH, MW 22 000) after intubation to carp (Hertz 
et al., 1991). Intubation of the hormone in the presence of 50 mM deoxycholic acid 
(DOC) resulted in up to a 1000-fold increase in serum levels of the hormone. The peak 
plasma concentration of bioactive hGH was 30 min after oral intubation both in the 
presence and absence of DOC. Because of the large increase in the absorption ofhGH in 
the presence of DOC the authors suggest that DOC acts as a permeation enhancer rather 
then a protease inhibitor. Carp. Hertz et al. (1991) showed there was a difference in 
absorption ofhGH in the presence of DOC between fed fish and fish fasted for 12 days. 
For the fed fish, it was estimated that at least 2% of intubated hGH reached the systemic 
· circulation while for fish fasted only 0.5% reached systemic circulation. 
When antacid (sodium bicarbonate) and permeation enhancer (Mega-9) were included 
with recombinant porcine growth hormone (rpGH) in the feed of diploid and triploid 
salmon the growth enhancement by rpGH was potentiated (McLean et al., 1993). After 
sixteen weeks the weight of the triploid fish fed the prGH-only diet increased by 29% 
compared to control, while the weight of the fish fed prGH in the presence of excipients 











Interestingly, when the protein HRP was intubated with SBTI (1 mg/kg) and Mega-9 (1 % 
w/v) there was an enhanced uptake of the protein into tissues of the liver and spleen 
(McLean and Ash, 1990). However this cocktail did not increase the plasma 
concentration ofHRP, suggesting that the absorbed protein was delivered to the 
lymphatic system (Section -1.4.2.4). 
More recently micoencapsulation has been used to protect peptide drugs from the lumenal 
proteolytic activity of the intestine and the low pH of the stomach in teleosts. 
Recombinant chum salmon growth hormone (rsGH) entrapped in an enteric polymer 
matrix ofhydroxypropylmethyl cellulose phthalate (GH-EPM) improved the oral 
absorption of intact rsGH into the systemic circulation of juvenile rainbow trout 
(Moriyama et al., 1993). The higher absorption of the microencapsulated rsGH was 
believed to be due to the peptide being protected from the acidity and proteolytic activity 
of the stomach. However, this formulation may also allow rsGH to reach the posterior 
intestine where protein and peptide absorption is high (Georgopoulou and Vernier, 1986). 
A salmon LHRH analogue [D-Ala6- Pro9 NET] LHRH (sLHRHa) formulation induced 
ovulation in carp, catfish and trout (Breton et al., 1995). In vivo experiments showed that 
permeation eru1iancer (Tween 80 and oleic acid) and protease inhibitors EDTA and 
eggwhite trypsin inhibitor enhanced absorption of sLHRHa in the agastric species carp 
(Breton et al., 1995). To bypass the stomach of the gastric species catfish and trout, 
sLHRH-a and excipients were entrapped in a silica gel coated with cellulose-acetate-
phtalate to form microcapsules. Successful ovulation of rainbow trout was achieved with 
a dose of 90 µg/kg (Breton et al., 1995). 
This introduction reviewed the pancreatic enzymes isolated from teleosts. In comparison 
to the mammalian pancreatic enzymes the teleosts pancreatic enzymes had different; 
catalytic efficiencies, requirements for divalent ions and activity towards protease 
inhibitors. A number of protease inhibitors have been used to increase the oral 







pancreatic enzymes of teleosts differ to mammalian enzymes it is not known how 
effective these protease inhibitors are at reducing the lumenal proteolytic activity in 
teleosts. 
In comparison to lumenal proteases there has been minimal work on characterising the 
membrane-bound proteases of the intestinal tract of teleosts. Since the proteolytic activity 
of the membrane-bound proteases can.account for upto 90% of the peptide metabolism in 
mammalian species (Banga, 1995), investigations must focus on these enzymes and ways 
to inhibit their activity in teleosts. 
A number of researchers have targeted the teleost posterior intestine for peptide delivery 
as it is expected to have lower levels of pancreatic enzymes; however no researchers have 
characterised the regional metabolic barriers of the intestine towards peptide oral 
delivery. A systematic study of the regional metabolic barriers of the intestinal lumen and 
membrane-peptidases would allow for the development of formulations which would 
target the region of the gut with the most favorable metabolic environment for the 
absorption of peptides. 
1.5 Aims of the study 
The aim of the thesis was to investigate the metabolic barriers of the lower intestinal tract 
of the salmon to the oral absorption of peptides and protein. The thesis investigates the 
specificity, potency and mechanism of action of protease inhibitors towards intestinal 
proteases isolated from salmon. This thesis also investigates the effectiveness of several 
protease inhibitors in improving of metabolic stability of the human and salmon LHRH 

































Luteinizing Hormone-Releasing Hormones (LHRH) is a neuropeptide that links the brain 
with the pituitary gland, conveying all reproductive-related information from the central 
nervous system to the endocrine system in animals. LHRH analogues have been used for 
the induction of ovulation and spawning in several fish species (Donaldson and Hunter, 
1983). Human LHRH (hLHRH) is composed of 10 amino acids, pyroGlu-His-Trp-Ser-
Tyr-Gly-Leu-Arg-Pro-Gly-NH2, while salmon LHRH (sLHRH) differs by two amino 
substitutions Trp7 and Leu8. The aim of this section is to report the development of a 
quick, simple capillary electrophoresis (CE) assay to measure the metabolic stability of 
human and salmon LHRH analogues in various intestinal homogenates from salmon. 
CE offers a number of advantages when compared to the well established and widely 
used technique of high-performance liquid chromatography (HPLC). Principle 
advantages are likely to include high separation efficiency, shorter analysis times, 
cheaper running costs, low sample consumption, robustness and simplicity (Reiger, 
1992). There is a considerable literature on the use ofHPLC to study the metabolic 
stability ofLHRH and analogues (Goren et al., 1990, Han et al., 1995, Peter et al., 1996). 
However analysis by HPLC is time consuming, as separation requires gradient elution 
followed by re-equilibration of the column. For CE, the time between elution of the 
analyte and analysis of the next sample is much shorter. Once the analyte of interest has 
eluted the remaining analytes can be flushed from the capillary by a short run buffer wash 
(2 min) ready for the next analysis. Another major benefit of CE is the reduced costs of 
analysis. HPLC analysis requires the purchase of expensive columns, organic solvents 
and the disposal of organic solvents. The cost of CE silica capillaries is a fraction of 
reverse phase HPLC columns and CE analysis requires small volumes of the electrolyte 










no specific investigation has been carried out to determine the usefulness of CE for the 
analysis and separation of LHRH analogues from its proteolytic metabolites. 
CE is a relatively new technique that uses electrical forces to drive separation in capillary 
tubes (Jorgenson and Lukacs, 1983). The essential components of a CE apparatus are 
illustrated in Figure 2.1. CE system consists of a buffer-filled capillary placed between 
two buffer reservoirs with a potential field applied across the capillary. The separation in 
capillary electrophoresis is based on the different migration velocities of analytes in the 
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The riet mobility of an analyte depends on its electrophoretic motility ( charge to mass 
ratio) and the electro-osmotic flow (EOF) associated with the buffer system. EOF is the 
bulk flow of liquid in the capillary (Figure 2.2). 
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Figure 2.2 Schematic of electro-osmotic flow. 
The bulk movement of solvent is caused by a small Zeta potential at the shear plane 
between static and mobile phases. The Zeta potential is a result of ionised silanol groups 
(pKa of 6-7) on the surface of the capillary and cationic counterions which are attracted 
to the negatively charged surface to form an electrical double layer. This Stem layer of 
the double layer is static and adjacent to the Stem layer are the diffuse or mobile cations. 
This region is known as the Outer Helmoltz plane. Under an electrical field the cations of 
the diffuse layer migrate towards the cathode. The water molecules solvating the cations 
also move causing a net solution flow along the capillary. This process is called the EOF 
and enables all molecules ( cationic, neutral and anionic) to move along the capillary 
towards the detector. 
The magnitude of the EOF can be expressed by equation (2.1). 
µEOF = (E Qri) (2.1) 
where µEOF = the movement of molecules due to the EOF, E = dielectric constant of the 

















that altering any of these parameters will result in changes in EOF. Since Zeta potential is 
essentially determined by surface charge of the wall and surface charge of the capillary is 
dependent on the pH of the buffer, the magnitude ofEOF varies with pH of the run 
buffer. Typically for fused silica capillaries the EOF increases with increasing pH above 
pH 4.0 (McLaughlin et al., 1992). The Zeta potential is also dependent on the ionic 
strength of the buffer, as described by double layer theory (McLaughlin et al., 1992). 
Increased ionic strength results in double-layer compression, decreased Zeta potential, 
and reduced EOF. Under conditions ofEOF, the order of elution will follow: cations of 
the lowest mass / charge ratio > cations of a higher mass / charge ratio > neutral species > 
anions with higher mass/ charge ratio > anions of a lower mass / charge ratio. A 
significant feature ofEOF is that instead of parabolic flow profiles as in pressure driven 
HPLC systems, the driving force originates from the wall of the capillary producing a 
plug like flow that has a flat velocity. This increases the resolution of separations by 
reducing the band broadening of the analyte peak during migration along the capillary 
(Huang et al., 1989). The theory for electrophoretic separations has been discussed and 
reviewed more extensively by others (Jorgenson and Lukacs, 1983, McLaughlin et al., 
1992). 
CE has now been applied in many areas of peptide analysis (Landers, 1993) and has been 
shown to be a powerful tool in resolving peptides (Grossman et al., 1988, McCormick, 
1988, Grossman et al., 1989, Camilleri et al., 1991). Although CE has been used for 
peptide analysis it has been used rarely to measure the kinetic stability of peptides in the 
presence of proteases. This is in part due to problems associated with the analysis of 
peptides in aqueous solutions containing proteins and electrolytes. Proteins and peptides 
can interact with the negatively charged surface of the capillary wall, resulting in peak 
broadening and changes in the EOF (Hjerten, 1985). Changes to the EOF have been 










Electrolytes present in the sample can result in uneven migration and zone spreading due 
to poor sample stacking (Weinberg et al., 1990, Satow et al., 1991). Sample stacking 
causes the sample to be concentrated into a smaller zone which then migrates along the 
capillary under the electrophoresis conditions of the run buffer (Burgi and Chein, 1991). 
Sample stacking requires significantly lower concentrations of electrolytes in the sample 
relative to the run buffer. Under such conditions when an electrical field is applied a 
proportionally greater field will develop across the sample zone causing the ions to 
migrate faster. Once the ions reach the run buffer boundary the electrical field decreases 
and they migrate slower, thereby concentrating the sample into a small zone (Burgi and 
Chein, 1991). 
There are various approaches by which these difficulties may be overcome. High ionic 
strength buffers suppress the ion-exchange effects between analytes and the capillary 
surface (Green and Jorgenson, 1989) and also increase the conductivity difference 
between the sample buffer and the capillary run buffer resulting in more efficient sample 
stacking (McLaughlin et al., 1992). The cost of using high ionic strength buffers is longer 
analysis times due to suppressed EOF and Joule heating (Jorgenson and Lukacs, 1983). 
Joule heating causes a temperature gradient within the capillary, creating greater 
electrophoretic mobilities at the center of the capillary resulting in non-symmetrical 
peaks, lower theoretical plates and reduced reproducibilities. Joule heating can be 
reduced in four ways. Firstly, by performing electrophoresis at lower field strengths at the 
cost of increased elution time of the analyte. Secondly, capillaries with smaller inner 
diameter can be used as their high surface to volume ratio means heat is dissipated more 
efficiently. Capillaries with smaller inner diameter have a shorter path length for 
detection and therefore decrease the sensitivity of the assay. Thirdly, increasing column 
length provides greater electrical resistance to lower Joule heating under constant voltage. 
The cost of longer capillaries is longer analysis times as elution is proportional to the 
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square of the column length. Longer capillaries also result in reduced peak efficiency, as 
there is greater opportunity for analyte-capillary wall interaction. Finally, Joule heating 
can be reduced by cooling the outer surface of the capillary by high velocity air or cooled 
liquid. 
It was shown that capillary surface interactions can also be reduced by using 
electrophoteric buffers at low pH (2-3) (Grossman et al., 1988, Bergman et al., 1991). At 
low pH the silanol groups of the fused silica are essentially protonated and uncharged, 
thereby reducing the ionic interaction between the positively charged peptides and 
capillary. Again the cost is the reduction in EOF which increases the analysis time. 
Accordingly, in this study the sample and buffer ion concentration and buffer pH were 
varied. As sensitivity was not an issue in these in vitro metabolic studies, capillaries of 
50 µm I.D. were used to minimise Joule heating. Further, to reduce Joule heating, 
capillaries were cooled with recirculating water maintained at 20°C. To reduce the 
analysis time, the minimum recommended length of capillary was used ( effective length 
of 60 cm). The effect of sample stacking and pH of the run buffer on the LHRH 
proteolytic digests were examined with respect to the reproducibility of peak heights, 
peak area, migration times and selectivity. This thesis reports a CE assay that is relatively 
simple and quick and also reports intra- and inter- day variability for analysis of both 
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2.2 Materials 
Human and salmon luteinizing hormone-releasing hormones were purchased from 
Bachem (California, USA). All other chemicals were analytical grade purchased from 
either Ajax chemicals Pty. Ltd. (Auburn, NSW, Australia) or BDH chemicals Ltd. (Poole, 
England) unless otherwise specified. Deionised distilled water was produced with a 
Millipore Milli-Q Reagent Water System (Continental Water Systems, USA). Micro-
vials C.E.S. (0.5 ml) were purchased from Dionex Corporation (California, USA). Fused 
silica capillary tubing (50 µm I.D. with a 360 µm 0.D.) was purchased from Supelco Inc. 
(Bellefonte, PA, USA). Dimethylchlorosilane (Lot 589198) was obtained from Pierce 
(Rockford, IL, USA). Light mineral oil with a specific gravity of 0.875 - 0.885 at 77°F 
and a.-chymotrypsin (EC 3 .4.21.1, TLCK treated Type VII) were purchased from Sigma 
Chemical Co. (St Louis, MO, USA). Nylon filter membranes (0.45 µm) were purchased 
from Alltech (Auckland, New Zealand). Sample tubes of 0.5 ml and 1.5 ml were 
purchased from Eppendorf (EppendorfNetheler Hinz GmbH Hamburg, Germany). 
2.3 Methods 
2.3.1 Instrumentation and standard conditions 
The capillary electrophoresis system was an Dionex CES I (Dionex Corporation, 
Sunnyvale, CA, USA) interfaced to a computerised data handling system (Dionex AI-450 
Chromatography Automated Software v 3.3.2). Data were collected at the rate of 5 Hz 
and electrophoresis was carried out towards the cathode. Neslab RTE-111 (NESLAB 
Instruments, Inc. Portsmouth, USA) recirculating bath maintained the temperature of the 
water in the capillary cooling jacket at 20 ± 0.1 °C. The cooling jacket covered 33 cm of 
the capillary. Sample vials containing the capillary inlet were elevated to 150 mm higher 
than the destination capillary outlet th~n lowered to the height of the destination outlet; 
the loading process took 60 s to complete. Unless otherwise specified, electrophoresis 







and holding the current at 60 µA for the remainder of the run. The peptides were detected 
by a UV detector set at 215 nm. 
2.3.2 Capillaries 
Capillary preparation and installation was according to that described in the Dionex 
User's Manual. Polyimide-coated fused silica capillary tubing (50 µm I.D. with a 360 µm 
O.D.) was cut to a length of 60 cm. Approximately 5 cm from the destination outlet of the 
capillary a narrow segment of the outer coating was burnt and cleaned with isopropyl 
alcohol to make a window for the UV-Vis detector. The capillary was inserted into the 
capillary water cooling jacket which was connected to a water recirculating bath, N eslab 
(RTE-111). New capillaries were reactivated by flushing with 0.1 M H3P04, followed by 
filling the capillary with 0.5 M NaOH and waiting for 10 min before flushing with 
deionised water and run buffer. At the start of each day the installed capillary and the 
source and destination reservoirs were washed by with 0.1 M NaOH, deionised water and 
the run buffer. The rinse time at 6 psi for the capillary was 120 s, the rinse and refill times 
for the source and destination vial was 6 s. Prior to each run the capillary, source and 
destination reservoirs were rinsed with the run buffer as described above. 
2.3.3 Buffers 
Phosphate buffer at pH 2.5 was prepared by diluting a 0.1 M stock of NaH2P04 10-fold 
in deionised water containing ionic strength adjuster sodium chloride. The pH was 
adjusted with phosphoric acid. Phosphate buffers at pH 6.5 and 7.5 were prepared by 
diluting 0.1 M stocks ofNaH2P04 and NaH2P04 10-fold in deionised water containing 
sodium chloride. The diluted stocks were mixed to give the desired pH. Sodium acetate 
buffer at pH 4.0 was prepared by diluting a 0.1 M stock of sodium acetate 10-fold in 
deionised water containing variable concentrations of sodium chloride. Glacial acetic 
acid was added to adjust the pH to 4.0. Buffers were filtered through 0.45 µm membrane 







2.3.4 LHRH digests 
Chymotryptic digests of human and salmon LHRH were prepared by incubating LHRH 
analogues (0.2mM) with chymotrypsin (2.5 µg of protein in 250 µl) in 50mM sodium 
phosphate buffer pH 8.0 at 10°C. Digestion of human and salmon LHRH was stopped by 
addition of equal volumes of 0.2 M HCI after 5 and 10 min, respectively. Samples were 
then centrifuged at 20 000 g for 5 min at room temperature to remove particluates. 
Samples (50 µ1) of the supernatant were transferred to 0.5 ml sample tubes and stored at 
-20°C. 
2.3.5 Silanisation 
Dionex sample vials were placed in a peaker inside a desiccator and a 5% (v/v) solution 
of dimethylchlorosilane in heptane was added to the beaker, placed in the desiccator. The 
desiccator was evacuated until the dimethylchlorosilane had evaporated (1-2 h). The 
sample vials were rinsed once in methanol and then several washes with deionised water. 
The sample vials were dried in an oven at 60°C. 
2.3.6 hLHRH standards - in the presence of a-chymotrypsin 
Human LHRH stock solution (1.2 mg/ml) was diluted with 50 mM sodium phosphate 
buffer pH 8.0. Standards (20 µ1) were chilled on ice and diluted with an equal volume of 
ice cold chymotrypsin (20 µg/ml) in 50 mM sodium phosphate buffer pH 8.0 and 
0 
immediately diluted 1: 1 with 0.2 M HCI and stored at -20 C for five days. Prior to 
analysis standards were centrifuged at 20 000 g for 5 min and 20 µ1 of the supernatant 
transferred into a silanised Dionex micro-vial containing 60 µI of deionised water and 
mixed. The solutions were immediately covered with approximately 1 mm layer of light 










2.3. 7 hLHRH standards - variability studies 
Triplicate standard curve curves for solutions of hLHRH and sLHRH in 50 rnM sodium 
phosphate buffer pH 8.0 analysed by CE were plotted. For hLHRH three independently 
prepared stock solutions (1.5, 1.6, 1.6 mg/ml) were diluted with 50 rnM sodium 
phosphate buffer pH 8.0 to give final concentrations of60.8, 81, 121.4 and 242.7 µg/ml. 
Three independently prepared stock solutions of sLHRH (1.3, 1.5, 1.6 mg/ml) were 
prepared and diluted in 50 rnM sodium phosphate buffer pH 8.0 to give final 
concentrations of 75.2, 150.4, 180.8, 240 and 304 µg/ml. LHRH standards were then 
diluted with equal volume of 02 M HCl to give a total volume of 40 µ1 and centrifuged at 
20 000 g for 5 min. Supematants (20 µl) were placed in silanised Dionex sample vials 
containing 60 µ1 of deionised water and mixed. The solutions were immediately covered 
with approximately 1 mm layer light mineral oil to prevent evaporation and analysed by 
capillary electrophoresis. Linear regression analysis was carried out using the computer 
program Minitab (MinitablOXtra, Minitab Inc. PA, USA). The intraday variation of the 
assay for hLHRH at 15 µg/ml and was determined by injecting each of the three 
independently prepared standards six times. Interday variation was also determined at 


















The precision of peak areas and peak heights were determined. LHRHs at lmg/ml in 
deionised water were analysed by capillary electrophoresis in 50 mM sodium phosphate 
buffer at pH 2.5 (Section 2.3.1) (Figure 2.3). A constant voltage of 15 kV gave an 
approximate current of 60 ± 4 µA. Relative standard deviations (RSD%) for migration 
times, peak heights, and areas for both analogues from six consecutive runs are shown in 
Table 2.1. The.RSD for migration times are low(< 1.0%) however the RSD for peak 
height and peak area are relatively high. The reason lies in a significant trend which can 
be recognised by looking at the percentage increase in peak height and peak area between 
the first and last injection. The percentage increase in peak height and area suggested 
sample evaporation. 
Table 2.1 Reproducibility of peak migration time (min), peak height (m V) and area (m V) 
for hLHRH and sLHRH. 
hLHRH sLHRH 
Injection Migration Peak Peak Migration Peak Peak 
number time (min) height area time (min) height area 
1 21.43 3800 49830 35.35 5250 11744 
2 21.65 3890 51000 35.20 5356 11905 
3 21.56 3999 52400 35.48 5447 12344 
4 21.67 4235 55545 35.93 5556 12410 
5 21.80 4356 57150 35.80 5888 13022 
6 21.75 4378 57495 35.69 5978 13560 
Mean 21.64 4110 53903 35.58 5581 12498 
s.d. 0.13 247 3269 0.28 292 686 
RSD (%) 0.62 6.0 6.1 0.79 5.2 5.5 
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Figure 2.3 Capillary electrophoretic separation of hLHRH (A) and sLHRH (B) (0.1 
mg/ml in deionised water) in 50 mM sodium phosphate buffer pH f5 (Section 2.3.1) 
To prevent evaporation the samples were covered with a film of approximately 1 mm 
light mineral oil. Table 2.2 shows that for samples covered with a 1 mm layer of mineral 
there is a decrease in peak height and area with consecutive injections. The light mineral 
oil had no effect on peak shape or migration time. The percentage decrease in peak height 




Table 2.2 Effect of light mineral oil on reproducibility and percentage change in peak 
height (mV) and area (mV) for hLHRH and sLHRH. 
hLHRH sLHRH 
Injection Migration Peak Peak area Migration Peak Peak area 
number time (min) height time (min) height 
1 . 21.45 3865 50685 35.35 5456 12687 
2 21.70 3976 50566 35.20 5120 11906 
3 21.57 3700 49018 35.48 4890 10895 
4 21.67 3706 46789 35.93 4789 10990 
5 21.87 3600 46778 35.80 4705 10987 
6 21.73 3479 45759 35.69 4678 10870 
Mean 21.64 3721 48266 35.58 4940 . 11390 
sd 0.13 179 2116 0.28 300 746 
RSD (%) 0.62 4.8 4.4 0.79 6.1 6.6 
Percentage (-) 10 (-) 9.7 (-) 14.3 (-) 14.3 
change 
It has been documented previously that LHRH analogues at low concentrations adhere to 
glass and other surfaces (Anik and Hwang, 1983, Mistry; 1993). Dionex sample vials 
were silanised (Section 2.3.5) for the analysis of hLHRH and sLHRH (0.1 mg/ml in 
deionised water). Table 2.3 shows that the percentage decrease of both analogues over 
the analysis was reduced by approximately half when sample vials were silanised. All 







Table 2.3 Effect of silanisation of sample vials on the reproducibility of and percentage 
change in peak height and area for hLHRH and sLHRH 
hLHRH sLHRH 
Injection Migration Peak Peak area Migration Peak Peak area 
number time (min) height time (min) height 
1 21.43 3865 50685 35.78 5301 118404 
2 21.65 3940 54179 35.45 5243 118063 
3 21.56 3854 51100 35.48 5025 117121 
4 21.67 3865 50685 35.60 4985 111336 
5 21.80 3800 48833 35.55 4944 110340 
6 21.75 3689 48378 35.65 4982 110221 
Mean 21.64 3836 50643 35.60 5080 114248 
sd 0.13 84.5 2055 0.12 152 4001 
RSD (%) 0.62 2.2 4.1 0.34 3.0 3.5 
Percentage (-) 4.6 (-) 4.6 (-) 6.0 (-) 6.9 
change 
Electrophoretic mobility of analytes is dependent upon the field strength. High voltages 
are often applied in CE; however this can generate Joule heat causing the analyte zone to 
be dispersed. The maximum recommended current before Joule heating of the run buffer 
occurs is reported to be 60 µA (Dionex, 1989). Electrophoresis can be carried out at 
either constant voltage or constant current. To determine which gave the better 
reproducibility, human LHRH (0.1 mg/ml in deionised water) was injected in twelve 
consecutive runs alternating between electrophoresis at constant voltage of 15 kV and 
constant current of 60 µA using 50 mM sodium phosphate buffer at pH 2.5 (Section 
2.3.1). There were no significant differences in peak heights (p > 0.4) or peak areas 
(p > 0.1) between samples electrophoresed at constant current and constant voltage 
(Table 2.4). In order to maximise the applied field without Joule heating of the run buffer, 
all subsequent ·experiments were performed at constant current of 60 µA. 
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Table 2.4 Effect of electrophoresis under constant voltage and constant current on 
reproducibility of CE assay for hLHRH (n=3). 
Constant voltage Constant current 
MT PH PA MT PH PA 
Mean 22.36 1071 13898 22.02 1092 14511 
s.d. 0.22 28.87 499 0.17 27.5 432 
RSD (%) 0.98 2.7 3.6 0.77 2.5 2;98 
MT = migration time of the analyte, PH = peak height, PA = peak area 
It was found consistently that the RSD of peak height was less than the RSD of peak area 
during the analysis ofLHRH by CE (Tables 2.1 - 2.4). We concluded that under our 
electrophoresis conditions peak height gives better precision than peak area. In the 
subsequent experiments peak heights only were used. 
2.4.2 Optimisation of sample stacking 
Chymotryptic digests ofhLHRH and sLHRH (Section 2.3.4) were used to investigate the 
effect of sampie stacking on resolution and reproducibility of the CE assay. The effect of 
sample electrolyte concentration on stacking was determined by diluting human and 
salmon LHRH chymotryptic digests 2.5-, 4- and 6-fold in deionised water (Figures 2.4 & 
2.5). For both hLHRH and sLHRH lower sample dilution (or high electrolyte 
concentration) reduced sample stacking and decreased resolution. High ionic strength of 
the run buffer improved the reproducibility of the CE assay by improving stacking and 
reducing interaction between analyte and wall. Figure 2.6 summarises the effect of 
dilution of the digests with deionised water and the run buffer ionic strength on peak 
height and area. Diluting the digests resulted in reduction of both peak height and area; 
however the reduction in peak area was greater than for peak height. In other words, 
diluting the digests with deionised water resulted in improved stacking which can be seen 
by the greater peak height/peak area ratios (Figure 2.7). Stacking was the greatest for 
digests electrophoresed in buffer containing 75 mM sodium chloride. Run buffer 
containing 25 :tpM sodium chloride concentration was insufficient to stack the analyte 
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Figure 2.4 Capillary electrophoretic separation of the chymotryptic hLHRH digest in 
10 mM sodium phosphate buffer pH 2.5 containing 7 5 mM sodium chloride (Section 
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Figure 2.5 Capillary electrophoretic separation of the chymotryptic sLHRH digest in 
10 mM sodium phosphate buffer pH 2.5 containing 75 mM sodium chloride (Section 
2.3.1). Digests were diluted 2.5-fold (A), 4.0-fold (B) and 6-fold (C) in deionised water. 
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Figure 2.6 Effect of diluting hLHRH (A) and sLHRH (B) chymotryptic digest in 
deionised water on the peak heights (triangle) and peak area (diamonds) when 
-) electrophoresed (Section 2.3.1) in 10 mM sodium phosphate buffer at pH 2.5 containing 
50 mM sodium chloride (open symbols) and 75 mM sodium chloride (closed symbols). 
Each point represents the mean of three experiments. 
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Figure 2.7 Effect of diluting hLHRH (closed symbols) and sLHRH (open symbols) 
chymotryptic digests in deionised water on sample stacking (peak height/peak area) when 
electrophoresed (Section 2.3 .1) in 10 mM sodium phosphate buffer at pH 2.5 containing 
75 mM sodium chloride (squares) and 50 mM sodium chloride (triangles). Each point 
represents the mean of three experiments. 
Increasing the ionic strength of the run buffer resulted in longer migration times and 
increased peak heights (Figure 2.8). At the highest ionic strength (100 mM sodium 
chloride) the hLHRH and sLHRH analogues eluted after 32.0 and 46.5 min, respectively. 
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Figure 2.8 Effect of the ionic strength of the run buffer on the migration time ofhLHRH 
(open circles) and sLHRH (closed circles) when electrophoresed in 10 mM sodium 
phosphate buffer pH 2.5 containing 50, 75 or 100 mM sodium chloride (Section 2.3.1). 
Each point represents the mean of three experiments. 
Figure 2.9 shows that diluting the chymotryptic LHRH digests 2.5- to 4-fold in deionised 
water improved the RSD (%) of peak height; however there was no improvement in RSD 
from a 4 to 6-fold dilution. The precision of the migration times of both analogues were 
not affected by the difference in ionic strengths between run and sample buffer. All RSD 
were less than 1 %. Under the electrophoresis at pH 2.5 containing 75 mM sodium 
chloride (Section 2.4.1) it would appear that for optimum stacking conditions the digest 
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Figure 2.9 Effect of diluting the digests in deionised water on RSD (%) for migration 
time (open bars) and peak height (closed bars) when electrophoresed (Section 2.3.1) in 
10 mM sodium phosphate buffer pH 2.5 containing 50 mM sodium chloride (A) and 




2.4.3 Optimisation of run buffer pH 
In an attempt to reduce analysis time, the pH of the run buffer was increased to 4.0, 6.5 
and 7.5 to increase the EOF of the system. Increasing the pH of the run buffer reduced 
the migration time of the LHRH analogues, which are indicated by arrows in Figures 2.10 
& 2.11. At pH 7.0 neither LHRH analogue was resolved from its chymotryptic 
metabolites (data not shown). However at pH 2.5, 4.0 and 6.5 both LHRH analogues 
were resolved from their chymotryptic metabolites (Figures 2.10 & 2.11 ). Table 2.5 
shows that migration time and peak height decrease with increasing pH. Run buffer at pH 
6.5 resulted in relatively high RSD for migration time and peak height for both hLHRH 































0 ,..... ll..JIJ'-'W~ 
0 5 10 15 20 25 
· Time (min) 
Figure 2.10 Capillary electrophoretic separation of the chymotryptic hLHRH digest at pH 
2.5 (A), 4.0 (B) and 6.5 (C) containing 75 mM sodium chloride (Section 2.3.1). Arrows 
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Figure 2.11 Capillary electrophoretic separation of the chymotryptic sLHRH digest at pH 
2.5 (A), 4.0 (B) and 6.5 (C) containing 75 rnM sodium chloride (Section 2.3.1). Arrows· 








Table 2.5 Effect of run buffer pH on reproducibility of migration time (MT), and peak 
height (PH) ofhLHRH and sLHRH (n=3). 
hLHRH sLHRH 
buffer MT PH MT PH 
pH mean RSD(%) mean RSD(%) mean RSD(%) mean RSD(%) 
/ 
2.5 23.2 0.5 419 2.9 37.34 0.6 353 3.3 
4.0 12.5 0.67 384 3.3 18.5 0.74 321 3.2 
6.5 6.9 0.79 352 4.5 8.3 1.0 166 6.0 
It was concluded that the optimum conditions for CE analysis of both human and salmon 
LHRH digests under standard conditions (Section 2.3.1) was in 10 mM sodium acetate 
buffer at pH 4.0 containing 75 mM sodium chloride, with a 4-fold dilution of digest in 
deionised water. 
2.4.4 The effect of chymotrypsin on the reproducibility 
The effect of chymotrypsin on the reproducibility of peak height and migration time was 
determined. Human LHRH replicates (n = 6) at 50 and 100 µg/ml were prepared in the 
presence and absence ofchymotrypsin (Section 2.3 .6) and analysed by CE under the 
optimum conditions described in Section 2.4.3. Analysis of peak heights showed that 
there was no significant difference in hLHRH prepared in the presence or absence of 
chymotrypsin at 150 µg/ml (p > 0.4) or 25 µg/ml (p > 0.3) (Table 2.6). 
Table 2.6 Effect of chymotrypsin on reproducibility of peak height ofhLHRH. 
Chymotrypsin Phosphate buffer only 
150 µg/ml 25 µg/ml 150 µg/ml 25 µg/ml 
Mean 1104 139 1090 135 
s.d. 32.7 7.5 28.2 7.1 







2.4.5 Storage stability 
Human LHRH replicates (n = 9) at 25 and 150 µg/ml were prepared in the presence of 
chymotrypsin (Section 2.3.6) and stored at -20°C for 5 days. On the day of analysis stored 
samples were thawed and in addition fresh samples at 25 and 150 ~Lg/ml were prepared in 
the presence of chymotrypsin (Section 2.3.6). Stored and fresh samples were analysed 
under optimum capillary electrophoresis conditions (Section 2.4.3). Table 2.7 shows that 
there was no significant difference between stored and fresh samples at 150 ~Lg/ml and 
25 µglml (p > 0.3). No LHRH metabolites were detected in electophoretograms 
indicating no degradation of the native hLHRH occurred during storage under the 
conditions described. 
Table 2.7 Effect of storage on the stability ofhLHRH in the presence of chymotrypsin. 
ample 
Fresh 25 µg/ml rzi:g---:;:-~- --, ± . 5. 
I Stored 25 µg/ml 155 ± 7.9 I 5.1 
I Fresh 150 µg/ml 1265 ± 42.1 I 3.3 
I 
Stored 150 µglml 1266 ± 45.2 I 3.6 
2.4.6 CE analysis of LHRH 
Standards ofLHRH analogues (Section 2.3.7) were analysed by CE under the optimum 
conditions described in Section 2.4.3. Regression analysis of the calibration curve of peak 
height versus concentration ofhLHRH showed that it was linear over the concentration 
range 7.6 to 30.34 µglml, (PH= 20.14 (± 0.52) - 77.40 (± 9.40), r2 = 0.993, n=12). The 
intra-day coefficient of variation for the CE assay was 1.25 % at 15 ~Lg/ml. The inter-day 
coefficient of variation was 4.97 % at 15 µg/ml. 
Regression analysis of the calibration curve of peak height versus concentration of 
sLHRH showed that it was linear over the concentration range 9.2 to 38.0 ~Lg/ml, with 














In this study sample stacking and pH of the run buffer were identified as important 
factors in controlling peak shape, separation and reproducibility of chymotryptic digests 
ofLHRH. In summary, electrophoresis at high pH (6.5 & 7.0) resulted in loss ·of 
resolution and efficiency (Section 2.4.3). Low pH (2.5 & 4.0) produced a dramatic 
reduction in the EOF that gave greater efficiency at the cost of longer elution times 
(Section 2.4.3). Sample stacking was improved by diluting the LHRH digest sample in 
deionised water and increasing the concentration of the sodium chloride in the run buffer 
(Section 2.4.2). 
At low pH (2.5) human and salmon LHRH migrated as sharp symmetrical peaks 
characteristic of CE (Figure 2.3) and exhibited large differences in migration times. 
Human LHRH eluted after 21.5 min while salmon LHRH eluted after 36.5 min. The large 
differences in migration time was expected as at low pH the EOF is suppressed and 
analytes migrate according to electrophoretic velocity which is proportional to their 
charge-mass ratio. At pH 2.5, hLHRH will carry two positive charges due to the 
ionisation ofHis2 and Arg8, while salmon LHRH will carry a single positively charged 
His2• For both LHRH analogues the N- and C-terminus will not be ionised as they are 
blocked. 
Since the Dionex sample vials could not be capped sample evaporation became a 
potential problem (Table 2.1). Obviously, for accurate determination ofLHRH 
concentration when no internal standard was used, sample evaporation had to be 
prevented. To do this and to allow for gravity loading a 1 mm layer of light mineral oil 
was placed on top of the sample. When present, the PH of sequential samples did not 
increase suggests evaporation of the solvent was eliminated or minimised. (Table 2.2). 
Having eliminated sample evaporation it became evident that human and salmon LHRH 
analogues were adsorbing to the wall of the sample vials (Table 2.2). LHRH analogues at 






1983, Mistry, 1993). Silanisation of the Dionex sample vials reduced the absorption of 
hLHRH from 10% to 4.5%, whilst for sLHRH the absorption was reduced from 14% to 
6.5 %. This equated approximately to a 50 % reduction in LHRH adsorption (Table 2.3). 
On the assump~ion that the small residual adsorption is constant it was considered that 
this assay was suitable for quantitation of the degradation ofLHRH analogues in vitro. 
The maximum recommended current before Joule heating of the run buffer becomes 
unacceptable is 60 µA (Dionex, 1989). There was no significant difference in 
reproducibility between separation at constant current and constant voltage (Table 2.4). 
Consequently all subsequent experiments were performed at a constant current of 60 µA 
in order to maximise the applied field; to reduce the analysis times without excessive 
Joule heating of the run buffer. 
In CE, peak width is a function of the velocity of the analytes passing in front of the 
detector. Thus peaks that migrate slowly exhibit a larger peak area irrespective of their 
concentration (Huang et al., 1989, Altria, 1993). For accuracy, correction for velocity 
band width based on migration time is necessary (Huang et al., 1989). However, since the 
RSD for migration times w:as less than 1 %, this correction was insignificant. 
Nethertheless, for electrophoresis at pH 2.5 (Tables 2.1- 2.4) peak height was a more 
precise measure of concentration than peak area for both hLHRH and sLHRH. This is in 
agreement with Watzig (1995) who found that the precision of peak height was often 
better than for peak area and concluded this was due to peak height being less influenced 
by migration times and integration errors. 
Electrophoretograms ofLHRH chymotryptic digests diluted in various volumes of 
deionised water illustrate the efficiency of sample stacking (Figures 2.4 & 2.5). There 
was peak-shape distortion (asymmetry) when the chymotryptic digest was diluted 
2.5-fold in deionised water. At dilutions greater than 2.5-fold, symmetrical peaks were 
eluted and resolution (Figures 2.4 & 2.5) and reproducibility were improved (Figure 2.9). 















further evidence for the utility of sample stacking. Dilution of digests in deionised water 
resulted in greater peak height/area ratios (Figure 2. 7) with minimal decreases in peak 
heights (Figure 2.6). Figure 2.9 shows that RSD of migration time was less than 1 % 
under all ionic strengths indicating no analyte wall interaction. This could be attributed to 
the combination of low pH and high sodium chloride concentration in the run buffer and 
the removal of the protein component (chymotrypsin) by acid precipitation prior to 
analysis. However higher ionic strength of run buffer resulted in slightly longer analysis 
times due to the suppression of the EOF (Figure 2.8). 
However as the EOF increased the resolution and reproducibility of the assay decreased 
(Figures 2.10 & 2.11). At pH 7.0, human and salmon LHRH analogues were not resolved 
from their chymotryptic metabolites. It would appear that although the greater EOF 
decreases the run time it does not contribute to the separation. Sutcliffe and Corran 
(1993) found that for the analysis of neurohypophyseal peptides and analogues, high EOF 
conditions (pH> 6.0) resulted in shorter migration times with reduced resolution. The 
best separation ofneurohypophyseal peptides and analogues was achieved at pH 2.5 
(Sutcliffe and Corran 1993). 
Decreasing the elution time by increasing the pH of the run buffer also decreased the 
peak heights of the LHRH analogues (Table 2.5). This was presumably due to the higher 
velocities of the analytes passing the detector (Hjerten, 1985). The reproducibilities of 
LHRH migration times and peak heights were better at pH 2.5 and 4.0 than at pH 6.5 
(Tables 2.5 & 2.6). This is presumably because at higher pH (> 4.0) the capillary surface 
becomes negatively charged resulting in higher EOF and greater analyte-:wall interaction. 
Adsorption of analytes to the wall surface will alter the surface charge resulting in a 
change in the EOF (Lambert and Middleton, 1990, Towns and Regnier, 1992). This 
problem may be overcome by washing the capillary with acid or alkali between runs 
(Lambert and Middleton, 1990). However this would increase analysis times and since 
good results were obtained at lower pH this was not investigated. 
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For the chymotryptic digest of LHRH analogues, a 4-fold dilution of the .digests in 
deionised water and a run buffer of 10 mM sodium acetate buffer at pH 4.0 containing 75 
mM sodium chloride appears to be the optimum for sample stacking and resolution using 
the standard conditions described in Section 2.3.1. Under these conditions, hLHRH and 
sLHRH migrated at 12.5 and 18.5 min, respectively. The presence of chymotrypsin in 
hLHRH chymotryptic digested samples had no significant effect on peak height or 
migration time reproducibility (Section 2.4.4). This indicates that chymotrypsin -
capillary wall interaction is not significant under these conditions. 
Standard replicates ofhLHRH in the presence of chymotrypsin in 0.1 M HCl were found 
to be stable after 5 days when stored at -20°C (Section 2.4.5). Subsequently all LHRH 
digest samples were stored in this manner. The standard curves for peak heights versus 
concentrations for hLHRH and sLHRH were linear within the concentration range of 7 .6 
to 34.34 µg/ml and 9.2 to 38.0 µglml, respectively. They-intercepts for both calibration 
curves were significantly below zero (Section 2.4.6). This phenomenon is likely due to 
the adsorption of the LHRH analogues to the silanised sample vial as observed in Section 
2.4.1. For hLHRH the intra- and inter-day coefficient of variation for the CE assay was 
found to be 1.25% and 4.97% at 15 µglml (Section 2.4.6). Some of this variance in 
precision may be attributed to injection volume fluctuations (Altria et al., 1995). This 
variance in precision could be investigated by the incorporation of an appropriate internal 
standard (Dose and Guiochon, 1991) but this was not pursued, as the variability of the CE 
assay was acceptable for our purposes. 
The results of this work demonstrate the usefulness of CE for the analysis of the 
degradation of peptides in vitro; however there are few reports in the literature that 
describe the use of CE in a similar application. Huang and Wu (1996) used CE to monitor 
the degradation of thyrotropin releasing hormone and insulin during iontophoretic 
transdermal delivery in vitro· However they did not report the CE assay conditions or the 




The most attractive features of the CE assay is its simplicity and low cost. A single 
inexpensive capillary is used, the run buffer is aqueous eliminating the purchase and 
disposal of organic solvents, and the same CE assay can be used for the analysis of both 
LHRH analogues. This assay was used in the subsequent work to determine the metabolic 
stability ofh~an and salmon LHRH analogues in the presence of intestinal extracts 
from salmon. 
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The proteolytic activity of the intestine is a major barrier to the oral delivery of proteins 
and peptides (Section 1.2.1). To our knowledge no investigators have characterised the 
metabolic barrier to oral delivery of proteins and peptides in teleosts. The purpose of this 
chapter is to report on the relative proteolytic activity of different regions of the lower 
intestinal tract of salmon. The degradation of the model protein, BSA and the model 
peptides, human and salmon LHRH analogues was evaluated in intestinal lumenal and 
mucosa homogenates in vitro. Degradation of BSA was determined by measuring the 
formation acid.soluble peptides, whereas the degradation of the LHRH analogues was 
determined using the capiHary electrophoresis assay described in Chapter 2.0. Protein and 
peptide degradation by lumenal and mucosa homogenates was also studied in the 
presence of inhibitors to evaluate their potential for improving oral bioavailability of 
proteins and peptides. The distribution of the major digestive proteases in the lower 
gastrointestinal tract was surveyed using synthetic substrates. The results presented in this 
section show that the lumenal proteolytic activity towards BSA and the LHRH analogues 
in the posterior section was significantly lower than that of the anterior and middle 
intestinal sections. However the proteolytic activity of the posterior mucosa! homogenate 
against BSA was significantly higher than for the middle mucosa! homogenate whi!e both 






Bovine serum albumin fraction V was purchased from SERVA (Feinbiochemica GmbH 
& Co., Heidelberg). Dimethyl sulphoxide (DMSO) and Triton X-100 laboratory reagent 
were obtained from BDH limited (Poole, England). N a-benzoyl-DL-Argp-nitroanilide, 
N-succinyl-Ala-Ala-Ala p-nitroanilide, L-leucine p-nitroanilide, N-benzoyl-L-Tyr ethyl 
ester, N-a-benzoyl-L-Arg ethyl ester (BABE), N-a-benzyol-L-Arg (BA), hippuryl-Arg, 
hippuryl-Phe, hippuric acid, human luteinizing hormone-releasing hormone (hLHRH), 
salmon luteinizing hormone-releasing hormone ( sLHRH), a- chymotrypsin (EC 3 .4.21.1, 
TLCK treated, Type VIII from bovine pancreas), trypsin (EC 3 .4.21.4, TPCK treated type 
XIII from bovine pancreas), elastase (EC 3.4.21.36, Type IV from porcine pancreas), 
soybean trypsin-chymotrypsin inhibitor (Bowman-Birk inhibitor) from soybean, 
ethylenediaminetetraacetic acid disodium salt (EDTA), deoxycholic acid sodium salt and 
bestatin were all obtained from Sigma Chemical Company (St Louis, MO, USA). All 
other chemicals were of analytical grade and were purchased from Ajax chemicals 
(Auburn, NSW, Australia). Sample tubes of 0.5 ml and 1.5 ml were purchased from 
Eppendorf (EppendorfNetheler Hinz GmbH Hamburg, Germany). Tissue extracts were 
homogenised by a Ystral homogeniser (Ystral GmbH, D-7801, Dottingen, Germany). 
Deionised water was obtained from a reverse osmosis Mill-Q® Reagent Water system 








Juvenile chinook salmon (Oncorhynchus tshawytscha) reared at the Big Sea Foods Ltd. 
hatchery, South Canterbury were transferred to the Portobello Marine Laboratory 
(Dunedin, New Zealand) where they were adapted to sea water and maintained in a 
continuous circulating tank. The salmon were fed a commercial feed daily. The salmon 
were killed with a blow to the head followed by cervical dislocation. The fish were 
weighed (weighting) and the biological samples were collected at the Portobello Marine 
Laboratory and transported to Dunedin. Ethics approval was obtained from the University 
of Otago Ethics Committee which is established under the "Animal Protection (Codes of 
Ethical Conduct) Regulation", 1987. This code is equivalent to the "Principles of 
Laboratory Animal Care" (NIH publication# 85 - 23, revised 1985). 
3.3.1.2 Collection and preparation of lumenal homogenates 
The lower intestinal tracts of salmon were removed and ligated into the anterior, middle 
and posterior intestinal sections. The lumenal contents of the section were carefully 
squeezed into a centrifuge tube (10 ml), the intestinal section was cut longitudinally and 
the remaining contents were washed into the centrifuge tubes with the minimum volume 
of ice cold saline. Each section was diluted with cold 50 mM sodium phosphate buffer 
pH 8.0 to give a final volume of 5 ml, homogenised at 4°C for 2 min using a Ystral 
homogeniser and centrifuged (3 000 g for 10 min, 4°C). The supernatant was collected 
and 100 µl volumes were dispensed into 0.5 ml sample tubes and stored under the 







3.3.1.3 In situ pH measurements 
The lumenal contents of the anterior, middle and posterior intestinal sections from 
salmon were collected into 1.5 ml samples tubes without washing (Section 3.3.1.2). The 
pH measurements were carried out with a micro pH electrode (Model Z451, SCHOTT 
GERATE, Germany) at room temperature. 
3.3.1.4 Preparation of mucosal homogenates from frozen intestine 
The mucosal surface area of the anterior section was too small and fragile to collect 
sufficient quantities of the mucosa. 
The lower intestinal tract was removed, the middle and posterior intestinal sections were 
ligated, cut and the lumenal contents washed from each section as described in Section 
3.3.1.2. The whole intestinal sections were immediately placed in liquid nitrogen and 
transported to Dunedin where they were stored at -80°C. The posterior intestinal sections 
(20 g frozen weight) were cut into small pieces and thawed in 60 ml of cold 300 rnM 
mannitol in 10 rnM sodium phosphate buffer pH 7.4. The suspension was vortexed in a 
50 ml test tube for 5 min. The suspension was passed through a Buchner funnel with 1 
mm holes and the filtrate was diluted 6-fold in 50 mM sodium phosphate buffer pH 7.4. 
The filtrate was homogenised at 4°C for 2 min using a Ystral homogeniser and 
centrifuged at 3 000 g at 4°C for 10 min. Samples of the supernatant (100 µ1) were 
transferred to 0.5 ml sample tubes and stored at -80°C. 
3.3.1.5 Preparation of mucosal homogenates from fresh intestine 
Middle and posterior intestinal sections were removed and lumenal contents washed from 
each section as described Section 3 .3 .1.2. The sections were cut longitudinally and the 
mucosal surface was washed with cold 50 mM sodium phosphate buffer pH 7.4 and 
gently cleaned with a soft moist tissue. The mucosa was removed from the intestine 
immediately by scraping off the epithelial cell layers with a microscope cover slip. The 
scrapings of the middle and posterior sections were pooled and homogenised in 5 ml of 
50 mM phosphate buffer pH 7.4 at 4°C using a Ystral homogeniser. The homogenate was 
:t 
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centrifuged at 3 000 g at 4°C for 10 min to remove cellular and nuclear debris. Samples 
of the supematants (100 µ1) were transferred to 0.5 ml sample tubes and stored under 
conditions described. 
3.3.1.6 Protein estimations 
Protein contents was estimated by the method of Lowry as modified by Peterson (1977). 
Trichloroacetic acid (TCA) precipitation was not required. Assays were performed in 
microtitre plate wells in a total volume of250 µ1, and the absorbance (750nm) was read 
using an Microplate Spectrophotometer (Spectra MAX 340) controlled by an external 
computer with SOFT-MAX PRO software (Molecular Devices Corporation, CA, USA). 
Protein concentrations were equilibrated using bovine serum albumin standards covering 
the range 1-10 µg. Determination of protein was done in triplicate. 
3.3.1.7 Measurement of surface tension 
A 200 mM stock solution of sodium deoxycholate was prepared in 50 mM sodium 
phosphate buffer pH 8.0. From the stock solution, appropriate dilutions were made in 
50 mM sodium phosphate buffer pH 8.0 producing concentrations 0.156, 0.3125, 0.625, 
1.25, 2.5, 3.0, 5, 10, 20, and 40 mM. Surface tension data, as a function of concentration, 
were determined employing the ring-detachment method Choulis and Loh (1971) using a 
torsion balance (White Blee. Inst. Co. Ltd). The surface tension of distilled water was 74, 
73, and 73 mN/m at room temperature in agreement with Bloor et al. (1970). All 
measurements were performed at room temperature and the averages of two experiments 
are reported. All glass apparatus used and the platinum ring were washed thoroughly with 
distilled water. The dish was rinsed with the sodium deoxycholate standard solution, 
25 ml of fresh standard added to the glass dish and the ring submerged just below the 
surface before the surface tension was determined. 
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3.3.1.8 Statistical analysis 
The statistical analyses (two way ANOVAs) were performed by the statistical program, 
MINITAB Release 10 (Minitab, Inc., PA. USA). Whenever an F-test showed a 
significant difference in means, the least-significant differences method was used to 
compare means pairwise. 
3.3.2 Proteolytic assays 
3.3.2.1 General proteolytic activity 
Lumenal or mucosal homogenate samples (15-20 µg of protein) were diluted with 50 mM 
sodium phosphate buffer with or without inhibitor to give a total volume of 0.5 ml. After 
incubation at 150c for 30 min, 0.5 ml of BSA (1 mg) in 50 mM phosphate buffer was 
added to start the assay. At various times after the start of the reaction, 100 µ1 samples 
were removed and added to 5 µ1 of 50 % (w/v) TCA to stop the enzyme reaction and to 
precipitate protein. Reaction samples were left to stand at room temperature for at least 
30 min, centrifuged at 20 000 g for 5 min and 50 µ1 of the supernatant was assayed for 
acid-soluble peptides by the modified Lowry method (Section 3.3.1.6). The amount of 
acid-soluble peptide was determined using bovine serum albumin as the standard over the 
range 1 - 10 µg. Units of general proteolytic activity are µg of acid-soluble peptides 
formed per minute. 
3.3.2.2 LHRH analogues 
Lumenal and mucosa! homogenates (1.25 - 12.5 µg of protein) were diluted with 50 mM 
sodium phosphate buffer and were incubated at 15°C for 30 min (total volume 200 µI) in 
the presence or absence of inhibitor. To start the reaction, 50 µ1 ofLHRH was added and 
at predetermined times, 25 µl was withdrawn from the incubates and mixed with 25 µ1 of 
0.2 M HCl to precipitate tissue proteins and terminate the reaction. The resulting mixture 
was centrifuged (20 000 g for 10 min) to remove precipitated protein and particulates and 












Samples (20 µl) were transferred to a Dionex sample vials and diluted with 60 µl of 
water. A 1 mm layer of mineral oil was placed on top of the sample to prevent sample 
evaporation. Capillary electrophoresis (CE) was carried out in a Dionex Model CES-1 
capillary electrophoresis instrument (Dionex, Sunnyvale, CA, USA). The electrophoresis 
conditions are the same as for the optimum conditions described in Section 2.4.3. 
3.3.2.3 Assays usingp-nitroanilides 
Trypsin activity was assayed based on the method of Erlanger et ql. (1961) using Na-
benzoyl-DL-Argp-nitroanilide (BAPNA) as substrate. BAPNA (43.5 mg) was dissolved 
in 1 ml of dimethylsulfoxide (DMSO) and then diluted 100-fold in 50 mM sodium 
phosphate buffer at pH 7.4 for mucosal studies and at pH 8.0 for lumenal studies. 
Elastase activity was assayed using the substrate N-succinyl-Ala-Ala-Ala p-nitroanilide 
(SucAla3NA). SucAla3NA (4.5 mg) was dissolved in 1 ml ofDMSO and diluted 10-fold 
in the appropriate sodium phosphate buffer (Bieth et al., 1974). Leucine aminopeptidase 
was assayed using the substrate L-Leu-p-nitroanilide (Lin and Van Wart, 1982). 
Homogenates (50 µ1 total volume) and the p-nitroanlilide substrates (250 µl total volume) 
were preincubated at 25°C for 10 min in the microtitre plate wells. To start the assay a 
200 µ1 sample of the p-nitroanlilide substrate (1.0 mM) was transferred to the wells 
containing the homogenate. The release of p-nitroaniline was followed by the increase in 
absorbance at 410 nm using a Microplate Spectrophotometer (Spectra MAX 340) plate 
reader. The apparent extinction coefficient of p-nitroaniline was calculated to be 6500 at 
pH 8.0 in the microtitre wells. 
3.3.2.4 Chymotryptic activity 
The assay of chymotryptic activity was based on the method of Rao and Lombardi (1975) 
with N-benzoyl-L-Tyr ethyl ester (BTEE) as the substrate. BTEE (16 mg) was dissolved 
.. in 0.5 ml of methanol and a solution of0.2% Triton X-100 in 50 mM sodium phosphate 
buffer was added slowly with shaking to give a final volume of 50 ml and substrate 
concentration of 1.0 mM. Enzyme samples were diluted with 50 mM sodium phosphate 
buffer at the appropriate pH and 50 µ1 of the samples were incubated in the presence and 
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absence of 50 µ1 of inhibitor in 50 mM sodium phosphate buffer at 25°C. After 30 min, 
50 µ1 of the incubate was transferred to a 1 ml quartz cuvette of 1 cm path length, 
containing 150 µ1 of sodium phosphate buffer. To initiate the reaction 0.8 ml of substrate 
stock was added. Buffer and substrate .stock were both preincubated at 25°C for at least 
10 min prior to the assay. The reaction was monitored by a Hewlett Packard 8452A diode 
array spectrophotometer at 256nm, with a jacketed cell maintained at 25°C by 
recirculating water. The molar extinction coefficient of was 964 (Rao and Lombardi, 
1975). Unit definition, 1 unit hydrolysed 1 µmole ofBTEE per min at 25°C. 
3.3.2.5 Carboxypeptidase A and B · activity 
The measurement of carboxypeptidase A and B was based on the relative absorbance 
difference ofhippuric acid to their the respective substrates hippuryl-L-Phe (Hipp-L-Phe) 
(King et al., 1987) and hippuryl-L-Arg (Hipp-L-Arg) (Folk et al., 1960) at 254nm. The 
molar extinction coefficients were determined by measuring the absorbance difference 
between a 1 mM solution ofhippuric acid in 5 mM sodium phosphate buffer pH 8.0 and 
1 mM solutions of Hipp-L-Phe or Hipp-L-Arg in 50 mM sodium phosphate buffer pH 
8.0, in 1 ml quartz cuvette of 1 cm path length. The molar extinction coefficients for 
Hipp-L-Phe and Hipp-L-Arg were 2 600 and 573 M-1 cm-1, respectively. Hipp-L-Phe and 
Hipp-L-Arg were dissolved in 100 ml of 50 mM sodium phosphate buffer pH 8.0 to give 
a final concentration of 1 mM. Lumenal homogenates (0.5 ml) were incubated at 25°C for 
10 min and a 0.2 ml sample was transferred to 1 ml quartz cuvettes of 1 cm path length. 
To initiate the reaction, 0.8 ml of substrate stock pre-incubated at 25°C for 10 min was 
added to the quartz cuvette. The activities were measured by following the increase in 
absorbance at 254nm resulting from the liberation hippuric acid. Absorbance was 
monitored by a Hewlett Packard 8452A diode array spectrophotometer, with a j ack:eted 





3.4.1 Lumenal proteolytic activity 
3.4.1.1 Intestinal lumen pH 
Lumenal contents of four salmon (354 ± 96 g, mean± s.d.) where collected 12 h after 
food was last released into their tank (Section 3 .3 .1.3 ). The mean pH of two readings of 
individual lumenal contents are shown in Table 3.1. 
Table 3.1 pH of the lumenal contents of salmon. 
Gut section Fish 1 Fish2 Fish 3 Fish4 Mean± s.d. 
Anterior 7.7 7.88 8.00 8.18 7.94 ± 0.2 
Middle 8.20 8.25 8.15 8.00 8.15±0.1 
Posterior 8.50 8.16 8.19 8.42 8.28 ± 0.2 
There was no significant difference in the pH of the lumen in the three sections in the 
four fish analysed (p > 0.1). For all subsequent lumenal metabolic studies 50 mM sodium 
phosphate buffer at pH 8.0 was used for consistency. 
3.4.1.2 Optimum storage conditions for lumenal extracts 
Enzyme samples had to be collected from salmon at the Portobello Marine Laboratory 
and transported to Dunedin for analysis. Lumenal gut extracts were collected (Section 
3 .3 .1.2) from the anterior, middle and posterior gut sections of a salmon (296 g), stored 
under various conditions and then assayed for proteolytic activity towards BSA (Section 
3.3.2.1). To determine the best method for enzyme storage lumenal extracts collected 
from the salmon were either immediately snap frozen in liquid nitrogen or stored on ice 
until arrival to Dunedin where the homogenates stored on ice were immediately assayed 
for general proteolytic activity (3 hr post mortem). The remaining lumenal extracts stored 
on ice together with the extracts snap frozen in liquid nitrogen were stored at -80°C for 
later analysed for general proteolytic activity. The anterior (12.7 µg of protein), middle 
I, 
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(12.9 µg of protein) and posterior (15.8 µg of protein) were incubated with BSA (1 mg, 1 
ml total volume) in 50 mM sodium phosphate buffer pH 8.0 at 15°C. Samples taken at 0, 
30, 60, 120 and 180 min were assayed for acid-soluble peptides (Section 3.3.2.1). Figure 
3 .1 illustrates that the formation of acid-soluble peptides followed pseudo-zero kinetics. 
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Figure 3.1 Time-course of the formation of acid-soluble peptides from BSA when 
incubated with the anterior (A), middle (B) and posterior (C) lumenal homogenates at pH 




Protein concentrations of the anterior, middle and posterior homogenates were 6.35, 6.45 
and 4.0 mg/ml, respectively (Section 3.3.1.6). The general proteolytic activity of anterior, 
middle and posterior gut sections after the different storage treatments are shown in Table 
3 .2. The rank order of general proteolytic activity in the three sections followed anterior > 
middle > posterior. 
Table 3.2 General proteolytic activity ofintestinal lumenal homogenates stored at 4°C for 
3h, -80°C after being stored on ice and -80°C after being snap frozen in liquid nitrogen 









3.46 ± 0.13 
2.08 ± 0.12 
Liquid nitrogen 
3.87 ± 0.19 
3.66 ± 0.16 
Posterior I · 1.56 ± 0.1 0.87 ± 0.07 1.76 ± 0.08 
a Units of proteolytic activity are mg of acid soluble peptides / h / mg of gut protein 
The proteolytic activities of the lumenal homogenates snap frozen in liquid nitrogen and 
stored at -80°C were not significantly different to freshly prepared extracts. All 
subsequent gut lumenal extracts were immediately snap frozen in liquid nitrogen on 
collection and stored at -80°C. 
3.4.1.3 Effect of feeding on lumenal protein content 
The effect of feeding on protein content in the intestinal lumen of the lower intestinal 
tract was studied. Anterior, middle and posterior lumenal contents of fish which had no 
food released into the tank for 12 h (237 ± 16 g, n = 5) and 24 h (220 ± 23 g, n = 5) prior 
to sacrifice were collected (Section 3.3.1.2). The supematants were aliquoted (100 µ1) 
into 0.5 mi sample tubes. Samples (10 µl) were analysed for protein content (Section 
3.3.1.5). Two-way analysis of variance of the total protein content of intestinal sections 
after 12 hand 24 h without food release showed there is no significant difference in 
amount of protein in the respective sections (p > 0.1, Table 3.3). However there was a 
significant difference in protein contents of the different intestinal sections. The average 
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total protein contents for the anterior, middle and posterior sections were 20.1 ± 9.3, 4.7 ± 
1.62 and 4.6 ± 1.77 mg (mean± s.d., n=lO), respectively. Post anova-analysis by least-
significant differences showed the protein content of the anterior section to be 
significantly greater than the middle or posterior sections (p < 0.001) while the difference 
between middle and posterior sections was not significant (p > 0.5). 
Table 3.3 Two-way analysis of variance of the protein content of the anterior, middle and 
posterior intestinal sections after 12 and 24 h without food release. 
























The lumenal samples of the salmon which had no feed released into the tank 12 h and 24 
h prior to collection were assayed for general proteolytic activity (Section 3.3.2.1). Table 
3 .4 shows the specific activities and total proteolytic activities in each section for both 
feeding groups of salmon. 
Table 3.4 Effect of feeding on specific activities and total activities of the anterior, 






2338 ± 468a 
2255 ± 366 
1110 ± 424 
12h 
Total Act. 
51156 ± 1805° 
8917 ± 2010 
4964 ± 1093 
a µg /h/mg of protein (mean± s.d., n=5) 
b µg/h/gut section (mean± s.d., n=5) 
Sp Act. 
3231 ±.524 




58196 ± 2345 
9819 ± 1810 





Two-way analysis of variance showed that there was no significant difference in the 
proteolytic activity (Table 3.5) or total activity (Table 3.6) between salmon which had no 
food released for 12 hand those which had no food released for 24 h (p > 0.1). However 
there was a significant difference in proteolytic activities and total activities between the 
three gut sections (p < 0.001). 
Table 3.5 Two-way analysis of variance of specific proteolytic activity of the anterior, 
middle and posterior intestinal sections after 12 and 24 h without food release. 
Source DF ss MS F-value 
Time 1 821377 821377 1.06 
Section 2 14700659 7350329 9.5 
Interaction 2 1199766 599883 0.77 
Error 24 18648618 777026 
Total 29 35370420 
Table 3.6 Two-way analysis of variance of total activity of the anterior, middle and 
posterior intestinal sections after 12 and 24 h without food release. 























The mean specific proteolytic activities of the anterior, middle and posterior sections for 
combined fed groups were 2784 ± 490, 2242 ± 395 and 1107 ± 123 µg / h per mg of 
protein (mean± s.d., n = 10), respectively. Post anova analysis by least significant 
differences show that the proteolytic a~tivity of the posterior section was significantly 
lower than the anterior (p < 0.05) and middle sections (p <0.1). However there was no 
significant difference between the anterior and middle intestinal sections (p > 0.1 ). Total 













2.0 and 5.1 ± 0.9 mg/ h per intestinal section (mean± s.d., n = 10), respectively. The 
total activity of the anterior intestinal section was significantly greater than the middle (p 
< 0.05) and posterior sections (p < 0.025). There was no significant difference in total 
proteolytic activity between the middle and posterior sections (p > 0.1 ). The rank order of 
proteolytic and total activities in the anterior, middle and posterior sections of individual 
fish is shown in Table 3.7. For proteolytic activity and total activity no fish had the rank 
order middle > posterior > anterior or posterior > anterior > middle. The order of activity, 
anterior > middle > posterior Was observed in 5 salmon for specific proteolytic activity 
and 7 for total activity. The probability of such an event or a more extreme result 
occurring randomly is 0.015 and 0.000267, respectively. 












Mid>Anter>Post Post>Mid> Anter 
++ + 
a No fish showed the frequency order ofMid>Post>Anter or Post>Anter>Mid for either 
proteolytic activity and total activity 
3.4.1.5 LHRH digestion by pancreatic enzymes 
The digestion of human and salmon LHRH by pure pancreatic enzymes trypsin, 
a-chymotrypsin and elastase was investigated. LHRH (0.1 mM) analogues were 
incubated with the pancreatic enzymes at 2.5 µg/ml in 50 mM sodium phosphate buffer 
pH 8.0 at 15°C. Electrophoretograms of human and salmon LHRH chymotryptic digests 
are shown in Figures 3.2 and 3.3. The rate of the disappearance of the human and salmon 
LHRH in electrophoretograms peak followed pseudo-zero kinetics with half-lives of2.5 
± 0.3 and 2.7 ± 0.4 min (mean± s.d., n=3), respectively. Chymotryptic digestion of 






9.4 min, with native human LHRH eluting after 10.7 min (Figure 3.2). Salmon LHRH 
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Figure 3.2 Capillary electrophoretic separation of the chyrnotryptic hLHRH digest 
(Section 3.3.2.2). Digests were analysed after O (A), 2 (B) and 10 (C) min incubation at 
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Figure 3.3 Capillary electrophoretic separation of the chymotryptic sLHRH digest 
(Section 3.3.2.2). Digests were analysed after O (A), 2 (B) and 10 (C) min incubation at 





Elastase from porcine pancreas hydrolysed human LHRH resulting in the formation of a 
single metabolite migrating after 8.18 min, with the native LHRH eluting after 10.7 min 
(Figure 3.4). Elastase digestion of the salmon LHRH resulted in the formation of a single 
metabolite that eluted after 13.8 min with the native salmon LHRH eluting after 17.8 min 
(Figure 3.5). The half-lives of human and salmon LHRH in the presence of elastase were 
90 ± 15 and 114 ± 21 min (mean± s.d., n=3), respectively. When trypsin (TPCK treated) 
:from bovine pancreas was incubated with human and salmon LHRH, no degradation was 
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· Figure 3.4 Capillary electrophoretic separation of the elastase digest ofhLHRH (Section 
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Figure 3.5 Capillary electrophoretic separation of the elastase digest of sLHRH (Section 
3.3.2.2). Digests were analysed after O (A) and 60 (B) min incubation at pH 8.0, 15°C 
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Figure 3.6 Capillary electrophoretic separation of the trypsin hLHRH (A) and sLHRH 
(B) digest (Section 3.3.2.2). Digests were analysed after 120 min incubation at pH 8.0, 








3.4.1.6 LHRH digestion by lumenal enzymes 
Lumenal contents were collected from salmon (234 ± 34 g, n=6) and intestinal sections 
dissected, prepared and pooled (Section 3.3.1.2). Anterior (1.3 µg of protein), middle (1.3 
µg of protein) and posterior (1.35 µg of protein) lumenal extracts were incubated in 
50 mM sodium phosphate pH 8.0 (200 µl total volume) for 30 min at 15°C. LHRH was 
added (0.2 mM, 250 µl total volume), samples taken at 0, 60 and 120 min were analysed 
by capillary electrophoresis (Section 3.3.2.2). Electrophoretograms of human and salmon 
LHRH analogues digested by the anterior, middle and posterior lumenal extracts are 
shown in Figures 3.7 and 3.8. The human and salmon LHRH analogues eluted after 15.5 
and 24.5 min, respectively. Each LHRH analogue digested to give a unique metabolic 
profile that was common to each of the lumenal sections. Degradation followed pseudo-
zero order kinetics. Table 3.8 shows the half-lives of both hLHRH and sLHRH in the 























































Figure 3.7 Capillary electrophoretic separation ofhLHRH (A) and hLHRH lumenal 
digests by the anterior (B), middle (C) and posterior (D) intestinal section (Section 
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Figure 3.8 Capillary electrophoretic separation of sLHRH (A) and sLHRH lumenal 
digests by the anterior (B), middle (C) and posterior (D) intestinal section (Section 





Table 3.8 Half-lives (min) ofhLHRH and sLHRH in the anterior, middle and posterior 
lumenal homogenates. 
Half-lives (minl 
LHRH analogue I Anterior Middle Posterior 
hLHRH I 28.8 ± 2.9 27.4 ± 4.2 58.4 ± 5.0 
sLHRH I 26.9 ± 2.9 26.7 ± 4.1 52 ± 3.6 
a Half-lives represents the mean± s.d., n = 3. 
Two-way anova analysis showed that there was no significant difference between the 
half-lives ofhLHRH and sLHRH (p > 0.1) in each intestinal section, however the half-
lives of the LHRH analogues were significantly different between intestinal sections 
(p < 0.001, Table 3.9). Post anova analysis by least-significant differences methods 
showed that there were no significant differences between half-lives ofLHRH analogues 
in the anterior and middle extracts (p > 0.5), however the half-lives in the anterior and 
middle extracts were significantly shorter than in the posterior section (p < 0.001). 
Table 3.9 Two-way analysis of variance of half-lives ofhLHRH and sLHRH in the 
anterior, middle and posterior lumenal homogenates. 
Source .DF ss MS F-value 
LHRH analogue 1 29.6 29.6 2.5 
Section 2 28565 1432.5 122.4 
Interaction 2 9.7 4.9 0.42 
Error 12 140.8 11.7 
Total 17 3045.3 
3.4.1.7 Specific proteolytic activity 
The lumenal activity towards specific substrates of different proteases was determined in 
the anterior, middle and posterior of the intestinal tract. The intestinal lumenal 
homogenates (10 µg of protein) were assayed for specific activity using synthetic 
substrates at pH 8.0 at 25°C (Sections 3.3.2.3-3.3.2.5). Figure 3.9 shows that highest 
proteolytic activity of trypsin, chymotrypsin, elastase, and carboxypeptidase A and B 










ofleucine aminopeptidase was found in the posterior section. The relative distribution of 
trypsin, chymotrypsin, elastase, carboxypeptidase A & Band aminopeptidase (total units) 
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Figure 3.9 Specific activity of trypsin (A), chymotrypsin (B), elastase (C) and 
carboxypeptidase A (D) and B (E) and leucine aminopeptidase (F) in the 
anterior, middle and posterior intestinal sections (mean± s.d., n=3). The intestinal 
lumenal homogenates (10 µg of protein) were assayed for specific activity at pH 8.0, 
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Figure 3.10 Relative distribution of general proteolytic activity, trypsin, chymotrypsin, 
elastase, carboxypeptidase A and B and leucine aminopeptidase activity of the lower 
intestinal tract. General proteolytic activity was measured using BSA as the substrate 
(Section 3 .3 .2.1) remaining proteolytic activities were determined using synthetic 
substrates (Sections 3.3.2.3-3.3.2.5). Anterior C• ), middle (D) and posterior (fl) 
intestinal sections. The data represents the mean of three experiments. 
3.4.2 Mucosal proteolytic activity 
3.4.2.1. Collection and storage of mucosal homogenates 
Methods for the extraction and storage of mucosal homogenates were investigated based 
on proteolytic activity of posterior mucosal homogenate towards human LHRH. Firstly, 
the mucosa was prepared from whole frozen intestine of salmon (234 ± 15 g, n=5) 
(Section 3.3.1.4). The homogenised mucosae were prepared from whole frozen intestine 
immediately assayed for hLHRH metabolism (Section 3.3.2.2) and the remaining 
material stored at -80°C to be assayed for hLHRH metabolic activity at a later date. 









50 mM sodium phosphate buffer pH 7.4 at 15°C. The degradation ofhLHRH followed 
pseudo-zero order kinetics. Fresh posterior mucosa prepared from whole intestine 
hydrolysed hLHRH with a half-life of 51 ± 2.5 min (mean± s.d., n=3), while the mucosa 
stored at -80°C hydrolysed hLHRH with a half-life of93 ± 14 min (mean± s.d., n=3). 
Secondly, mucosa was prepared from fresh intestine and snap frozen in liquid nitrogen at 
the Portobello Marine Laboratory and stored at -80°C on arrival to Dunedin (Section 
3.3.1.4). The half-life ofhLHRH in this posterior mucosal homogenate was 41 ± 4.0 min 
(mean± s.d., n=3). Since the mucosa extracted, homogenised and snap frozen at 
Portobello Marine Laboratory gave the highest metabolic activity towards hLHRH, 
mucosa prepared this way were used for all subsequent studies. 
3.4.2.2 Stability of LHRH in mucosal homogenates 
The metabolic stability of human and salmon LHRH in middle and posterior mucosal 
homogenates were determined. Both human and salmonLHRH (0.2 mM) were 
metabolically stable in the middle mucosa (50 µg/ml of protein) when incubated at 15°C, 
pH 7.4 for 4 h. However under the same conditions both LHRH analogues were degraded 
in the posterior mucosal homogenate (Figure 3 .11 ). The degradation of both LHRH 
analogues followed pseudo-zero order kinetics. The half-lives of the human and salmon 
LHRH analogues in the posterior mucosal homogenate were 111 ± 10 min and 101 ± 8 
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Figure 3.11 Capillary electrophoretic separation ofhLHRH (A), and hLHRH posterior 
.l. mucosal digest (B), sLHRH (C) and sLHRH posterior mucosal digest (D) (Section 












3.4.2.3 General proteolytic activity 
The proteolytic digestion of BSA in the middle and posterior mucosal homogenates 
(Section 3.3.2.1) is shown in Figure 3.12. Mucosal homogenates (20 µg of protein) were 
incubated with BSA (1mg, · 1 ml total volume) in 50 mM sodium phosphate buffer pH 7.4 
at 15°C (Section 3 .3 .2.1 ). The formation of acid-soluble peptides from BSA followed 
pseudo-zero order kinetics. The general proteolytic activities of the middle and posterior 
mucosa! homogenates were 442.4 ± 28 µg / h per mg of protein and 664 ± 36 µg / h per 
mg ofmucosal protein, respectively (mean± s.d., n = 3) and were significantly different 
(p < 0.005). 




"O -'[) ~ 15 -
ro '-' 
C+-t f/l 
0 ~ 10 i:1 ...... 
. 8 a .._. ~ 5 § 0.. . R---
• 
& 0 I-~~~~~.--~~~~--.~~~~~-, 
0 20 40 60 
Time (min) 
Figure 3.12 Time-course of the formation of acid-soluble peptides from BSA after 
incubation with the middle (open circles) and posterior (closed circles) mucosal 










3.4.2.4 Distribution of proteolytic enzymes 
The distribution of proteolytic enzymes was determined in the middle and posterior 
mucosa. Mucosal homogenates (12.5 µg of protein) were assayed for specific proteolytic 
activities towards synthetic substrates at pH 7.4, 25°C (Sections 3.3.2.3 & 3.3.2.4). 
Specific activities towards the synthetic substrates for trypsin, chymotrypsin, elastase and 
leucine aminopeptidases are shown in Table 3.10. Posterior tryptic-like and 
chymotryptic-like activity was 2.5- and 6-fold higher than in the middle mucosa (p < 
0.001), respectively. Leucine aminopeptidase activity in the middle and posterior mucosa 
were similar (p > 0.05) and no elastase proteolytic activity was found in the middle or 
posterior mucosa. 
Table 3 .10 Specific activities of the middle and posterior mucosal homogenates towards 
the synthetic substrates for trypsin, chymotrypsin, elastase and leucine aminopeptidase. 
Specific activitiesa 
Intestinal Trypsin-like Chymotrypsin Elastase-like Leucine 
section -like aminopeptidase 
Middle 2.6 ± 0.06 80 ± 21 0 53 ± 1.5 
Posterior 6.2 ± 0.5 470 ± 26 0 57 ± 1.1 












3.4.3 Inhibition of proteolytic activity 
3.4.3.1 Inhibition of proteolysis by bile salts 
The effect of bile salts on the proteolytic activity of intestinal lumenal extracts were 
tested at bile salt concentrations of 2 mM and 5 mM. Bile salts at concentrations above 
the critical micelle concentration (CMC) have the potential to trap lipophilic enzyme 
substrates inside the micelles, resulting in reduced enzyme hydrolysis. The CMC of 
deoxycholic acid (DOC) in 50 mM sodium phosphate buffer pH 8.0 was determined 
using a surface tension method (Section 3.3.1.7). Figure 3.13 shows the plot of surface 
tension against the log concentration of DOC. The CMC of DOC was determined 
graphically from the intersection of the extrapolated linear portions of the data. The CMC 
of DOC in 50 mM sodium phosphate buffer pH 8.0 was 3 mM. 
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Figure 3.13 Change in surface tension with concentration of sodium deoxycholate in 
50 mM sodium phosphate buffer pH 8.0 (Section 3.3.1.7) . 
DOC at concentrations above and below the CMC was effective in inhibiting salmon 
lumenal proteolytic activities of trypsin, chymotrypsin and aminopeptidase as shown in 
Table 3.11 (p < 0.005). Samples of lumenal homogenates (15-20 µg of protein) were 














µl total volume) for 30 min at 25°C and were assayed for specific proteolytic activities 
(Sections 3.3.2.3 & 3.3.2.4). The rank order of DOC inhibition of these enzymes 
followed: leucine aminopeptidase > trypsin > chymotrypsin. DOC at 2 and 5 mM was 
ineffective in inhibiting elastase proteolytic activity. 
Table 3 .11 Effect of sodium deoxycholate on proteolytic activities of the intestinal 
lumenal contents. 
Inhibition of proteolytic activity in intestinal 
lumenal sections (% inhibitiont 
Proteolytic DOC(mM) Anterior Middle Posterior 
activity 
Tryptic 2 43 ±2.0 21 ± 1.7 10 ± 0.5 
5b - - -
Chymotryptic 2 11 ± 1.0 8 ± 0.8 11 ± 1.2 
5 10 ± 0.8 8 ± 1.2 10 ± 0.9 
Elastase 2 0 0 0 
5 0 0 0 
Leucine 2 100 100 100 
aminopeptidase 5 100 100 100 
a data are means± s.d., n=3. 
b substrate precipitated in the presence of bile salt 
Table 3.12 shows that DOC at 2 mM and 5 mM significantly inhibited the intestinal 
lumenal activity towards BSA in all intestinal sections (p < 0.005). Samples of the 
anterior (13.77 µg of protein), middle (16.5 µg of protein) and posterior (17 µg of 
protein) intestinal lumenal homogenates were assayed for general proteolytic activity 
(Section 3.3.2.1) in 50 mM sodium phosphate buffer pH 8.0 in the absence and presence 
of DOC at 2 mM and 5 mM. The inhibition of proteolytic activity at 5 mM was 











Table 3 .12 Percentage inhibition of general proteolytic activity of lumenal homogenates 
in the presence of 2 mM and 5 mM sodium deoxycholate. 
Intestinal section Inhibition of proteolytic activity in the intestinal lumenal sections 
(% inhibitiont 
Control0 DOC (2mM) DOC (5 mM) 
Anterior 2599 ± 241 40 ± 2.5 45 ±2.6 
Middle 2226 ± 262 46 ± 1.9 54 ± 3.5 
Posterior 1088 ± 73 · 29 ± 1.5 40 ±4.6 
a data are means± s.d., n=3. 
b Specific activity µg / h / mg of protein (mean± s.d., n=3). 
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3.4.3.2 Inhibition of proteolysis by chelators 
The divalent ion chelators, Carbopol934P (CP934P), citric acid and EDTA had variable 
effects on the inhibition of the proteolytic activities of the intestinal lumen (Table 3.13). 
Samples of the anterior (13.77 µg of protein), middle (16.5 µg of protein) and posterior 
(17 µg of protein) intestinal lumenal homogenates were assayed for general proteolytic 
activity (Section 3.3.2.1) in 50 mM sodium phosphate buffer pH 8.0 in the absence and 
presence of CP934P 0.35 % (w/v), citric acid (10 mM) and EDTA (2 mM). The rank 
order of the effectiveness of the chelators followed EDTA > CP93P > citric acid (Table 
3.13). The formation of acid-soluble peptides in the presence of CP934P followed 
pseudo-zero order kinetics, in contrast to the autolytic profile described by LueBen et al. 
(1995). In comparison to CP934P, EDTA was several-fold more effective as an inhibitor 
of general proteolytic activity and most effective in the posterior intestinal region (Table 
3.13). When lumenal extracts (15-20 µg of protein) were assayed for trypsin, 
chymotrypsin and elastase activity at pH 8.0, 25°C in the presence of 2 mM EDTA no 
inhibition of activity was observed (Sections 3.3.2.3 & 3.3.2.4). Under the same 
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Table 3 .13 Percentage inhibition of general proteolytic activity of the intestinal lumen in 
the presence of CP934P, citric acid and EDT A. 
Intestinal Controt Percentage inhibitionu 
section CP934P Citric acid 
Anterior 2599 ± 241 7±2 7 ± 1.5 
Middle 2226 ± 262 14± 3 2 ± 0.5 
Posterior 1088 ± 73 11 ±2 3 ± 1.2 
a Specific activity µg / h / mg of protein (mean± s.d., n=3) 
b data are means± s.d., n=3 . 
3.4.3.3 Effect of soybean trypsin inhibitor 
EDTA 
15 ±2 
16 ± 1.5 
30 ± 2.5 
The effect of the SBTI on proteolytic activities of the intestinal lumen was studied. The 
effect of SBTI on the general proteolytic activity could not be determined as the 
formation of acid-soluble peptides was masked by the polypeptide inhibitor itself. The 
inhibition of lumenal trypsin, chymotrypsin and elastase by soybean trypsin inhibitor was 
determined using their respective synthetic substrates (Sections 3.3.2.3 & 3.3.2.4) . 
Anterior, middle and posterior sections (10 µg of protein) were incubated with 0.5 and 
1.0 mg soybean trypsin inhibitor (200 µl total volume) at 15°C for 10 min. Aliquots (50 
µ1 sample) were assayed for trypsin, chymotrypsin and elastase activity at pH 8.0, 25°C 
(Sections 3.3.2.3 & 3.3.2.4). Trypsin and chymotrypsin activity was completely inhibited 
in all intestinal sections at both concentrations of the inhibitor; however SBTI was only 
partially effective in inhibiting elastase activity (Table 3.14). 
Table 3.14 Percentage inhibition oflumenal elastase proteolytic activity by soybean 
trypsin inhibitor at 1 :50 and 1: 100 intestinal extract : soybean trypsin inhibitor. 
Intestinal section Percentage inhibitiona 
1:50 1:100 
Anterior 61 ± 2.0 65 ± 2.5 
Middle 55 ± 2.4 62 ± 2.0 
Posterior 66 ±2.2 56 ± 1.5 









3.4.3.4 Inhibition of lumenal LHRH proteolysis 
The effects of various inhibitors on the lumenal proteolytic activity towards human and 
salmon LHRH (0.2 mM) were determined. The inhibitors EDTA (2 mM), SBTI (2.0 
mg/ml), DOC (5 mM) and CP934P (0.35 % w/v) were incubated with the lumenal 
homogenates (1.25 µg of protein) in 50 mM sodium phosphate buffer pH 8.0 at 15°C 
(Section 3.3.2.2). Figures 3.14 & 3.15 show the half-lives of human and salmon LHRH in 
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Figure 3.14 Half-lives ofhLHRH in anterior (A), middle (B) and posterior (C) lumenal 
homogenates in the absence (control) and presence ofEDTA, SBTI, DOC and 
CP934P. Half-life represents the mean time (min± s.d., n = 3) for the LHRH 
concentration to drop to half its initial concentration. N.S. not significantly different 
from control,(*) p < 0.01, (**) p < 0.005, (***) p < 0.0025, (****) p < 0.001. 
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Figure 3.15 Half-lives of sLHRH in anterior (A), middle (B) and posterior (C) lumenal 
homogenates in the absence ( control) and presence of EDTA, SBTI, DOC and 
CP934P. Half-life represents the mean time (min± s.d., n = 3) for the LHRH 
concentration to drop to half its initial concentration. N.S. not significantly different 
from control,(*) p < 0.01, (**) p < 0.005, (***) p < 0.0025, (****) p < 0.001, compared 












Human and salmon LHRH analogues were most stable in the presence of soybean trypsin 
inhibitor, which increased the half-lives of the LHRH analogues between 7.5- to 15-fold 
in the anterior, middle and posterior intestinal sections. CP934P increased the half-lives 
of the LHRH analogues in the anterior, middle and posterior sections between 1. 7 and 
2. 7-fold. Figure 3 .16 shows a typical peak height versus time profile of human LHRH 
incubated in the anterior lumenal homogenate in the presence and absence of CP934P. 
The rank order of effectiveness of protease inhibitors at the concentrations tested to 
protect human and salmon LHRH analogues in the lumen of the anterior, middle and 
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Figure 3.16 Time-course ofhLHRH proteolysis when incubated with the anterior lumenal 
homogenate in the presence ( open circles) and absence of CP934P (0.35% w/v) ( closed 







3.4.3.5 Inhibition of mucosal proteolytic activity 
Since both human and salmon LHRH analogues were stable in the middle intestinal 
mucosa homogenates (Section 3.4.2.2) the effects of various protease inhibitors on 
stabilising the LHRH analogues were only tested in the posterior mucosa! homogenate. 
The effects of SBTI (2 mg/ml), DOC (5 mM), bestatin (3.5 mM) and EDTA (2.0 mM) on 
the rates of hydrolysis of human and salmon LHRH analogues in the posterior mucosal 
homogenates (50 µg/ml) are shown in Figure 3.17 (Section 3.3.2.2). The human and 
salmon LHRH analogues were markedly stabilised by EDTA, DOC and the 
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Figure 3.17 Half-lives of hLHRH (A) and sLHRH (B) in posterior mucosal homogenates 
in the absence (control) and presence ofEDTA, DOC, bestatin and SBTI. Half-life 
represents the mean time for the concentration of LHRHs to fall to half its original 
concentration (min± s.d., n = 3). N.S. not significantly different from control, 








3.5.1 Lumenal proteolytic activity 
The intestine of the salmon was divided into three anatomically distinct sections: anterior, 
middle and posterior as described in (Section 1.4.1). There was no significant difference 
in the lumenal pH of the anterior, middle and posterior intestinal sections (Section 
3.4.1.1 ). Consequently the lumenal proteolytic activities of the three intestinal sections 
were determined at pH 8.0 for consistency. Previously, Ash (1980) measured the pH of 
the lumenal contents of trout and reported lower pH values for the anterior section of7.5-
7.6 with similar pH values for the middle (7.8-8;0) and posterior of (7.8-8.4) sections. 
Supematants of lumenal homogenates that were immediately snap frozen in liquid 
nitrogen and stored at -80°C had the highest lumenal proteolytic activity towards BSA 
(Section 3.4.1.2). Therefore all subsequent homogenates were stored in this way for 
metabolic analysis. 
There was no significant difference in the general proteolytic activity or protein content 
between salmon which had no food released into their tank either 12 h or 24 h prior to 
collection (p > 0.1) (Sections 3.4.1.3 & 3.4.1.4). Previous studies by Einarsson et al. 
(1996) reported that Atlantic salmon starved from 2 days onwards resulted in 
significantly lower levels of trypsin and chymotrypsin activity in the intestinal lumen. It 
would appear that the extra 12 h period without release of feed was not long enough to a 
cause significant decrease in the lumenal proteolytic activity. The relative standard 
deviation of the general proteolytic activities of combined intestinal sections from the 12 
and 24 h fasted groups were 57 and 54%, respectively. Therefore the longer period 
without feeding did not improve the reproducibility of proteolytic activities among 
individual fish. 
In both fasted groups of fish there was a significant difference between both the specific 
proteolytic activities and total proteolytic activities of the anterior, middle and posterior 
intestinal sections (p < 0.001). The proteolytic activity and the total proteolytic activity 















(p < 0.05) and middle (p < 0.1) intestinal sections (Section 3.4.1.4). A large biological 
variation in proteolytic activities was observed among individual fish. The RSD for the 
anterior, middle and posterior general proteolytic activity were 62, 43 and 59%, 
respectively. Potentially, this high biological variability in proteolytic activity among fish 
will effect the oral bioavailability of protein and peptide drugs among salmon. The 
observation that proteolytic activity decreases distally along the intestinal tract was 
further supported by ranking the proteolytic activities and total activities of individual 
salmon (Section 3.4.1.4). The rank order anterior> middle> posterior was observed in 5 
out 10 salmon for proteolytic activities and for 7 out of 10 for total activities. Since the 
probabilities these frequencies (or greater) occurring randomly are 1 in 67 and 1 in 3750 
then we can conclude that the posterior intestine has the lowest proteolytic activity 
towards BSA. 
The progressive decrease in lumenal proteolytic activity towards the anus has been 
observed in a number of other fish species (Hofer and Schiemer, 1981, Hofer, 1982), 
including trout (Krogdahl et al., 1994). In trout the lumenal tryptic activity towards the 
synthetic substrate benzoyl-L- Arg- p-nitroanilide of the middle intestine was 3-fold 
greater than in the posterior intestine (Krogdahl et al., 1994). The lower levels of 
activated pancreatic endopeptidases in the lower intestinal lumen have been investigated 
in a number of mammals, with conflicting conclusions. Investigators believe that the 
lower levels of activated pancreatic enzymes are due to, autolytic degradation (Roy et al., 
1967, Bohe et al., 1983) enteropancreatic circulation (Beyon and Kay, 1976, Diamond, 
1978) inactivation by the intestinal microflora (Genell et al., 1977) or binding to 
intestinal particles (Goldberg et al., 1969). In vitro experiments with the intestinal 
lumenal fluid of roach showed only small losses of proteolytic activity during the time 
corresponding to the natural gut passage times, suggesting that the progressive decrease 
in proteolytic activity along the fish intestine is not due to autolysis (Hofer and Schiemer, 
1981). 
The pancreatic endopeptidases, trypsin, chymotrypsin and elastase were expected to be 










intestinal lumen. Human and salmon LHRH analogues are C-terminally and N-
terminally blocked and therefore were not expected to be hydrolysed by the 
exopeptidases carboxypeptidases A and B or the aminopeptidases (MacCann, 1977). The 
possible cleavage sites for the pancreatic endopeptidases are summarized in Figure 3 .18. 
Trypsin activity is specific towards lysine and arginine residues (Keil-Dlouha et al., 
1971 ), chymotrypsin activity is specific towards phenylalanine, tryptophan and tyrosine 
(Baumann et al., 1970), whereas elastase has a broad specificity hydrolysing adjacent to 
alanine, serine, glycine and valine amino acid residues (Atlas et al., 1970). 
C E E T 
Human LHRH pGlu-His-Trp-!.--serl.·-Tyrt-G1y-!.--Leu-Arg-!.--Pro-Gly-NH2 
C 
C E E 
Salmon LHRH pGlu-His-Trp-!.--ser-!.--Tyrt-G1y-!.--Trp-Leu-Pro-Gly-NH2 
C 
Figure 3.18 Potential cleavage sites of human and salmon LHRH by trypsin (T), 
chymotrypsin (C) and elastase (E). 
In order to determine the relative contribution of each of the pancreatic endopeptidases to 
the lumenal degradation of the LHRH analogues, bovine trypsin (TPCK-treated), bovine 
a-chymotrypsin (TLCK-treated) and porcine elastase were incubated at 15°C at pH 8.0 
with 0.1 mM of human and salmon LHRH (Section 3.4.1.5). Under these conditions only 
chymotrypsin and elastase hydrolysed the LHRH analogues. Chymotrypsin rapidly 
degraded both human and salmon LHRH analogues with half-lives (min) of 2.5 ± 0.3 and 
2.7 ± 0.4 min (mean± s.d., n = 3), respectively. Human and salmon LHRH were 
considerably more stable in the presence of elastase with half-lives (min) of 90 ± 15 and 
114 ± 21 (mean± s.d., n = 3), respectively. The metabolic stability of salmon LHRH 
analogue to trypsin was expected as there are no potential cleavage sites for trypsin; 
however, for human LHRH the Arg8 residue is a potential cleavage site for trypsin 





endopeptidases can be divided into sul;,sites which bind residues of the peptide substrate 
on either side of the scissile bond. Schechter and Berger (1967) introduced a binding site 
notation to indicate the position of the amino acid residues in relation to the enzyme 
cleavage site described by Figure 3.19. Using a series of peptides Schellenberger et al. 
(1993) showed that the presence of a Pro residue in the P' 1 site of the substrates is not 
tolerated in the S' 1 subsite of trypsin and thereby prevents the catalytic acyl transfer 
reaction. This supports the stability ofhLHRH to trypsin. 
acyl enzyme 
C 
S3 S2 S1 I S1' Si S3' 
COOH 
Figure 3 .19 Schematic representation of enzyme-substrate complex. The active subsites 
(S) of the enzyme are located on both sides of the catalytic site (C) of the substrate (P). 
The primary chymotryptic and elastase metabolites generated from the respective human 
and salmon LHRH analogues had similar electrophoretic mobilities (Section 3.4.1.5). 
Figure 3 .18 shows that the predicted :fragments generated by elastase cleavage would 
differ by only one small unionised amino acid to that predicted for chymotrypsin. This 
small increase in molecular weight may not alter the electrophoretic mobility sufficiently 
to resolve a different cleavage pattern from elastase digestion compared to chymotrypsin. 
Elastase proteolytic activity towards the LHRH analogues was dramatically lower than 
the proteolytic activity observed by chymotrypsin. Using synthetic substrates it was 
shown that the specificity of elastase is reduced greatly by large amino acids at the P' 1 
residue subsite (Schellenberger et ai., 1989). According to Scheme 3.1 the P'l side 
chains of the predicted elastase cleavage sites of human LHRH include tyrosine and 
leucine while the corresponding P' 1 side chains of salmon LHRH include tyrosine and 






therefore are expected to reduce the subsite specificity of the porcine elastase for those 
sites. The low proteolytic activity observed by the porcine elastase could alternatively be 
attributed to contaminant chymotrypsin activity, as the elastase preparation has no 
specific inhibitor of chymotrypsin. These results indicate that chymotrypsin is the major 
metabolic barrier of the intestinal lumen to LHRH. 
The rates of proteolysis of human and salmon LHRH by the intestinal lumen were similar 
and showed regional differences within the lower intestinal tract of salmon. The rate of 
degradation of human and salmon LHRH analogues in the anterior and middle intestinal 
sections were approximately 2-fold higher than in the posterior intestinal section 
(p < 0.01). However the electrophoretic profiles of human and salmon LHRH digests 
were the same in each intestinal section. The generation of the same metabolic fragments 
from human and salmon LHRH in each intestinal section suggests that the same 
proteolytic enzymes are involved in the proteolysis of LHRH. The similar degradation 
rates of human and salmon LHRH in the different intestinal sections suggests that both 
LHRH analogues are hydrolysed by the same protease. The primary metabolites of the 
hLHRH lumenal digests (Figure 3.7, B-D) had a similar electrophoretic pattern to the 
a-chymotrypsin digest ofhLHRH (Figure 3.2, B). This suggests that a-chymotrypsin is 
the major intestinal enzyme for the metabolism of both LHRH analogues. The 
electrophoretic pattern of the sLHRH digest by lumenal enzymes (Figure 3.8) was much 
more complex than for a-chymotrypsin digest of sLHRH (Figure 3.3). This suggests that 
lumenal proteases other than a-chymotrypsin are involved in the hydrolysis of sLHRH. 
However this observation does not preclude a-chymotrypsin as being the primary 
protease involved in the hydrolysis of sLHRH. The lumenal proteases involved in 
generating the new metabolic fragments may only be active on the primary metabolites 
generated by a-chymotrypsin. 
By the use of specific synthetic substrat.es the distribution of the major proteases of the 
intestinal lumen was surveyed (Section 3 .4.1. 7). Because each enzyme has different 
catalytic activities towards its synthetic substrate, specific activities of the different 








enzyme activities exist in the intestinal lumen of salmon and serves as evidence of the 
ability of the lumen to digest a wide range of protein and peptide drugs. The proteolytic 
activities observed include trypsin, chymotrypsin, elastase, carboxypeptidase A, 
carboxypeptidase Band leucine aminopeptidase. Most of the proteolytic activities were 
shown to reside in the anterior and middle intestinal sections (Figure 3.10). The higher 
proteolytic activities in the anterior and middle sections correlate with the higher 
proteolytic activities towards BSA and the LHRH analogues observed in these regions. 
The effects of inhibitors in stabilising the LHRH analogues in the lumenal homogenates 
were variable (Section 3.4.3.4). The relative potency of each inhibitor was similar in each 
intestinal section, supporting the previous observation that the same proteases are 
involved in the hydrolysis of the LHRH analogues in each intestinal section. 
Soybean trypsin inhibitor (SBTI), a known inhibitor of mammalian trypsin and 
a-chymotrypsin activity was shown to completely inhibit lumenal chymotrypsin and 
trypsin activity of salmon (Section 3.4.3.3). SBTI also inhibited lumenal elastase activity 
by 55-65% of control activity. SBTI was the most effective inhibitor for stabilising the 
LHRH analogues against lumenal proteolytic attack. This indicates that the serine 
endopeptidases are the principle proteases involved in LHRH hydrolysis in the salmon 
intestinal lumen. 
Using synthetic substrates, it was observed that chymotrypsin and trypsin activities of the 
salmon intestinal lumen are also inhibited by DOC. Metabolic studies with purified 
pancreatic enzymes (Section 3.4.1.5) suggest that the inhibition ofLHRH hydrolysis by 
DOC is due to the inhibition of chymotrypsin activity. The divalent ion chelator EDTA, 
has no effect on the trypsin, chymotrypsin and elastase activities of the salmon intestinal 
lumen (Section 3.4.3.2). Likewise EDTA was ineffective in stabilising the LHRH 
analogues in the intestinal lumen of salmon (Figures 3.14 & 3.15). The divalent ion 
chelators EDTA and CP934P were effective in inhibiting lumenal proteolytic activity 
towards BSA (Section 3.4.3.2), indicating the involvement ofmetalloproteinases 







CP934P. EDTA inhibition in the posterior intestine was 2-fold greater than the anterior 
and posterior sections (Table 3 .13), suggesting a higher concentration of 
metalloproteinases reside in the posterior intestine. 
CP934P was effective in reducing the intestinal lumenal proteolytic activity towards the 
LHRH analogues (Section 3.4.3.4). The half-lives of the LHRH lumenal hydrolysis were 
increased between 1. 7 and 2. 7-fold in the presence of CP934P. The rates of hydrolysis in 
the presence of CP934P followed pseudo-zero order kinetics (Figure 3.16). This is in 
contrast to work by Junginger and co-workers (LueBen et al., 1995 and 1996c) who 
reported the rates of cx-chymotrypsin and trypsin hydrolysis in the presence of CP934P 
followed second-order kinetics, indicative of enhanced enzyme autolysis. They 
postulated that CP934P chelates essential divalent ions from the proteases, resulting in 
the opening the protease structure to autolytic attack. The comparatively lower inhibition 
of salmon lumenal proteases by CP934P suggests that the lumenal proteolytic enzymes of 
the salmon intestine may either have a lower requirement for divalent ions or a higher 
affinity for their divalent ions compared to the mammalian proteases (Section 1.4.2.1). 
4.5.2 Mucosal proteolytic activity 
The posterior mucosal homogenates prepared from fresh intestines and snap frozen in 
liquid nitrogen gave the higher hLHRH proteolytic activity compared to mucosa prepared 
from frozen intestine and assayed immediately after homogenisation (Section 3 .4.2.1 ). 
Subsequently mucosal homogenates were prepared from fresh intestine and snap frozen 
in liquid nitrogen for later storage at -80°C. 
The degradation of BSA and human and salmon LHRH by intestinal mucosa 
homogenates was section dependent (Sections 3.4.2.2 & 3.4.2.3). In contrast to lumenal 
proteolytic activities the mucosal activities were found to be higher in the posterior 
intestinal section. Interestingly, both of the LHRH analogues were metabolised in the 
posterior mucosa! homogenate but not by the middle mucosa. Previous studies have 
shown that due to presence ofN terminal pyrogulatamate residues and C terminal amide 
)• 
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bonds in LHRH analogues, these peptides are resistant to degradation by most 
exopeptidases such as amiriopeptidases and carboxypeptidases (MacCann, 1977). The 
proteolytic activity of the lysosomal enzymes of the enterocytes should be negligible at 
pH 7.4, as they are most active in an acidic environment (Barrett and Heath, 1977). 
Capillary electrophoretograms of the posterior mucosal digests of human and salmon 
LHRH analogues showed the formation of multiple metabolic fragments (Figure 3.17). 
The large number of metabolites suggests that there are a large number ofLHRH bonds 
susceptible to the proteases of the intestinal mucosa. Much of this activity could be 
attributed to the exopeptidases hydrolysing the fragments generated by the principal 
cleavage by the endopeptidases. Although it is possible that amidases and 
pyroglutamidases are also present in the mucosa! homogenates . 
. The proteo.lytic activity of the posterior mucosa towards LHRH corresponded to the 
higher activity towards the ·synthetic substrate of chymotrypsin, N-benzoyl-L-Tyr ethyl 
ester (Section 3.4.2.4). This hydrolytic activity is most likely due to the activity ofbrush-
border membrane endopeptidase 24.18, which has previously been shown to hydrolyse 
N-benzoyl-L-tyrosyl-p-amino benzoic acid, in the presence of the specific chymotrypsin 
inhibitor TPCK (Sterchi et al., 1982). In vitro, endopeptidase 24.18, has been shown to 
hydrolyse hLHRH at three bonds: Trp3-Ser4, Ser4-Tyr5 and Tyr5-Gly6, with Trp3-Ser4 
being the preferred site (Stephenson and Kenny, 1988). The LHRH hydrolytic activity of 
the posterior mucosa may also be due to the brush-border membrane peptidases 
endopeptidase 24.11 and angiotensin converting enzyme (ACE) which have been shown 
to cleave hLHRH at the Gly6-Leu7 bond (Lasdun et al., 1989) and the Trp3-Ser4 site (Han 
. et al., 1995), respectively. Amino acid analysis ofLHRH fragments generated from 
rabbit rectal mucosa in vitro, indicated the involvement of endopeptidase 24.11, ACE and 
endopeptidase 24.15 in the hydrolysis ofhLHRH (Han et al., 1995). The HPLC profile 
showed that endopeptidase· 24.15 is the primary degrading enzyme in rabbit rectal 








Digestion of hum.an and salmon LHRH in mucosal homogenates was significantly 
inhibited by DOC, EDTA and the aminopeptidase specific inhibitor bestatin (Section 
3.4.3.5). SBTI a serine endopeptidase inhibitor, did not inhibit the hydrolysis ofLHRH 
analogues in the posterior mucosal homogenate, indicating the absence of the serine 
proteases in the mucosal preparations. Contrary to previous results by MacCann (1977) 
inhibition by bestatin indicates that aminopeptidases are involved in the hydrolysis of the 
LHRH analogues. 
EDTA, a metal chelator was the most effective inhibitor ofmucosal proteolytic activity 
towards LHRH analogues (Section 3.4.3.5). EDTA is known to inhibit metalloproteases 
such as carboxypeptidases, ACE, aminopeptidases and endopeptidase 24.15 (Lanzillo et 
al., 1986, Han et al., 1995). Of these ACE and endopeptidase 24.15 have been shown 
previously to hydrolyse hLHRH (Han et al., 1995). DOC was reported to be an inhibitor 
ofleucine aminopeptidases (Hirai et al., 1981) and endopeptidase 24.11 (Bai, 1994). As 
endopeptidase 24.11 has been reported to hydrolyse hum.an LHRH (Han et al., 1995), the 
effect of DOC is therefore most likely due to the inhibition of this enzyme. 
The inhibitory .effect of the divalent ion chelator CP934P was not tested on the mucosal 
homogenates, since CP934P was previously shown to be ineffective in inhibiting the 
proteolytic activity of the rat brush-border membrane vesicles (BBMV) towards the 
LHRH analogue buserelin (LeuJ3en et al., 1996a). It was suggested that the lack of 
proteolytic inhibition by CP934P was due to the proteases being embedded or attached to 
the epithelial membrane, thereby reducing the accessibility of the protease divalent ions 
for chelation (LeuJ3en et al., 1996a). Alternatively, the lack of inhibition ofBBMV 
proteolytic activity by CP934P maybe unrelated to chelation. This possibility is explained 
in Chapter 4. 
Since EDTA and DOC when used as proteolytic inhibitors have a broad inhibitory 
specificity, it is not possible to determine which specific enzymes are involved in the 











specific inhibitors should make it possible to identify the cleavage sites of the LHRH and 
identify the proteolytic enzymes involved. 
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Chapter 4: Polyacrylic Acid Inhibition Studies 
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In vitro metabolic studies showed that the polyacrylic acid Carbopol934P® (CP934P) 
increased the enzymatic stability ofLHRH analogues in the intestinal lumenal 
homogenates from salmon (Section 3.4.3.4). 
Two mechanisms have been proposed by which acrylic acid polymers inhibit the 
proteolytic activity of enzymes (Section 1.3 .1.5). Bai et al (1995b) demonstrated that 
the degree of proteolytic inhibition by polyacrylic acids correlated with their ability to 
reduce the pH of incubates below the optimum pH of the proteolytic enzymes. Bai et al. 
(1995b) however speculated that with the constant secretion of bicarbonate and 
carbonate ions into the intestinal lumen the polyacrylic acids would have limited ability 
to reduce the local pH in vivo. 
Under buffered conditions at pH 6.7, dispersions ofpolyacrylic acids were shown to 
inhibit the activity of trypsin, a-chymotrypsin and carboxypeptidase A and Band the 
cytosolic leucine aminopeptidase (Lue.Ben et al., 1996c ). The rate of proteolysis in the 
presence of polymer dispersions followed second-order kinetics and the authors 
speculated that this was due to autolysis (LueBen et al., 1996c). The proposed 
mechanism of inhibition was that the polyacrylic acids bind the essential enzyme co-
factors calcium and zinc from the enzyme, causing a conformational change resulting in 
enhanced enzyme autolysis and loss of enzyme activity (Lue.Ben et al., 1995). In 
contrast, initial studies with salmon lumenal homogenates showed that the reduced rate 
ofLHRH hydrolysis in the presence of CP934P followed pseudo-zero kinetics (Section 
3.4.3.4). 
This chapter reports that the CP934P dispersions at pH 7.0 inhibited the proteolytic 
activity of bovine trypsin and bovine a-chymotrypsin. In the presence of CP934P, the 
rates of hydrolysis of the proteolytic substrates followed pseudo-zero order kinetics as 
observed in Section 3.4.3.4. It was found that CP934P reduces proteolytic activity by 
interacting with the proteolytic enzyme, thereby identifying another mechanism by 











lumen. A kinetic model is proposed to describe the possible routes for protease 










Carbopol ® 934P (C934P) was gifted from BF Goodrich (Cleveland, OH, USA). 
Bovine trypsin (TPCK treated, Type XIII), bovine a-chymotrypsin (TLCK treated, 
Type XII), porcine pepsin (A, P-7125), N-a-benzoyl-L-Arg ethyl ester (BABE), N-a-
benzyol-L-Tyr ethyl ester (BTEE), soybean trypsin-chymotrypsin inhibitor (Bowman-
Birk inhibitor), human luteinizing hormone-releasing hormone (hLHRH) and mineral 
oil (heavy white oil) were purchased from Sigma Chemical Co. (St. Louis, MO, USA). 
Bovine serum albumin fraction V (BSA) was purchased from Serva (Feinbiochemica 
GmbH & Co., Heidelberg, Germany). Sample tubes of 0.5 ml and 1.5 ml were 
purchased from Eppendorf (Eppendorf-Netheler-Hinz-GmbH Hamburg, Germany). 
Ultrafree® - MC (0.45 µm, 0.2 cm2 membrane area) centrifugal filtration units were 
purchased from Millipore Corporation (Bedford, MA, USA). All other chemicals were 
of analytical grade and were purchased from Ajax Chemicals (Auburn, NSW, 
Australia). 
4.3 Methods 
4.3.1 Analytical methods 
4.3.1.1 Protein estimations 
Protein was determined by the method of Lowry as modified by Peterson (1977); TCA 
precipitation was not required. Assays were performed in microtitre plate wells in a total 
volume of 250 µ1, and the absorbance (750 nm) was read using a Microplate 
Spectrophotometer (Spectra MAX 340) controlled by an external computer with SOFT-
max PRO software (Molecular Devices Corporation, CA, USA). Protein was 











4.3.1.2 BSA hydrolytic activity 
Bovine trypsin (1 mg) was prepared in 50 mM sodium phosphate buffer pH 7.0 (1 ml 
total volume). Trypsin solution was transferred to a 1.5 ml sample tube containing 50 
mM sodium phosphate buffer pH 7.0 with or without CP934P (total volume 0.5 ml), 
pre-equilibrated at 37°C. After 30 min BSA (1 mg) in 50 mM sodium phosphate buffer 
pH 7.0 pre-equilibrated at 37°C was added (1 ml total volume). Samples (0.1 ml) were 
removed immediately after mixing and after 30, 60 and 90 min and transferred to 0.5 ml · 
sample tubes containing 5·µ1 of 30% (v/v) TCA to stop the reaction and precipitate 
intact protein. The samples were centrifuged at 20 000 g for 10 min and the supernatant 
was analysed for acid-soluble peptides (Section 4.3.1.1). 
4.3.1.3 BAEE hydrolytic activity 
BABE was prepared in a solution of 50 mMsodium phosphate buffer pH 7.0 to give a 
final concentration of 1.0 mM. The enzyme solution (0.1 ml) was transferred to a 1 ml 
quartz cuvette of 1 cm path length containing 0.1 ml of phosphate buffer. To initiate the 
reaction, 0.8 ml of the BABE stock was added. Buffer and substrate stock solution were 
both pre-incubated at 37°C for at least 10 min. The reaction was monitored by a Hewlett 
Packard 8452A diode array spectrophotometer at 253 nm, with a jacketed cell 
maintained at 37°C by recirculating water. 
4.3.1.4 BTEE hydrolytic activity 
The chymotrypsin substrate BTEE (0.059 mmoles) was initially dissolved in 31.7 ml of 
methanol then diluted with 50 mM sodium phosphate buffer pH 7 .0 to give a final 
volume of 50 ml and substrate concentration of 1.18 mM (Wirt, 197 4). The enzyme 
solution (0.05 ml) was transferred to a 1 ml quartz cuvette of 1 cm path length, 
containing 0.36 ml of phosphate buffer. To i11itiate the reaction 0.59 ml of the synthetic 
substrate solution was added. Buffer and substrate stock were both pre-incubated at 
37°C for at least 10 min. The reaction was monitored by a Hewlett Packard 8452A diode 
array spectrophotometer at 256 nm, with a jacketed cell maintained at 37°C by 
recirculating water, using a molar extinction coefficient of 964. The unit of activity is 





4.3.1.5 Capillary electrophoresis 
Capillary electrophoresis was carried out in a Dionex Model CES-1 capillary 
electrophoresis instrument (Dionex, Sunnyvale, CA, USA) under conditions described 
in Section 2.3.1. Samples were electrophoresed in 10 mM sodium phosphate buffer at 
pH 2.5 containing 75 mM NaCL Rates ofLHRH proteolysis were reported as changes 
in peak height of the principal metabolite. 
4.3.1.6 HPLC of LHRH 
The HPLC system consisted of a Shimadzu pump (LC - 6A), a Rheodyne injector with a 
50 µl loading loop and a Shimadzu spectrophotometric UV visible detector (SPD-6AV). 
Data were collected via a Dionex advanced computer interface at 5 Hz and integrated 
using the Dionex A-450 Chromatography Automation Software v 3.3.2. The column, 
Phenomenex C18 (250 x 4.60 mm, 5 µm) was equilibrated in a mobile phase of 21 % 
acetonitrile in 0.1 % trifluoroacetic acid at 1.0 ml/min. The eluate was monitored at 
215 nm. All samples were diluted 10-fold in mobile phase before analysis. 
4.3.1.7 Gel electrophoresis 
Sodium dodecylsufate-polyacrylamide gel electrophoresis (SDS PAGE) of trypsin was 
done using the method ofLaemmli and Farve (1973) using 10% acrylamide separating 
gels and 5% stacking gels. Samples (0.1 ml) were lyophilized, resuspended in 15 µl of 
dissociation buffer, boiled for 1 min, centrifuged at 5 000 g for 5 min then loaded onto 
the gel. Electrophoresis was at constant voltage of 150 V (25 - 30 µA). Gels were 
stained by a reductive silver stain (Morrisey, 1981 ). The molecular weight markers were 
soybean trypsin inhibitor (MW 20 000), trypsinogen (MW 24 000), carbonic anhydrase 
(MW 29 000), glyceralderhyde-3-phosphate dehydrogenase (MW 36 000) and 
ovalbumin (MW 45 000). 
4.3.1.8 Gel filtration 
The instrumentation consisted of a Spectra-Physics (SP88 l 0) HPLC pump, a Rheodyne 
injector with a 100 µl loading loop, Shimadzu SPD-6A UV detector set at 215 nm and a 













column (Waters Protein-Pak TM SW, 7.8 x 300 mm) and separated using a mobile phase 
of 10 mM phosphate buffer pH 6.5 containing 150 mM sodium chloride at 1 mVmin. 
4.3.1.9 HPLC of trypsin 
Analysis of trypsin by reverse phase HPLC were conducted using a Spectra-Physics 
ternary pump (SP8800), Phenomenex on-line mobile phase degasser (DS-4000), 
Rheodyne injector with a 50 µl loop and Spectra-Physics Spectra 100 variable 
wavelength detector while data were recorded on Spectra-Physics ChromJet integrator. 
The column, Jupiter C4 (150 x 4.6 mm, 5 µm) were equilibrated in 5% acetonitrile in 
0.08% trifluoroacetic acid at 1.0 mVmin. Samples were eluted from the column with a 
linear gradient of acetonitrile (5-65%, 30 min) in 0.08% trifluoroacetic acid at a flow 
rate of 1 mVmin. The eluate was monitored at 215 nm. 
4.3.2 Inhibition studies 
The enzyme stability studies were determined in 50 mM phosphate buffer adjusted to 
pH 7.0 with sodium hydroxide. CP934P 0.5% (w/v) was dispersed in water by low 
speed stirring, disodium hydrogen phosphate was added to give a final concentration of 
50 mM and the dispersion was adjusted to pH 7.0 with sodium hydroxide. The 
proteolytic enzyme was dissolved in phosphate buffer, pH 7.0 to give a stock solution of 
1 mg/ml. The enzyme stock solution (10 µI) was mixed with either 0.7 ml of the 
0.5% (w/v) CP934P or 0.7 ml of phosphate buffer and incubated at 37°C. After 30 min 
the substrate dissolved in the phosphate buffer pH 7.0 was added to give a final volume 
of 1 ml. The stability of BABE and LHRH to proteolytic digestion was determined at 
20 mM and 0.4 mM, respectively. At various time intervals 50 µl samples were 
removed and added to 50 µl of 0.2 M HCl to stop the reaction and to precipitate the 
CP934P. Samples were centrifuged (20 000 g for 10 min) and the supematants were 
analysed. LHRH was analysed by capillary electrophoresis (Section 4.3.1.5). BABE was 
determined by measuring the formation of N-a-benzoyl-L-Arg from N-a-benzoyl-L-
Arg ethyl ester, based on the method of Schwert and Takenaka (1955): supematants 
(50 µl) were transferred to a 1 ml quartz cuvette of 1 cm path length containing 950 µl 
of 50 mM sodium phosphate buffer pH 7 and the absorbances read at 252 nm, using a 




4.3.3 Binding studies 
4.3.3.1 Centrifugal filtration 
CP934P (0.5% w/v) dispersed in 50 mM phosphate buffer pH 7 .0, was mixed with the 
proteolytic enzyme (12.5 µg) and LHRH (0.1 µmol) or BABE (5 µmol) to give a final 
CP934P concentration of 0.35% (w/v) and a total volume of 0.25 ml. In the control 
experiment, the CP934P was replaced with phosphate buffer pH 7.0. Following 
incubation at 370c for 30 min, 0.2 ml samples of the suspensions were removed, placed 
in a Ultrafree® - MC centrifugal filtration units and centrifuged at 5 000 g for 2 h at 
room temperature. The filtrates were analysed for unbound material. BABE was 
measured by the change in absorbance at 252 nm and LHRH was measured by capillary 
electrophoresis (Section 4.3.1.5). The enzyme filtrates were assayed for protein content 
by the modified Lowry assay (Section 4.3 .1.1) and trypsin or chymotrypsin activity 
using their respective synthetic substrates, BABE (Section 4.3.1.3) and BTEE (Section 
4.3.1.4). The trypsin filtrates were also analysed by SDS-PAGE (Section 4.3.1.7), gel 
filtration (Section 4.3.1.8) and reverse-phase HPLC (Section 4.3 .1.9). 
4.3.2.2 Langmuir isotherm 
The effect of protein concentration on the binding of trypsin to 0.35% (w/v) CP934P 
was evaluated over a range of trypsin concentrations (35, 50, 70, 80, 150, 285, and 525 
µg/ml) in 50 mM phosphate buffer pH 7.0. CP934P 0.5 % (w/v) in 50 mM phosphate 
buffer pH 7.0 (0.7 ml) was pre-incubated at 37°C for 10 min, then the appropriate 
volume of trypsin (2 mg/ml) was added with phosphate buffer pH 7.0 to give a total 
volume of 1 ml. The dispersion was vortexed and incubated at 37°C for 30 min. The 
incubates (0.4 ml) were transferred to the centrifugal filtration unit and centrifuged at 
5 000 g for 2 h at room temperature. The filtrates were assayed for protein content 
















The data obtained were fitted to the linearised form of the Langmuir equation Langmuir 
(1918): 
c/(x/m) = 1/ab + c/a Equation 4.1 
where xis the mass of trypsin abound to CP934P, mis the mass of the CP934P, a is the 
capacity of CP934P to bind trypsin, b is the affinity constant of trypsin for CP934P, c is 
the concentration of free trypsin. 
4.3.2.3 Effect of ionic strength and pH on the adsorption of trypsin to 
CP934P 
CP934P 0.5% (w/v) was dispersed in deionised water by low speed stirring. Sodium 
chloride was added to give final concentrations of 70, 130 and 215 mM and the pH was 
adjusted with sodium hydroxide. For control experiments the buffer was prepared the 
same but 5 mM disodium phosphate was added instead ofCP934P. Trypsin was 
dissolved in deionised water to give a stock solution of lmg/ml. The trypsin stock was 
mixed with either 0.7 ml of CP934P dispersion or 0.7 ml of the control buffer to give a 
final volume of 1.0 ml and incubated at 37°C. After 30 min incubation 0.4 ml samples 
of the suspensions were removed and placed in Ultrafree® - MC centrifugal filtration 
units and centrifuged at 5 000 g for 2 h at room temperature. The filtrates were assayed 
for protein content by the modified Lowry assay (Section 4.3.1.1 ). 
4.3.2.4 Adsorption of proteins to CP934P 
CP934P 0.5% (w/v) was dispersed in deionised water by low speed stirring. Sodium 
chloride was added to give final concentrations of 70 mM and the pH was adjusted to 
pH 7.0 with sodium hydroxide. For control experiments the buffer was prepared the 
same but 5 mM disodium phosphate was added instead ofCP934P. Proteins were 
dissolved in deionised water to give a stock solution of lmg/ml. The protein stock was 
mixed with either 0.7 ml of CP934P dispersion or 0.7 ml of the control buffer to give a 
final volume of 1.0 ml and incubated at 37°C. After 30 min incubation 0.4 ml samples 






units and centrifuged at 5 000 g for 2 h at room temperature. The filtrates were assayed 





4.4.1 Inhibition of trypsin 
4.4.1.1 Inhibition studies 
Initial experiments using BSA as the substrate showed that CP934P 0.35 % (w/v) 
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Figure 4.1 Time-course of the formation of acid-soluble peptides from BSA after 
incubation with bovine trypsin (10 µg/ml) in the presence ( open circles) and in the 
absence (closed circles) ofCP934P (0.35% w/v) at pH 7.0 (Section 4.3.1.3). Each point 
represents the mean ± s.d. of three experiments. 
However under the same conditions, CP934P inhibited the tryptic digestion of both 
BABE and LHRH (Figures 4.2 & 4.3). The rate of the formation of BA from BABE in 
the presence and absence of CP934P was constant over the period assayed. In the 
presence of CP934P the rate of BABE hydrolysis was 34% of the control (Figure 4.2). 
Using capillary electrophoresis the proteolysis ofLHRH was monitored by measuring 
the peak height during formation of a principal metabolite (mobility 12.5 ± 0.1 min, 
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Figure 4.2 Formation of BA from BABE (20 m.M) by trypsin (10 µg/ml) in the presence 
of CP934P (0.35% w/v) (closed circles) and in the absence of CP934P (open circles) at 
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Figure 4.3 Formation of the principal metabolite ofhLHRH following incubation of 
hLHRH (0.4 m.M) with trypsin (10 µg/ml) in the presence of CP934P (0.35% w/v) 
(closed circles) and in the absence of CP934P (open circles) at pH 7.0 (Section 4.3.2). 













Figure 4.4 shows capillary electrophoretograrns of LHRH extracts after 24 h digestion 
with trypsin in the presence and absence of CP934P. The rate of metabolite formation 
was constant over 24 h in the presence and absence of CP934P (Figure 4.3). In the 















'f' ~ ~ ( 
138 




0 5 10 15 20 
. 0.030 l ,--. (B) ~ 
--< .._, 










t 0.000 0 
0 5 10 15 20 




0 5 10 15 20 
Time (min) 
Figure 4.4 C_apillary electrophoretic separation of incubations ofhLHRH with trypsin 
(10 µg/ml): in the presence of CP934P (0.35% w/v) at pH 7.0 immediately after 
addition of trypsin (A), after 24 h incubation in the presence of CP934P (B) and after 
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4.4.1.2 Binding studies 
The spectrum of CP934P (0.005 % w/v) from 190 to 300 nm is shown in Figure 4.5. 
The absorption maximum of CP934P in 50 mM sodium phosphate buffer pH 7 .0 was 
204 nm. The standard curve for absorbance at 204 nm versus concentration of CP934P 
was linear (r > 0.99) within the concentration range of 0.00125 to 0.01 % (w/v). 
0.345 
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Figure 4.5 Absorbance spectrum of CP934P 0.005% (w/v) in 50 mM sodium phosphate 
buffer pH 7.0 (Section 4.4.1.2) 
Dispersions of CP934P (0.35% w/v) in 50 mM sodium phosphate buffer pH 7 .0 
(Section 4.3.2) were centrifuged at 800, 1 500 and 20 000 g for 30 or 60 min. Samples 
(50 µ1) were taken from the top of the supernatant, diluted to 1 ml with 50 mM sodium 
phosphate buffer pH 7.0, transferred to quartz cuvette and the absorbances at 204 nm 
was determined using a Hewlett Packard 8452 A diode array spectrophotometer (Table 
4.1). Only after CP934P dispersions were centrifuged at 20 000 g for 30 and 60 min 
were two phases observed. The CP934P concentration of the upper phase of the 
dispersions centrifuged at 20 000 g for 30 and 60 min were 0.052 and 0.047% (w/v), 
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Table 4.1 Sedimentation of CP934P 0.35 % (w/v) in 50 mM sodium phosphate buffer 
pH 7. 0. Data are absorbances of samples taken from the upper region of the dispersion. 
Centrifugation 
Control 
800 g for 30 min 
1 500 g for 30 min 
20 000 g for 30 min 
20 000 g for 60 min 
Absorbance at 204 nm 
1.05 ± 0.01 a 
0.923 ± 0.11 
0.92 ± 0.16 
0.168 ± 0.011 
0.156 ± 0.0046 
a each value represents the mean ± s.d., n=3. 
As we were unable to pellet the CP934P by centrifugation as described by LueBen et al. 
(1995) we investigated centrifugal filtration as a method for studying the binding of 
proteolytic substrates and proteins to CP934P (0.35% w/v) at pH 7.0. Samples (0.4 ml) 
of CP934P (0.35% w/v) at pH 7 .0 were transferred into Ultrafree® - MC centrifugal 
filtration units and centrifuged at 5 000 g for 2 hat room temperature (Section 4.3.3.1). 
The filtrates were analysed for CP934P by diluting the filtrate (50 µl) in 50 mM sodium 
phosphate buffer to give 1 ml final volume and measuring the absorbance at 204 nm as 
described above. Analysis showed that the CP934P was completely retained by the 
membrane. Consequently the bindingofLHRH (0.4 mM), BABE (20 mM) and trypsin 
(50 µg/ml) to CP934P 0.35% (w/v) at pH 7.0 was investigated using centrifugal 
filtration (Section 4.3.3.1), Non-specific binding to the membrane was not observed 
during filtration of either BABE or LHRH, and less than 5% of the trypsin protein was 
bound to the membrane during filtration. 
There was no significant binding ofLHRH to CP934P and only 10 ± 2% of BABE was 
bound to CP934P at pH 7.0. Analysis of the trypsin filtrate for protein content showed 
that 32 ± 5% of the protein was filtered implying 68% binding to the CP934P (Table 
4.2). Using BABE the synthetic substrate of trypsin (Section 4.3.1.3) only 11± 2% of the 
tryptic activity was filtered after incubation with CP934P and this had a specific activity 




Table 4.2 The protein concentration, activity and specific activity of trypsin solutions 
(50 µg/ml) filtered after incubation with pH 7 buffer alone ( control) and after incubation 
with CP934P (mean± s.d., n = 3). 
Control CP934P % Filtered 
Protein concentration 50.0 ± 2.0 16.0 ± 1.9 32 
(µg/ml) 
Trypsin activitl 0.118 ± 0.02 0.0129 ± 0.001 11 
(µmol/min/ml) 





Tryptic activity for BABE 
b 
Relative specific activity 
4.4.1.3 Gel electrophoresis 
SDS-PAGE was used to identify trypsin and investigate lower molecular weight 
autolytic forms of trypsin in the centrifugal filtrates (Section 4.3.1.7). Figure 4.6 shows 
the SDS-P AGE analysis of the filtrates after reductive silver staining (Section 4.3 .1. 7). 
The filtrate of trypsin incubated in buffer alone gave a single band that migrated 
identically with unfiltered trypsin and the migration of the protein corresponded to a 
molecular weight of23 500. No protein bands were observed when the filtrates of the 
CP934P treated trypsin were analysed and stained with Coomassie Blue ( data not 
presented). However a faint band of23 500 molecular weight was observed in filtrates 
of the CP934P treated trypsin when the gel was stained with the more sensitive 
reductive silver stain (Section 4.3.1.7). No autolytic protein fragments were observed 




































Figure 4.6 SDS-PAGE of trypsin filtrates after silver staining. Trypsin filtrates after 
incubation in the presence of CP934P (0.35% w/v) (lane 1) in the absence of CP934P 
(lane 2) in 50 mM sodium phosphate buffer pH 7.0. Migration and molecular weights of 
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4.4.1.4 Gel filtration 
Trypsin had a retention time of 10.2 ± 0.5 min (mean± s.d., n=3) when analysed by gel 
filtration (Section 4.3.1.8). Trypsin (50 µg/ml) was autolysed by heating at 60°C for 45 
min. Samples of the trypsin before and after heating were analysed by gel filtration and 
assayed for protein content by the modified Lowry assay (Section 4.3.1.1). Gel :filtration 
(Figure 4. 7) showed a dramatic reduction in the peak area and height for the autolysed 
trypsin with respect to the control. In addition a shoulder of lower molecular weight 
material eluting after 12 min was also observed for the autolysed trypsin. Protein 
determinations of control and autolysed trypsin showed no significant difference 
(p > 0.05), presumably because the modified Lowry assay (Section 4.3.1.1) measures 
the tyrosine content of peptides and proteins and is not influenced by autolysis of the 
protein. 
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Figure 4.7 Gel filtration of trypsin (50 µg/ml) stored on ice (A) and after incubation at 
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CP934P (0.35% w/v) and trypsin (50µg/ml) in 50 mM sodium phosphate buffer pH 7.0 
were incubated alone and together at 37°C for 30 min and the centrifugal filtrates were 
analysed by gel filtration (Section 4.3.1.8). In the absence of CP934P, trypsin eluted as 
a single peak with a retention time 11. 7 ± 0.8 min (Figure 4.8 A). No peaks were 
observed for phosphate buffer pH 7 .0 only ( chromatograph not shown) suggesting that 
the peak observed for CP934P only (Figure 4.8 C) is a low molecular weight fraction of 
the CP934P. CP934P treated trypsin eluted after 10.6 ± 0.6 min (Figure 4.8 B) and the 
peak area was corrected by subtracting the peak area of the CP934P contaminant. The 
corrected peak area of the trypsin filtrate in the presence of CP934P was 32 ± 4% of the 
area of the control trypsin. There was no low molecular weight shoulder on the CP934P 
treated trypsin filtrate peak. The protein contents of the control filtrate and CP934P 
treated trypsin filtrate determined by the modified Lowry assay (Section 4.3.1.1) were 
48 ± 3 µg/ml and 14 ± 2 µg/ml, respectively, implying that 29% only of the protein was 
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Figure 4.8 Gel filtration of centrifugal filtrates of trypsin (50 µg/ml) in the absence of 
CP934P (0.35% w/v) (A) and in the presence of CP934P (0.35% w/v) (B) and of 
CP934P (0.35% w/v) in the absence of trypsin (C) in sodium phosphate buffer pH 7.0 










4.4.1.5 HPLC of trypsin 
The centrifugal filtrates of trypsin in 50 mM sodium phosphate buffer pH 7.0 in the 
presence and absence of CP934P (Section 4.3.3.1) were analysed by reverse phase 
HPLC (Section 4.3 .1.9). The chromatograms of the filtrates of trypsin in phosphate 
buffer only show that trypsin after heating at 37°C for 30 min has a greater number of 
peaks (Figure 4.9 B) than trypsin that was maintained at 4°C (Figure 4.9 A). Filtrates 
from trypsin incubated at 37°C for 30 min in the presence of CP934P had a greater 
number of peaks than trypsin incubated in the absence of CP934P and the dominant 
peak at 20 min was not present in the filtrate (Figure 4.9 C) . 
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Figure 4.9 Reverse-phase HPLC of centrifugal filtrates of trypsin (50 µg/m1) 
maintained at 4°C (A), trypsin incubated at 37°C in the absence of CP934P (0.35% 
w/v) (B), and incubated in the presence of CP934P (0.35% w/v) at 37°C (C) in 










4.4.1.6 Langmuir isotherm 
The binding of trypsin to CP934P (0.35% w/v) at pH 7.0 over the concentration range 
35-525 µg/ml was determined (Section 4.3.3.2). The data fitted the linearised form of 
the Langmuir isotherm with/= 0.997 (Figure 4.10). The binding capacity of trypsin for 
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Figure 4.10 Langmuir absorption isotherm of trypsin onto CP934P (0.35% w/v) 
incubated in 50 mM sodium phosphate buffer pH 7.0 at 37°C for 30 min (Section 
4.3.3.2). Each point represents the mean of three experiments. 
4.4.1.7 Effect of ionic strength and pH on the adsorption of trypsin to 
CP934P 
The effect of ionic strength and pH on the binding of trypsin to CP934P was 
investigated (Section 4.3.2.3). Figure 4.11 shows that the amount of unbound trypsin 
decreased significantly (p < 0.05) from 50 to 90 mM sodium chloride concentration, 
while from 90 to 150 mM sodium chloride concentration there was no significant 
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Figure 4.11 Effect of sodium chloride concentration on binding of trypsin (300 µg/ml) 
to CP934P (0.35% w/v) at pH 7.0 (Section 4.4.1.6). Each point represents the 
mean± s.d. of three experiments. 
The effect of pH on trypsin binding to CP934P was tested similarly with CP934P 
dispersed in 50 mM NaCl at pH 6.0, 7.0 and 8.0 (Section 4.3.2.3). Figure 4.12 shows 
there was no significant difference (p > 0.05) in binding of trypsin to CP934P at pH 6.0, 
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Figure 4.12 Effect of pH on binding of trypsin (300 µg/ml) to CP934P (0.35% w/v) at 









4.4.1.8 Protein binding 
The amount of BSA, SBTI, trypsin, chymotrypsin and pepsin (300 µg/ml) bound to 
CP934P (0.35% w/v, 50 mM NaCl at pH 7) was determined (Section 4.3.2.4). Table 4.3 
shows the protein content of the filtrates after incubation in pH 7 buffer alone (control) 
and after incubation with CP934P. Under these conditions the rank order of protein 
binding to CP934P was BSA > SBTI >trypsin - chymotrypsin - pepsin. 
Table 4.3 Concentration of protein solutions (300 µg/ml) filtered after incubation with 
pH 7 buffer alone (control) and after incubation with CP934P at 37°C for 30 min in 
phosphate buffer pH 7.0 (mean± s.d., n = 3). 
Protein Control CP934P % Filtered 
BSA 288 ± 26a 0 0 
SBTI 283 ± 7.0 139 ± 11 49 
Trypsin 298 ± 15 244 ± 18 82 
Chymotrypsin 290 ±20 238 ± 12.3 82 
Pepsin 290± 30 231 ±29 80 
a Protein content (µg/ml) 
4.4.2 Inhibition of a-chymotrypsin activity 
4.4.2.1 Inhibition studies 
The hydrolysis ofhLHRH (0.4 mM) by bovine a-chymotrypsin (10 µg/ml) in the 
presence and absence of CP934P (0.35% w/v) was determined (Section 4.3.2). The 
stopped reaction samples were analysed by reverse phase HPLC (Section 4.3 .1.6). 
Figure 4.13 shows that hLHRH was rapidly hydrolysed by chymotrypsin at pH 7. 0 at 
37°C. One-way analysis of variance showed that in the presence of CP934P (0.35 % 
w/v) the hLHRH peak heights of the reaction samples did not significantly change over 
the 2 min period of incubation (p > 0.2). However regression analysis shows there is a 
significant relationship between peak heights and time (p < 0.05), indicating that 
hLHRH is being slowly degraded by chymotrypsin. HPLC chromatograms ofhLHRH 
and hLHRH after 1.5 min incubation with chymotrypsin (10 µg/ml) in the presence and 
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Figure 4.13 Time-course of the hydrolysis ofhLHRH by chymotrypsin in the presence 
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Figure 4.14 Reverse phase_ HPLC chromatograms ofhLHRH bovine chymotrypsin 
digests in the presence of CP934P (0.35% w/v) at pH 7 after 0.5 min (A) and 2.0 min 
(B) incubation at 37°C and after 2 min incubation in the absence of CP934P at 37°C 













4.4.2.2 Binding studies 
The binding of chymotrypsin (50 µg/ml) to 0.35% (w/v) CP934P at pH 7.0 was 
investigated using Ultrafree® - MC centrifugal filtration units (Section 4.3.2.1). No 
chymotrypsin protein was bound to the membrane during filtration. Analysis of the 
chymotrypsin filtrate for protein content (Section 4.3 .1.1) showed that 78% of the 
protein was filtered implying 22% binding to the CP934P (Table 4.4). Using BTEE, the 
synthetic substrate for chymotrypsin (Section 4.3.1.4) no significant chymotryptic 
activity was detected in the filtrate after incubation of chymotrypsin with CP934P 
(Table 4.4). 
Table 4.4 Protein concentration, activity and specific activity of chymotrypsin (50 
µg/ml) solutions filtered after incubation with pH 7 buffer alone ( control) and after 
incubation with CP934P (mean± s.d., n = 3). 
Control CP934P 
Protein concentration 51.3 ± 4.9 40 ± 3.8 
(µg/ml) 
Chymotrypsin 1.61 ± 0.13 0.1 ± 0.03 
. . a 
activity 




Chymotryptic activity for BTEE, µmol/min/ml of filtrate 
b 
not significantly different from blank 
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4.5.1 Inhibitor studies 
Initial results showed that a CP934P dispersion at pH 7.0 did not inhibit trypsin activity 
when BSA was used as the substrate (Figure 4.1 ). The lack inhibition of proteolytic 
activity towards BSA by CP934P was in agreement with previous studies with salmon 
intestinal lumen homogenates (Section 3.4.3.2). Using the low molecular weight 
synthetic substrate BABE, CP934P was shown to inhibit trypsin activity (LueBen et al., 
1995). When the inhibition experiment was repeated with BABE or LHRH as the 
substrate, reduced hydrolytic activity by trypsin in the presence of CP934P was 
observed (Section 4.4.1.1). The degree of proteolytic inhibition by CP934P was similar 
for both BABE and LHRH with hydrolysis rates 34 and 28% of the controls, 
respectively (Figures 4.2 & 4.3). Under the conditions of this study the rate of 
metabolite formation from BABE and LHRH was constant both in the presence and 
absence of CP934P. The constant rate of metabolite formation in the presence of 
CP934P suggests that enhanced enzyme autolysis does not play a role in the reduced 
proteolytic activity of trypsin. This is in contrast to the enhanced autolysis due to 
chelation postulated by Junginger and co-workers (LueBen et al., 1995). 
CP934P could reduce the proteolytic activity by interacting with either the substrate or 
the enzyme or both. LueBen et al. (1995) previously investigated protein binding to 
0.35% (w/v) CP934P at pH 6.7; however they measured the binding of 125I-BSA to 
CP934P and not trypsin. They reported that the binding of 125I-BSA to CP934P at pH 
6.7 was not significant after separating the unbound 125I-BSA from CP934P by 
centrifugation· at 800 g for 30 min. However, under similar conditions the CP934P was 
not completely pelleted, even at higher centrifugal force (Section 4.4.1.1 ). This suggests 
that the 125I-BSA measured after centrifugation at 800 g by LueBen et al. (1995) could 
still have been bound to CP934P. Centrifugal filtration was used to assess the binding of 
trypsin, BABE and LHRH to CP934P (Section 4.4.1.2). The centrifugal filtration units 
(Ultrafree® - MC) completely retained CP934P (Section 4.4.1.2). No LHRH and only 
10% of the BABE was bound to the CP934P suggesting that it is the enzyme that binds 








Protein analysis of the trypsin filtrate showed that 68% of the trypsin bound to the 
CP934P under the conditions of the study (Table 4.2). These results suggest that 
CP934P inhibits trypsin activity by binding the enzyme thereby decreasing the 
concentration of free enzyme to hydrolyse substrate. However, CP934P treated trypsin 
filtrates had only 11 % of the control hydrolytic activity towards BABE, which 
corresponded to a relative specific activity of 34% (Table 4.2). This indicates that in the 
presence of CP934P trypsin does undergo inactivation. 
In comparison to trypsin, CP934P had a greater inhibitory effect on chymotrypsin 
activity. Human LHRH was completely hydrolysed after 2 min at pH 7.0 at 37°C 
whereas in the presence of 0.35 % (w/v) CP934P there was no significant difference (p 
> 0.2) in the peak heights of hLHRH reaction samples after 2 min (Figure 4.13). The 
significant regression analysis (p < 0.05) between peak height and time suggest that 
there is some residual chymotrypsin activity towards hLHRH. Binding studies showed 
that 22% of chymotrypsin (50 µg/ml) protein was bound to CP93P compared to 68% of 
trypsin under the same conditions (Tables 4.2 & 4.4). However it was expected that 
trypsin and chymotrypsin would bind similarly since they are both very similar in 
primary and teritary structure (Stryer, 1988, Hedstrom et al., 1994). Analysis of the 
CP934P treated chymotrypsin :filtrates for BTEE hydrolytic activity showed that the 
unbound chymotrypsin was completely inactive (Table 4.4). The lower binding of 
chymotrypsin to CP934P and higher proteolytic inhibition suggests that adsorbed 
chymotrypsin is more susceptible to denaturation. 
Previous studies by Junginger and co-workers used trypsin as a model protease to 
characterise the mechanism of inhibition by polyacrylic acids (LueBen et al. 1995). 
They suggested that CP934P inhibits trypsin by chelating essential calcium ions from its 
structure resulting in a conformational change in the protein opening it to autolysis. 
Autolysis is associated with the loss of activity of a proteolytic enzyme in solution 
incubated at optimum pH. In the case of trypsin, the trypsin molecules can cleave each 
other at lysyl and arginyl bonds. Three autolytic cleavage sites have been identified in 








numbering is used, Maroux and Desnuelle, 1969). It was shown that only cleavage at 
Lys61 -Ser62 resulted in lower tryptic activity (Maroux and Desnuelle, 1969). Maroux and 
Desnuelle (1969) also suggested that no fragment of the trypsin molecule will be 
released after cleavage at these sites because they will remain interconnected by 
disulfide bonds. Varallyay et al. (1998) more recently showed that if either the Arg117 -
Val118, or Lys61-Ser62 sites are cleaved, the multiple cleavage sites within the Arg117-
Val118, Lys61 -Ser62 segment will be subject to autolytic attack resulting in loss of activity. 
The 57 residue segment between the Arg117-Val118 and Lys61 -Ser62 (i.e. Ser62-Arg117) 
cleavage sites contains 10 potential cleavage sites and two members of the catalytic 
triad. It is believed that the loss of activity is due to the multiple cleavage of this 
segment resulting in either the disruption of the trypsin structure or the displacement of 
the members of the catalytic triad. The Ser62-Arg117segment is not interconnected by 
disulfide linkages and therefore multiple cleavages within this segment will result in the 
displacement of small fragments. Therefore it is expected that the displacement of these 
small autolytic fragments will not significantly change the molecular weight of the 
protein in relation to the native trypsin. 
SDS-PAGE is not expected to resolve autolysed from intact forms of trypsin. However, 
the lower staining intensity of the CP934P treated trypsin (Figure 4.6, Lane 1) supports 
the observation that trypsin is bound to CP934P (Section 4.4.1.2). The faint protein 
band of the CP934P treated trypsin had the same molecular weight as the trypsin only 
filtrate (Figure 4.6, lane 2). No lower molecular weight peptides or protein were 
identified in the CP934P treated trypsin filtrate. 
The gel filtration system also had insufficient power to resolve the autolysed trypsin 
from the intact trypsin. However, gel filtration (Section 4.4.1.4) was used to monitor 
autoiysis by reiating peak area of the trypsin species to the amount of tyrosine reactive 
groups by the modified method of Lowry. This was demonstrated by gel filtration 
(Figure 4.7) and protein estimations of trypsin that had undergone accelerated autolysis 
by heating at 60°C for 45 min (Section 4.4.1.4). For the autolysed trypsin sample there 
was a decrease in the peak area with no change in the protein content, estimated by the 








absorbing material as a result of the displacement oflow molecular weight fragments 
which could not be identified by the gel filtration system. The chromatogram of the 
CP934P treated trypsin filtrates showed a decrease in the area of the trypsin peak 
compared with the untreated trypsin (Figure 4.8). The CP934P only filtrate contained a 
low molecular weight contaminant which migrated similarly to trypsin. The peak area 
of the CP934P treated trypsin was subtracted from the CP934P contaminant peak. The 
peak area of the CP934P treated trypsin equated to 28% of the control. The decrease in 
peak area of the CP934P treated trypsin corresponded to the lower protein content of the 
CP934P treated trypsin filtrate (Table 4.2). The corresponding decrease in peak area and 
protein content (reactive tyrosines) indicates that binding of the enzyme plays an 
important role in the inhibition of trypsin by CP934P. This observation suggests that the 
binding of trypsin to CP934P is major mechanism of proteolytic inhibition. 
The CP934P treated trypsin eluted from the gel filtration column after 10.6 ± 0.6 min 
(mean± s.d., n=3) while trypsin alone eluted after 11. 7 ± 0.8 min. The slightly shorter 
elution time for the CP934P treated trypsin suggested that the treated trypsin might be 
of higher molecular mass compared to native trypsin. The apparent higher molecular 
mass of the treated trypsin could be due to a conformational change in the protease 
structure. It is well lmown that protein surface interaction can result in conformational 
change and loss of activity (Ghose and Bull, 1962, Tzannis et al., 1997, Norde and 
Zoungrana, 1998). The specific activity of the unbound CP934P treated trypsin being 
34% of the untreated trypsin also suggests that surface inactivation is occurring (Table 
4.2). 
Reverse phase HPLC of trypsin filtrates suggested a number of different structural 
conformations of trypsin present in the different treatments (Figure 4.9). Trypsin that 
was incubated at 37°C for 30 min had a greater number of peaks than the trypsin 
maintained and filtered at 4°C. The greater number of peaks could be due to limited 
autolysis of trypsin at the elevated temperature. A greater number of peaks were 
observed in the filtrate from the CP934P treated trypsin that was incubated at 37°C. The 
largest peak (20 min), presumably native trypsin, was not present in the filtrate from 









greater number of peaks in the filtrate from CP934P treated trypsin suggests that there 
are a greater number of conformational forms of trypsin. 
A number of kinetic models have been proposed for the adsorption and desorption of 
proteins in solution (Andrade and Hlady, 1986). The Sodequist and Walton model 
(Soderquist and Walton, 1980) is the most commonly accepted kinetic model for protein 
adsorption to surfaces (Figure 4.15). The adsorption of proteins is described by three 
stages: (1) an initial brief period where adsorption is reversible, (2) with time, adsorbed 
proteins undergo a slow conformational change and protein desorption is slow and (3) 
the more denatured adsorbed protein undergoes very slow desorption and is less likely 
to readhere. 
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Figure 4.15 Proposed kinetic mechanism for protein adsorption and denaturation 
(Soderquist and Watson, 1980). 
For proteolytic enzymes, conformational changes resulting from surface interaction 
could make them substrates for the native enzyme and result in enhanced autolysis. 
Maste et al. (1995) investigated the inactivation of the proteolytic enzyme subtilisin at 















inactivation by adsorption: (1) denatured protein on the surface is attacked by active 
enzyme on the surface, (2) denatured protein on the surface is attacked by active 
enzyme in solution (3) denatured protein at the surface is displaced by active enzyme. 
Using HPLC they measured the degree of subtilisin autolysis by determining the 
relative amount of unbound intact protein and acid soluble peptide fragments with time. 
Their results suggest that surface enhanced inactivation of subtilisin was due to the 
attack on adsorbed denatured subtilisin by subtilisin in solution (mechanism 2). 
The results of this work suggest that the lower proteolytic activity of proteases in the 
presence of polyacrylic acid is due to two processes. Firstly, direct adsorption of 
enzyme to the polymer thereby reducing the free concentration of active enzyme and 
secondly surface enhanced inactivation (Maste et al., 1995). The proposed kinetic 
model of protease inhibition by polyacrylic acid is shown in Figure 4.16. 
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Figure 4.16 Proposed routes for the inhibition of proteolytic activity in the presence of 
polyacrylic acid. A straight arrow denotes a change in state, a dashed arrow denotes 












(1) the protease is adsorbed to the polymer surface and denatured, (2) the adsorbed 
denatured protein is desorbed back into solution, (3) the denatured adsorbed protein is 
attacked by active protease, (4) the desorbed denatured protein is attacked by active 
protease in solution (Figure 4.16). 
Gel filtration, SDS-PAGE, and protein analysis of the filtrates from CP934P treated 
trypsin indicate that the loss oftryptic activity can largely be attributed to adsorption to 
the polymer and not autolysis (mechanism 1). Analysis of the filtrates for proteolytic 
activity and conformational stability (HPLC) indicated that the unbound trypsin has 
lower residual activity and present in different conformational forms. These 
observations suggest that mechanism 2 is also involved in the inhibition of proteolytic 
activity, however to a lesser extent. 
Inhibition studies showed that CP934P completely inhibited chymotrypsin activity 
towards hLHRH (Section 4.4.2.1) yet had lower binding to CP934P than trypsin 
(Section 4.4.2.2). The strong inhibitory activity of CP934P towards hLHRH was further 
supported by the unbound CP934P treated chymotrypsin having no activity towards 
BTEE (Table 4.4.). These observations suggest that mechanism 1 does not play a major 
role in the inhibition of chymotrypsin by CP934P whereas the denaturation mechanisms 
2, 3, and 4 play a greater role in inhibition. Further work is required determine whether 
this lower specific activity is solely due to conformational denaturation of the enzyme 
(mechanism 2), autolysis (mechanism 3 and 4) or a combination. 
The identification of autolysis products of trypsin in the presence of CP934P does not 
necessarily support the hypothesis of enhanced autolysis by bivalent ion chelation 
proposed by Junginger and co-workers (LueBen et al., 1996c). They based their 
hypothesis on the observed decline in proteolytic hydrolysis rate with time (LueBen et 
al., 1996c). It would appear from their control experiments that the decline in hydrolysis 
rate over time was likely to be due to deviation from substrate saturation conditions. For 
example, LueBen et al. (1995 and 1996c) measured the trypsin hydrolytic activity 
towards BABE at 1.5 mM over a 250 min period. Under similar conditions we were 













BABE by trypsin at 20 mM BABE. (Figure 4.2). During their inhibitions studies 
Junginger and co-workers demonstrated that the proteolytic activity of the CP934P 
inhibited protease could be partially elevated with the addition of calcium (LueBen et 
al., 1995). They postulated that this increase in activity was due to the replacement of 
calcium which was removed from protease by the CP934P. However, this observation 
could be due to the calcium binding to the CP934P and displacing the adsorbed 
protease. Junginger's group tested their proposed chelation mechanism by incubating 
trypsin with the strong divalent ion chelator EDTA (7.5% w/v) at pH 6.7. EDTA 
however did not effect the hydrolytic activity of trypsin towards BABE (LueBen et al., 
1996c). Junginger and co-workers suggested that the CP934P binding affinity for 
calcium is much higher than EDTA at pH 6.7. However they did not report any 
experimental evidence to support this statement. Previous work by Russin et al. (1974) 
showed that EDTA deprives trypsin of calcium only in the presence of 8 M urea, 
indicating that calcium is only accessible to chelation by EDT A after relaxation of the 
protein structure. 
4.5.2 Binding studies 
Typically, Michaelis-Menton kinetic parameters (Km, kcat, KJ are useful for determining 
the type of inhibition (non-competitive and competitive inhibition) and relative potency 
of inhibitors. These parameters however cannot be determined as the interaction 
between trypsin and CP934P is unlikely to be specific to a small number ofloci on the 
trypsin protein and the interaction will result in significant disruption of the three 
dimensional structure of trypsin. For this type of inhibition the binding capacity and 
affinity of trypsin for CP934P are more useful parameters for determining the potency 
of the CP934P to inhibit trypsin. The binding of trypsin to CP934P (0.35% w/v) at pH 
7 .0 (Section 4.4.1.6) showed a good fit to the Langmuir model (r = 0.997), with a 
binding capacity of trypsin for CP934P of30 mg/g and an affinity constant of 0.028 
ml/µg (Figure 4.10). 
The non-specific adsorption of proteins to interfaces have generally been attributed to 
electrostatic (Barroug et al., 1989), hydrophobic interactions (Elwing et al., 1987), and 



















polymer has a hydrophobic backbone and negatively charged carboxylic acid groups, 
the protein-polymer interactions can be expected to be hydrophobic, ionic or hydrogen-
bonding or a combination of these. The trypsin binding experiments showed that 
increasing the sodium chloride concentration from 50 mM to 90 mM significantly 
increased (p < 0.05) the amount of trypsin bound to CP934P whereas from 90 mM 
to150 mM sodium chloride concentration there was no significant change (p > 0.05) in 
protein binding (Figure 4.11). The enhanced adsorption of trypsin to CP934P from 50 
mM to 90 mM sodium chloride could be attributed to the reduced charge repulsions 
within and between trypsin molecules. Norde (1986) postulated that the existence of 
ions provides a less desirable environment for hydrophobic regions of the protein. 
Under these conditions, the proteins hydrophobic region is buried further into the 
interior of the protein to be away from the medium. In the presence ions the hydrophilic 
regions of the protein becomes less repulsive to each other (if oppositely charged) due 
to shielding effects of the medium. The reduced charge and the more compact trypsin 
structure allows the trypsin molecules to pack more closely on the polymer. Similarly, 
Tsai et al. (1996) postulated that the enhanced binding of the peptide calcitonin to 
poly(D,L-lactide-co-glycolide) with increasing sodium chloride concentration was due 
to the peptide being more compact with lower repulsive forces. Similar binding of 
trypsin to CP934P at 90 mM and 150 mM sodium chloride suggests that the binding 
capacity of CP934P for trypsin has been reached. However in these studies increasing 
the sodium chloride concentration will also reduce the size of the CP934P particles 
thereby reducing the surface area for protein binding (BFGoodrich, 1994b). The reduced 
CP934P particle size may also explain why there was no significant change in trypsin 
binding from 90 to 150 mM sodium chloride. 
The effect of pH on protein adsorption has been studied and generally the maximum 
adsorption occurs at or ne~ the pl of the protein (Norde, 1986, Luey et al., 1991). At its 
pl the protein will have less repulsive forces, resulting in compact packing of the protein 
and less repulsive forces between adsorbed proteins; again allowing for the adsorbing 
proteins to pack more tightly (Norde, 1986, Luey et al., 1991). As trypsin has a pl of 
approximately 10.5 (Cunningham, 1954) and CP934P has an apparent pKa value of 6. 7 






to 8 the amount of trypsin bound to CP934P will increase. However between pH 6.0 and 
8.0 there was no significant change (p > 0.05) in the amount of trypsin bound to 
CP934P. This suggests that at pH 8 the trypsin molecules are in the loose form to 
overcome intramolecular charge repulsions, rather than a compact form which promotes 
surface adsorption. 
BSA, trypsin, chymotrypsin, pepsin and SBTI (300 µg/ml) showed variable binding to 
CP934P 0.35 % (w/v) at pH 7.0 (Section 4.4.1.8). The rank order of protein binding to 
CP934P was BSA > SBTI > trypsin, chymotrypsin and pepsin. The pl values of the 
individual proteins did not correlate with their affinity for CP934P (Table 4.5). However 
work by Tsai et al. (1996) indicates that significant changes in protein adsorption only 
occurs within a range of 1-2 pH units of the protein pl. 
Table 4.5 CP934P binding, molecular weight and pl of proteins and peptides interacting 
with CP934P. 
Protein % filtereda MW pl Reference 
BSA 0 66 700 4.7 Giacomelli et al. (1997) 
SBTI 49 8 000 4.3 Birk (1985) 
Trypsin 82 23 800 10.5 Cunningham (1954) 
a-Chymotrypsin 82 23 500 9.1 Desuelle (1960) 
Pepsin 80 35 000 1.0 Borey and Yanari (1960) 
a calculate from data presented in Table 4.3 
The high binding of BSA to CP934P can be attributed to its low conformational 
stability (soft protein) (Giacomelli et al., 1997). Norde (1986) observed that the proteins 
with a relatively lower degree of conformational stability bind to variety of surfaces 
(hydrophobic or hydrophilic) even under adverse electrostatic conditions. In contrast, 
high stability proteins (hard protein) adsorb mainly on hydrophobic surfaces, whereas 
on hydrophilic surfaces only under conditions favorable to electrostatic interaction 
(Norde, 1986). In order to determine whether the conformational stability of the proteins 
is a driving force for protein binding to CP934P the relative conformation stability of 







relative conformational stability of proteins by their tendency to precipitate in varying 
amounts of ethanol in an aqueous solution. The higher binding of BSA to CP934P 
eludes to why CP934P did not inhibit trypsin activity when BSA was used as the 
substrate (Figure 4.1). Under these conditions the greater amount of BSA bound to 
CP934P will prevent trypsin from interacting with the polymer thereby remaining active 
in solution to hydrolyse the excess BSA in solution. 
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5.1 General discussion 
Oral delivery of peptide and protein drugs is the most convenient route and least intrusive 
for delivery to fish. Although the delivery of proteins and peptides across the intestine is 
difficult with respect to low mucosa! permeability and metabolic barriers (Section 1.2), it 
remains very attractive for highly potent peptide hormones. A number of investigators 
have demonstrated that the intestine of teleosts does absorb small amounts of peptides 
and proteins (Section 1.4.3). Despite the attempts to improve the oral delivery of peptides 
and proteins in teleosts (Section 1.4.4) there has been no systematic studies of the 
intestinal metabolic barriers to the oral delivery of peptides and proteins in teleosts. 
Previous studies characterising the intestinal proteases of teleosts show that they differ 
from mammalian proteases in their activity, stability, requirement for divalent ions and 
susceptibility inhibitors (Section 1.4.2). This suggests that the protease inhibitors used to 
stabilise peptides in the intestine of mammalian species may have different activities in 
teleosts. The aim of this dissertation was to study the metabolic barriers of the lower 
intestinal tract of salmon and investigate strategies to overcome this barrier to improve 
the oral bioavailability of peptide and protein drugs. 
The highly potent LHRH analogues have been used in the aquaculture industry to 
synchronise reproduction in fish (Donaldson and Hunter, 1983). To study the metabolic 
stability of human and salmon LHRH analogues in the lower intestinal tract of salmon a 
CE assay was developed (Section 2.0). Bovine a-chymotrypsin digests of human and 
salmon LHRH analogues were used to study separation and reproducibility of the CE 
assay. Sample stacking and run buffer pH were important variables in controlling 
separation and reproducibility of the assay (Sections 2.4.2 & 2.4.3). The optimum 
conditions for reproducibility and separation ofLHRH analogues from their metabolites 
were as follows: dilution of the LHRH digest 4-fold in deionised water, electrophoresis in 
10 mM sodium acetate buffer at pH 4.0 containing 75 mM sodium chloride at constant 
current of 60 µA. Under these conditions hLHRH and sLHRH eluted after 12.5 and _18.5 
min, respectively (Section 2.4.3). The CE assay offered a simple cheap assay that could 








instrument was unreliable with many instrument problems. Subsequently HPLC was also 
used to monitor the metabolic stability ofhLHRH. 
The lower intestinal tract of the salmon is divided into three anatomically distinct 
sections: the anterior, middle and posterior. The lumenal and mucosal homogenates were 
assayed for proteolytic activity towards BSA and LHRH analogues. BSA and the LHRH 
analogues were most stable in the posterior section (Sections 3.4.1.4 & 3.4.1.6). Both 
LHRH analogues had similar metabolic stabilities in each intestinal section, suggesting 
that both analogues are metabolised by the same protease (Section 3.4.1.7). The higher 
metabolic stability of BSA and LHRH analogues in the posterior intestine correlated with 
the lower hydrolytic rates towards the synthetic substrates of chymotrypsin, trypsin and 
elastase. CE oflumenal LHRH digests showed that the LHRH analogues had identical 
hydrolytic patterns in each intestinal section (Section 3.4.1.6). This suggests that the 
LHRH analogues are metabolised by the same protease(s) along the entire lower 
intestinal tract of salmon. 
The pancreatic endopeptidases, chymotrypsin, trypsin and elastase were expected to be 
the major enzymes involved in the metabolism ofLHRH analogues in the intestinal 
lumen. Incubations ofLHRH analogues with purified commercial preparations of 
a-chymotrypsin, trypsin and elastase showed that the LHRH analogues were extensively 
metabolised by bovine a-chymotrypsin, whereas the LHRH analogues were slowly 
hydrolysed by porcine elastase and bovine trypsin (Section 3.4.1.5). This suggests that 
the chymotryptic activity of the salmon intestinal lumen is the major lumenal metabolic 
barrier to the oral delivery LHRH analogues to salmon. 
Protease inhibitors are commonly used to increase the metabolic stability of peptides and 
proteins in the intestinal lumen to increase their opportunity for absorption across the 
intestinal epithelium. Different classes of protease inhibitors, including EDTA, C934P, 
DOC and SBTI, were tested for their ability to stablise the LHRH analogues in the 













inhibitor in stabilising the LHRH analogues against the lumenal proteolytic activity of the 
salmon intestine. The high inhibitory activity of SBTI (Seidl and Liener, 1972), a well 
known inhibitor of chymotrypsin, supports the hypothesis that chymotrypsin is the major 
protease involved in the metabolism of LHRH analogues in the intestinal lumen. 
To understand how the mucosal membrane peptidases may influence bioavailability of 
peptide and proteins, the stability of BSA and LHRH analogues were compared in 
mucosal homogenates prepared from the middle and posterior intestinal sections. 
Proteolytic activity of the posterior mucosal homogenate was 4-fold higher than that 
observed for the middle mucosal homogenate (Section 3.4.2.3). Mucosal enzymes of the 
posterior section hydrolysed the LHRH analogues, whereas for the middle mucosal 
homogenate had no hydrolytic activity towards the LHRH analogues (Section 3.4.2.2). 
The LHRH analogues had similar metabolic stabilities in the posterior mucosal 
homogenates, suggesting the same protease(s) are involved in their metabolism. 
The non-specific proteolytic inhibitors DOC, EDTA and the aminopeptidase specific 
inhibitor bestatin significantly inhibited (p < 0.005) the mucosal hydrolytic activity 
towards the LHRH analogues (Section 3.4.3.5). Despite the LHRH analogues being N-
and C- terminally blocked, the inhibitory activity ofbestatin, suggests that 
aminopeptidases are involved in the mucosal metabolism of the LHRH analogues 
(Section 3.4.3.5). However this anomaly was not investigated in this work. 
The higher proteolytic activity of the posterior mucosal homogenate towards BSA and 
the LHRH analogues correlated with higher activity towards the chymotryptic substrate 
N-benzoyl-L-Tyr ethyl ester. The lack of inhibition of mucosal proteolytic activity 
towards the LHRH analogues by the SBTI indicates that this activity is not due to 
pancreatic chymotrypsin activity. Previous studies suggests that this activity is due to the 
membrane bound protease endopeptidase 24.18 (Sterchi et al., 1982) which has also been 







In comparison to the middle intestinal LHRH proteolytic activity, the posterior intestinal 
section has lower lumenal activity but higher mucosa! activity. In order to determine 
which section is most metabolically favorable for the oral delivery of the LHRH 
analogues, the combined activities of the lumen and mucosa in each section must be 
considered. However the in vitro kinetics of proteolysis is likely to be quite different to in 
vivo. The activity towards the substrate will depend on its concentration. In this study the 
in vitro proteolysis ofLHRH was determined at 0.2 mM, a concentration is considerably 
higher than that expected in vivo after oral delivery of peptide. To estimate the catalytic 
activity towards a substrate at different substrate concentrations, the K.i1 (Michaelis-
Menton constant) and kcat (catalytic turnover) values of the proteolytic enzyme must be 
determined. However these values could not be determined for crude homogenates as 
they can only be determined by using purified enzyme preparations in vitro. Obviously, 
the concentrations of the lumenal proteases in vivo are also going to determine proteolytic 
activity towards the LHRH analogues. The in vitro lumenal activity towards the LHRH 
was determined at a protein concentration of 5 µg/ml (Section 3 .4.1.6), whereas the in 
vivo concentrations of proteins in the lumen are expected to be in the range of 5-10 mg/ml 
(Section 3.4.1.3). In addition, homogenisation of intestinal extracts may alter the activity 
of the enzymes, particularly intestinal membrane-bound proteases, which have been 
dislodged from their membrane. The true metabolic barrier of the intestinal tract can only 
be determined in vivo, however Schep et al. (1997) has shown that there are also regional 
differences in permeability of the salmonid lower intestine to the hydrophilic marker 
mannitol. To account for these regional differences in intestinal permeability the 
adsorption of the LHRH analogues could be related to the permeability of the intestine to 
mannitol. Mannitol is believed to be absorbed across membranes by the same route as 
peptides (Nellans, 1991, Ma et al., 1993, Sakai et al., 1997) and is not influenced by the 
metabolic barrier. 
Dispersions of CP934P (0.35 % w/v, pH 8.0 at 15°C) were not as effective at inhibiting 
proteolytic activity of the salmon intestinal lumen compared with purified pancreatic 









LHRH hydrolysis remained constant in the presence of CP934P, indicating no autolysis 
in contrast to that postulated by Lue13en et al. (1995). Commercial preparations of bovine 
trypsin and a-chymotrypsin were used to investigate the effect of proteolytic inhibition 
by enhanced autolysis in the presence of CP934P. Dispersions of CP934P (0.35 % w/v, 
pH 7.0 at 37°C) inhibited the proteolytic activity of bovine trypsin and chymotrypsin. In 
the presence ofCP934P, hydrolysis ofBAEE and hLHRH by trypsin was reduced to 34% 
and 28% of control activity, respectively (Section 4.4.1.1 ). The rates of substrate 
hydrolysis followed pseudo-zero kinetics, again indicating that inhibitions were not due 
to elevated autolysis of the enzyme. Under the same conditions, hLHRH was stablised 
against the activity of bovine a-chymotrypsin (Section 4.4.2.1 ). 
Binding studies using centrifugal filtration, showed binding of trypsin ( 68% bound), 
chymotrypsin (22%) at 50 µg/ml and BABE (10%) at 20 mM to CP934P (0.35% w/v, pH 
7.0), whereas no LHRH (0.4 mM) was bound (Tables 4.2 & 4.4). This suggests that 
CP934P reduces proteolytic activity by binding the proteases, thereby reducing the free 
concentration of protease available to hydrolyse the proteolytic substrates. However the 
lower relative specific activities of the filtrates suggests that surface inactivation of the 
proteases is also occurring (Tables 4.2 & 4.4). Chymotrypsin appeared to be more 
susceptible than trypsin to inactivation; the unbound CP934P treated chymotrypsin had 
no hydrolytic activity, whereas the unbound trypsin had a relative specific activity of 34% 
(Tables 4.2 & 4.4). Analysis of the unbound trypsin by gel filtration indicated that 
inhibition was due to trypsin binding to the polymer rather than elevated autolysis 
(Section 4.4.1.4). SDS-PAGE (Section 4.4.1.3) and reverse phase HPLC (Section 4.4.1.5) 
further supported lack of autolysis so suggesting in inhibition as being due to the binding 
of trypsin to CP934P. Reverse phase chromatography of the filtrates also showed that 
trypsin exists in a greater number of conformational forms in the presence of CP934P 
(Section .4.4.1.5). This suggests that the lower relative specific activity of the unbound 
trypsin is due to surface inactivation, resulting in irreversible confo1mational changes of 











A kinetic model was proposed for the inhibition of proteolytic activity by polyacrylic 
acids (Section 4.5). This model consists of four mechanisms: (1) the protease is adsorbed 
to the polymer surface and denatured (2) the adsorbed denatured protein is desorbed back 
into solution (3) the denatured desorbed protein is attacked by active protease and ( 4) the 
adsorbed denatured protein is attacked by active proteases in solution. 
Since Michaelis-Menton kinetic parameters cannot not be used for this type of inhibition, 
the binding capacity and affinity of trypsin for CP934P were determined. The trypsin 
adsorption data obtained fitted well to a Langmuir isotherm (Section 4.4.1.6). The 
equilibrium binding capacity of trypsin to CP934P (0.35% w/v) at pH 7.0 was 30 mg/g 
with an affinity constant of 0.028 ml/µg (Figure 4.10). 
The effect of sodium chloride concentration and pH on the binding of trypsin to CP934P 
was investigated to shed some understanding of the mechanism of binding and to 
determine what effect these variables might have on CP934P inhibition of trypsin activity 
in the salmon intestine (Section 4.4.1. 7). Preliminary studies showed that from 50 mM to 
90 mM sodium chloride concentration at pH 7.0 the amount of trypsin bound to CP934P 
significantly increased (p < 0.05) whereas from 90 mM to 150 mM sodium chloride there 
was no significant change in trypsin binding (p > 0.05). The higher binding of trypsin to 
CP934P from 50 mM to 90 mM sodium chloride concentration may be due to the trypsin 
molecule being more compact with lower repulsive forces, allowing the adsorbed proteins 
to pack more closely on the polymer (Norde 1986, Tsai et al., 1996). The similar binding 
of trypsin to CP934P at 90 mM and 150 mM suggests that maximum binding capacity of 
CP934P for trypsin has been reached. However increasing the sodium chloride 
concentration may also influence binding by reducing the size of the CP934P particles 
(BFGoodrich, 1994b). To overcome the effect of particle size, future binding studies 














It has been postulated that near the pl of the protein the repulsive forces within and 
between the protein are minimised, thereby reducing the interspace to overcome the 
repulsive force on adsorption (Norde, 1986). Since trypsin has a pl of approximately 10.5 
(Cunningham, 1954) it was therefore expected that trypsin binding to CP934P would 
increase from pH 6 to 8. However binding studies showed that there was no significant 
change (p > 0.2) in trypsin binding to CP934P over the pH range 6 to 8. This suggests 
that there is little change in the repulsive forces within and between trypsin molecules 
between pH 6 and 8. This work suggests that the pH range tested is not sufficiently close 
to the pl of trypsin to enhance adsorption of trypsin to CP934P. Calcitonin which has a pl 
around 9.4, was shown to have maximum adsorption to poly(D,L-lactide-co-glycolide in 
the 7.4 to 10 pH range (Tsai et al., 1996). Trypsin binding to CP934P should be test in 
the 8-10 pH range to determine whether maximum adsorption of trypsin occurs near its 
pl. It is expected that the size of the CP934P particles would not change over the 6-10 pH 
range and therefore will not effect trypsin binding to CP934P (BFGoodrich, 1994b). 
BSA, SBTI, trypsin, chymotrypsin and pepsin (300 µg/ml) showed variable binding to 
CP934P (0.35 % w/v, 50 rnM NaCl, at pH 7). CP934P had the highest binding for BSA, 
followed by soybean trypsin inhibitor and then trypsin, chymotrypsin and pepsin, with 
similar binding. The binding of the proteins did not correlate with the protein pl or 
molecular weight (Table 4.5). The reason for the poor relationship between pl and protein 
adsorption at pH 7 could be due to the pis of the proteins tested being more than 2 pH 
units away from pH 7. Previous work by Tsai et al. (1996) indicates that for significant 
changes in protein adsorption near the protein pl, the pH of the medium has to be within 
1-2 pH units of the protein pl. The high binding for BSA, may be due to its low 
conformational stability (BSA), since proteins with low conformational stability have 















5.2 Future perspectives 
The next stage of this work should assess the use of proteolytic inhibitors in improving 
the oral absorption ofLHRH analogues in vivo. This could be determined by the in vivo 
model developed by Schep (1999); in this model the salmon posterior intestine would be 
perfused enabling direct delivery ofLHRH and inhibitors to the posterior intestine. 
A number of parameters have to be considered in order to relate the in vitro inhibitory 
performance of CP934P dispersions to their in vivo performance. The components of the 
intestinal fluid, which could affect protease-polymer interaction, include: bile salts, 
proteins, sodium, potassium and calcium ions and their associated ions. The variable 
affinities of different proteins for CP934P suggest that lumenal proteases will have to 
compete with other lumenal proteins for binding to CP934P (Section 4.4.1.8). This effect 
was observed when CP934P was unable to inhibit trypsin activity in the presence of BSA 
(Figure 4.1). BSA was added to the incubate as the proteolytic substrate, however the 
higher CP934P binding of BSA compared to trypsin (Table 4.3) suggests that BSA 
displaced the CP934P bound trypsin to hydrolyse the excess unbound BSA. Given this it 
is expected that the composition and concentration of lumenal proteins will have a major 
influence on the ability of CP934P to protect peptides from metabolic attack in vivo. The 
in vitro CP934P inhibitory assays described could be used to suggest what effects these 
components would have on the in vivo inhibitory activity of CP934P. Individual 
components could be assayed at concentrations similar to those of the intestinal lumen 
and the inhibitory activity of CP934P towards various purified lumenal proteases would 
be tested. The inhibitory activities would be tested against the major lumenal proteases 
including, trypsin, chymotrypsin and elastase. 
In addition to using protease inhibitors to improve the oral absorption of peptides, a 
number of other strategies need to be investigated (Section 1.3). Intestinal regions with 
low proteolytic activity maybe targeted for peptide drug delivery (Section 3 .4.1 ). This 
work indicates that the posterior lumen is most favorable for LHRH delivery however the 






delivery systems use lumenal pH, gut enzymes or gut transit times to target specific 
regions of the intestine (Section 1.3.4) these parameters need to be investigated in salmon 
in order to delivery peptide drugs to specific regions of the intestine. Recent experiments 
by Schep (1998) demonstrate that the permeation of the salmonid posterior intestine to 
the hydrophilic marker mannitol was enhanced in the presence of DOC, suggesting that 
inclusion of DOC in oral formulations could also improve the oral absorption of peptides 
in salmon. Future investigations should also study analogues that are more resistant to 
metabolic degradation. McLean et al. (1991) showed that the oral delivery of the LHRH 
analogue des-Gly10[Ala6] LHRH ethylamide to salmon resulted in a 100-fold increase in 
peak plasma concentrations of the peptide compared to native LHRH. In order to achieve 
higher levels of orally absorbed peptide in salmon it is likely that a combination of all 
these strategies will be required. 
In conclusion, this thesis has demonstrated in vitro that there are regional differences in 
proteolytic activities of the lower intestinal tract of salmon towards BSA and LHRH 
analogues. The in vitro proteolytic stabilities of BSA and LHRH analogues can be 
improve by protease inhibitors. Therefore the addition of protease inhibitors in oral 
formulations could be useful in improving the oral bioavailabilities of peptides and 
proteins in salmon. In vitro metabolic studies show that polyacrylic acids inhibit 
proteases by protease-polymer interaction. A better understanding of the underlying 
mechanisms of proteolytic inhibition by acrylic acid polymers could lead to improved 
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